<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="634b4630-2dc7-4cae-9af1-036da98c608a"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <title>These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. <br/>
      <br/> HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use<br/> Initial U.S. Approval: 1996
</title>
   <effectiveTime value="20250401"/>
   <setId root="c6b8ff07-d3e2-457f-8a38-b60de60adf75"/>
   <versionNumber value="24"/>
   <author>
      <assignedEntity>
         <representedOrganization>
            <id extension="830016429" root="1.3.6.1.4.1.519.1"/>
            <name>A-S Medication Solutions</name>
            <assignedEntity>
               <assignedOrganization>
                  <assignedEntity>
                     <assignedOrganization>
                        <id extension="830016429" root="1.3.6.1.4.1.519.1"/>
                        <name>A-S Medication Solutions</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C73607" displayName="RELABEL" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="50090-1375" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C73607" displayName="RELABEL" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="50090-1663" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section ID="dcl-dpl">
               <id root="39cddf7e-cba5-4f0a-a3d1-1d7a55cbb62a"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL PRODUCT DATA ELEMENTS SECTION"/>
               <effectiveTime value="20240806"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="50090-1375" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>HUMALOG</name>
                        <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>Insulin lispro</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <asEquivalentEntity classCode="EQUIV">
                           <code code="C64637" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <definingMaterialKind>
                              <code code="0002-7510" codeSystem="2.16.840.1.113883.6.69"/>
                           </definingMaterialKind>
                        </asEquivalentEntity>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="[iU]" value="100"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="GFX7QIS1II" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>INSULIN LISPRO</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="GFX7QIS1II" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>INSULIN LISPRO</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator unit="mg" value="1.0"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="GR686LBA74" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Sodium Phosphate, Dibasic, Unspecified Form</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator unit="mg" value="16"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="PDC6A3C0OX" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Glycerin</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator unit="mg" value="3.15"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="GGO4Y809LO" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Metacresol</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="339NCG44TV" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Phenol</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator unit="mg" value=".0197"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="J41CSQ7QDS" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Zinc</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Water</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="QTT17582CB" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Hydrochloric acid</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="55X04QC32I" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Sodium hydroxide</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="10" unit="mL"/>
                              <denominator value="1" unit="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <formCode code="C43226" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="VIAL"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="1" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="50090-1375-0" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20141128"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" xsi:type="CV" displayName="Type 0: Not a Combination Product"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="19960614"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <subjectOf>
                        <approval>
                           <id extension="BLA020563" root="2.16.840.1.113883.3.150"/>
                           <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INTRAVENOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="50090-1663" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Humalog<suffix>KwikPen
</suffix>
                        </name>
                        <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>Insulin lispro</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <asEquivalentEntity classCode="EQUIV">
                           <code code="C64637" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <definingMaterialKind>
                              <code code="0002-8799" codeSystem="2.16.840.1.113883.6.69"/>
                           </definingMaterialKind>
                        </asEquivalentEntity>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="[iU]" value="100"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="GFX7QIS1II" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>INSULIN LISPRO</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="GFX7QIS1II" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>INSULIN LISPRO</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator unit="mg" value="16"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="PDC6A3C0OX" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Glycerin</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator unit="mg" value="1.88"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="GR686LBA74" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Sodium Phosphate, Dibasic, Unspecified Form</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator unit="mg" value="3.15"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="GGO4Y809LO" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Metacresol</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator unit="mg" value=".0197"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="J41CSQ7QDS" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Zinc</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="339NCG44TV" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Phenol</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Water</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="QTT17582CB" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Hydrochloric acid</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="55X04QC32I" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Sodium hydroxide</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="3" unit="mL"/>
                              <denominator value="1" unit="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <formCode code="C43202" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SYRINGE"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="5" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="50090-1663-0" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20150123"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C102836" codeSystem="2.16.840.1.113883.3.26.1.1" xsi:type="CV" displayName="Type 3: Prefilled Biologic Delivery Device/System (syringe, patch, etc.)"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20070906"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <subjectOf>
                        <approval>
                           <id extension="BLA020563" root="2.16.840.1.113883.3.150"/>
                           <code code="C73585" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INTRAVENOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section ID="s1">
               <id root="f5779c84-325e-476c-a8e5-5620f204ad08"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>1 INDICATIONS AND USAGE
</title>
               <text>
                  <paragraph>HUMALOG is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.
</paragraph>
               </text>
               <effectiveTime value="20230721"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>HUMALOG is a rapid acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. (<linkHtml href="#s1">1</linkHtml>)
</paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="s2">
               <id root="6ba743e0-fdbf-40d3-94ab-16b6afa46076"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>2 DOSAGE AND ADMINISTRATION
</title>
               <effectiveTime value="20230721"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered" styleCode="Disc">
                           <item>See Full Prescribing Information for important administration instructions. (<linkHtml href="#s3">2.1</linkHtml>, <linkHtml href="#s4">2.2</linkHtml>, <linkHtml href="#s9">2.3</linkHtml>, <linkHtml href="#s10">2.4</linkHtml>)
</item>
                           <item>Subcutaneous injection (<linkHtml href="#s4">2.2</linkHtml>):<list listType="unordered" styleCode="Circle">
                                 <item>Administer HUMALOG<sup>®</sup> U-100 or U-200 by subcutaneous injection into the abdominal wall, thigh, upper arm, or buttocks within 15 minutes before a meal or immediately after a meal.
</item>
                                 <item>Rotate injection sites to reduce risk of lipodystrophy and localized cutaneous amyloidosis.
</item>
                              </list>
                           </item>
                           <item>Continuous subcutaneous infusion (Insulin Pump) (<linkHtml href="#s4">2.2</linkHtml>):<list listType="unordered" styleCode="Circle">
                                 <item>Refer to the insulin infusion pump user manual to see if HUMALOG can be used. Use in accordance with the insulin pump instructions for use.
</item>
                                 <item>Administer HUMALOG U-100 by continuous subcutaneous infusion using an insulin pump in a region recommended in the instructions from the pump manufacturer.
</item>
                                 <item>Rotate infusion sites to reduce risk of lipodystrophy and localized cutaneous amyloidosis.
</item>
                                 <item>DO NOT administer HUMALOG U-200 by continuous subcutaneous infusion.
</item>
                              </list>
                           </item>
                           <item>Intravenous Infusion (<linkHtml href="#s4">2.2</linkHtml>):<list listType="unordered" styleCode="Circle">
                                 <item>Administer HUMALOG U-100 by intravenous infusion ONLY after dilution and under medical supervision. DO NOT administer HUMALOG U-200 by intravenous infusion.
</item>
                              </list>
                           </item>
                           <item>The dosage of HUMALOG must be individualized based on the route of administration and the individual's metabolic needs, blood glucose monitoring results and glycemic control goal. (<linkHtml href="#s9">2.3</linkHtml>)
</item>
                           <item>Do not perform dose conversion when using the HUMALOG U-100 or U-200 prefilled pens. The dose window shows the number of insulin units to be delivered and no conversion is needed. (<linkHtml href="#s3">2.1</linkHtml>, <linkHtml href="#s9">2.3</linkHtml>)
</item>
                           <item>Do not mix HUMALOG U-200 with any other insulin. (<linkHtml href="#s10">2.4</linkHtml>)
</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="s3">
                     <id root="a25c357a-e784-4a13-b32f-da058a4039ca"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.1 Important Administration Instructions
</title>
                     <text>
                        <list listType="unordered" styleCode="Disc">
                           <item>Always check insulin labels before administration <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s20">5.4</linkHtml>)]</content>.
</item>
                           <item>Inspect HUMALOG visually before use. It should appear clear and colorless. Do not use HUMALOG if particulate matter or coloration is seen.
</item>
                           <item>Use HUMALOG prefilled pens with caution in patients with visual impairment that may rely on audible clicks to dial their dose.
</item>
                           <item>Do NOT mix HUMALOG U-100 with other insulins when using a continuous subcutaneous infusion pump.
</item>
                           <item>Do NOT transfer HUMALOG U-200 from the prefilled pen to a syringe for administration <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s20">5.4</linkHtml>)]</content>.
</item>
                           <item>Do NOT perform dose conversion when using any HUMALOG U-100 or U-200 prefilled pens. The dose window shows the number of insulin units to be delivered and no conversion is needed.
</item>
                        </list>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
               <component>
                  <section ID="s4">
                     <id root="628817eb-55e2-4928-bb2e-c6456ea9ef81"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.2 Administration Instructions for the Approved Routes of Administration
</title>
                     <effectiveTime value="20230721"/>
                     <component>
                        <section ID="s5">
                           <id root="1b6e8916-1998-454a-8433-44cbf190f76d"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Subcutaneous Injection: HUMALOG U-100 or U-200</content>
                              </paragraph>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Administer the dose of HUMALOG U-100 or HUMALOG U-200 within fifteen minutes before a meal or immediately after a meal by injection into the subcutaneous tissue of the abdominal wall, thigh, upper arm, or buttocks.
</item>
                                 <item>Rotate the injection site within the same region from one injection to the next (abdominal wall, thigh, upper arm, or buttocks) to reduce the risk of lipodystrophy and localized cutaneous amyloidosis. Do not inject into areas of lipodystrophy or localized cutaneous amyloidosis <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s16">5.2</linkHtml>) and Adverse Reactions (<linkHtml href="#s25">6</linkHtml>)]</content>.
</item>
                                 <item>During changes to a patient's insulin regimen, increase the frequency of blood glucose monitoring <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s16">5.2</linkHtml>)]</content>.
</item>
                                 <item>HUMALOG administered by subcutaneous injection should generally be used in regimens with an intermediate- or long-acting insulin.
</item>
                                 <item>The HUMALOG U-100 KwikPen, HUMALOG U-100 Tempo Pen and HUMALOG U-200 KwikPen each dial in 1 unit increments and delivers a maximum dose of 60 units per injection.
</item>
                                 <item>The HUMALOG U-100 Junior KwikPen dials in 0.5 unit increments and delivers a maximum dose of 30 units per injection.
</item>
                              </list>
                           </text>
                           <effectiveTime value="20230721"/>
                        </section>
                     </component>
                     <component>
                        <section ID="s6">
                           <id root="5441d977-6dd5-43c8-bcf8-934b6bc08ada"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Subcutaneous Injection: Diluted HUMALOG U-100</content>
                              </paragraph>
                              <list listType="unordered" styleCode="Disc">
                                 <item>HUMALOG U-100 may be diluted with Sterile Diluent for HUMALOG for subcutaneous injection ONLY under medical supervision. Dilute one part HUMALOG U-100 to:<list listType="unordered" styleCode="Circle">
                                       <item>Nine parts diluent to yield a concentration one-tenth that of HUMALOG U-100 (equivalent to U-10).
</item>
                                       <item>One part diluent to yield a concentration one-half that of HUMALOG U-100 (equivalent to U-50).
</item>
                                    </list>
                                 </item>
                                 <item>Diluted HUMALOG for subcutaneous injection may be stored for 28 days when refrigerated at 41°F (5°C) and for 14 days at room temperature up to 80°F (30°C).
</item>
                              </list>
                           </text>
                           <effectiveTime value="20230721"/>
                        </section>
                     </component>
                     <component>
                        <section ID="s7">
                           <id root="6529d66e-567b-4c90-9b37-515bbe0a97bb"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Continuous Subcutaneous Infusion (Insulin Pump): HUMALOG U-100 ONLY</content>
                              </paragraph>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Do NOT administer HUMALOG U-200 using a continuous subcutaneous infusion pump.
</item>
                                 <item>Refer to the continuous subcutaneous insulin infusion pump user manual to see if HUMALOG can be used with the insulin pump. Use HUMALOG in accordance with the insulin pump system's instructions for use.
</item>
                                 <item>Administer HUMALOG U-100 by continuous subcutaneous infusion in a region recommended in the instructions from the pump manufacturer. Rotate infusion sites within the same region to reduce the risk of lipodystrophy and localized cutaneous amyloidosis. Do not inject into areas of lipodystrophy or localized cutaneous amyloidosis <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s16">5.2</linkHtml>) and Adverse Reactions (<linkHtml href="#s25">6</linkHtml>)]</content>.
</item>
                                 <item>Train patients using continuous subcutaneous insulin infusion therapy to administer insulin by injection and have alternate insulin therapy available in case of insulin pump failure <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s24">5.8</linkHtml>)].</content>
                                 </item>
                                 <item>During changes to a patient's insulin regimen, increase the frequency of blood glucose monitoring <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s16">5.2</linkHtml>)]</content>.
</item>
                                 <item>Change HUMALOG U-100 in the pump reservoir at least every 7 days or according to the pump user manual, whichever is shorter.
</item>
                                 <item>Change the infusion set and the infusion set insertion site according to the manufacturer's user manual.
</item>
                                 <item>Do NOT dilute or mix HUMALOG U-100 when administering by continuous subcutaneous infusion.
</item>
                                 <item>Do NOT expose HUMALOG U-100 in the pump reservoir to temperatures greater than 98.6°F (37°C).
</item>
                              </list>
                           </text>
                           <effectiveTime value="20230721"/>
                        </section>
                     </component>
                     <component>
                        <section ID="s8">
                           <id root="2ca3b43f-fab5-4cc8-8d89-cf8b357ae543"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Intravenous Administration: HUMALOG U-100 ONLY</content>
                              </paragraph>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Do NOT administer HUMALOG U-200 intravenously.
</item>
                                 <item>Administer HUMALOG U-100 intravenously ONLY under medical supervision with close monitoring of blood glucose and potassium levels to avoid hypoglycemia and hypokalemia <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s17">5.3</linkHtml>, <linkHtml href="#s22">5.6</linkHtml>)]</content>.
</item>
                                 <item>Dilute HUMALOG U-100 to concentrations from 0.1 unit/mL to 1.0 unit/mL using 0.9% Sodium Chloride Injection, USP.
</item>
                                 <item>Infusion bags prepared with HUMALOG U-100 are stable when stored in a refrigerator (2° to 8°C [36° to 46°F]) for 48 hours and then may be used at room temperature for up to an additional 48 hours.
</item>
                              </list>
                           </text>
                           <effectiveTime value="20230721"/>
                        </section>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="s9">
                     <id root="001aade5-e5a4-4408-8bf4-db4312b7f26f"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.3 Dosage Recommendations
</title>
                     <text>
                        <list listType="unordered" styleCode="Disc">
                           <item>Individualize and adjust the dosage of HUMALOG based on route of administration, the individual's metabolic needs, blood glucose monitoring results and glycemic control goal.
</item>
                           <item>When switching from another insulin to HUMALOG, a different dosage of HUMALOG may be needed <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s16">5.2</linkHtml>)]</content>.
</item>
                           <item>Dosage modifications may be needed with changes in physical activity, changes in meal patterns (i.e., macronutrient content or timing of food intake), changes in renal or hepatic function or during acute illness <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s16">5.2</linkHtml>, <linkHtml href="#s17">5.3</linkHtml>) and Use in Specific Populations (<linkHtml href="#s51">8.6</linkHtml>, <linkHtml href="#s52">8.7</linkHtml>)]</content>.
</item>
                           <item>Do NOT perform dose conversion when using any HUMALOG U-100 or U-200 prefilled pens. The dose window shows the number of insulin units to be delivered and no conversion is needed.
</item>
                        </list>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
               <component>
                  <section ID="s10">
                     <id root="5b6ffb1a-4877-43f6-8a8b-59867d3116bb"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.4 Dosage Modifications for Drug Interactions
</title>
                     <text>
                        <paragraph>Dosage modification may be needed when HUMALOG is used concomitantly with certain drugs <content styleCode="italics">[see Drug Interactions (<linkHtml href="#s38">7</linkHtml>)]</content>.
</paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
               <component>
                  <section ID="s11">
                     <id root="f97ad095-9b69-4b3a-a31e-a3002cc33f92"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.5 Instructions for Mixing with Other Insulins
</title>
                     <text>
                        <paragraph>The table below includes administration instructions regarding mixing HUMALOG U-100 and HUMALOG U-200 with other insulins.
</paragraph>
                        <table width="100%">
                           <col width="50.000%" align="left"/>
                           <col width="50.000%" align="left"/>
                           <tbody>
                              <tr>
                                 <td align="left" valign="middle" styleCode="Toprule Botrule Lrule Rrule">
                                    <content styleCode="bold">HUMALOG U-100 subcutaneous injection route</content>
                                 </td>
                                 <td align="left" valign="top" styleCode="Toprule Botrule Rrule">
                                    <list listType="unordered" styleCode="Disc">
                                       <item>HUMALOG U-100 may be mixed with NPH insulin preparations <content styleCode="underline">ONLY</content>.
</item>
                                       <item>If HUMALOG U-100 is mixed with NPH insulin, HUMALOG U-100 should be drawn into the syringe first. Injection should occur immediately after mixing.
</item>
                                    </list>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="left" valign="middle" styleCode="Botrule Lrule Rrule">
                                    <content styleCode="bold">HUMALOG U-100 continuous subcutaneous infusion route (Insulin Pump)</content>
                                 </td>
                                 <td align="left" valign="top" styleCode="Botrule Rrule">
                                    <content styleCode="underline">Do NOT mix</content> HUMALOG U-100 with any other insulin.
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="middle" styleCode="Botrule Lrule Rrule">
                                    <content styleCode="bold">HUMALOG U-200 subcutaneous injection route</content>
                                 </td>
                                 <td align="left" valign="top" styleCode="Botrule Rrule">
                                    <content styleCode="underline">Do NOT mix</content> with any other insulin.
</td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s12">
               <id root="f4023fae-6418-4819-82e9-9a07e1bfe5a4"/>
               <code code="43678-2" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE FORMS &amp; STRENGTHS SECTION"/>
               <title>3 DOSAGE FORMS AND STRENGTHS
</title>
               <text>
                  <paragraph>Injection: 100 units/mL (U-100) clear and colorless solution available as:
</paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>10 mL multiple-dose vial
</item>
                     <item>3 mL multiple-dose vial
</item>
                     <item>3 mL single-patient-use KwikPen prefilled pen
</item>
                     <item>3 mL single-patient-use Tempo Pen prefilled pen
</item>
                     <item>3 mL single-patient-use Junior KwikPen prefilled pen
</item>
                     <item>3 mL single-patient-use cartridges
</item>
                  </list>
                  <paragraph>Injection: 200 units/mL (U-200) clear and colorless solution available as:
</paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>3 mL single-patient-use KwikPen prefilled pen
</item>
                  </list>
               </text>
               <effectiveTime value="20230721"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>Injection: 100 units/mL (U-100) is available as: (<linkHtml href="#s12">3</linkHtml>)
</paragraph>
                        <list listType="unordered" styleCode="Disc">
                           <item>10 mL multiple-dose vial
</item>
                           <item>3 mL multiple-dose vial
</item>
                           <item>3 mL single-patient-use KwikPen<sup>®</sup> prefilled pen
</item>
                           <item>3 mL single-patient-use Tempo Pen™ prefilled pen
</item>
                           <item>3 mL single-patient-use Junior KwikPen<sup>®</sup> prefilled pen
</item>
                           <item>3 mL single-patient-use cartridges
</item>
                        </list>
                        <paragraph>Injection: 200 units/mL (U-200) is available as: (<linkHtml href="#s12">3</linkHtml>)
</paragraph>
                        <list listType="unordered" styleCode="Disc">
                           <item>3 mL single-patient-use KwikPen<sup>®</sup> prefilled pen
</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="s13">
               <id root="2f7e295e-b268-4402-a473-dcd5bcb67db2"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>4 CONTRAINDICATIONS
</title>
               <text>
                  <paragraph>HUMALOG is contraindicated:
</paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>during episodes of hypoglycemia <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s17">5.3</linkHtml>)]</content>.
</item>
                     <item>in patients who are hypersensitive to insulin lispro or to any of the excipients in HUMALOG <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s21">5.5</linkHtml>)]</content>.
</item>
                  </list>
               </text>
               <effectiveTime value="20230721"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered" styleCode="Disc">
                           <item>Do not use during episodes of hypoglycemia. (<linkHtml href="#s13">4</linkHtml>)
</item>
                           <item>Do not use in patients with hypersensitivity to insulin lispro or any of the excipients in HUMALOG. (<linkHtml href="#s13">4</linkHtml>)
</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="s14">
               <id root="6c116ad4-c11e-4883-b7e2-d12dd55d9607"/>
               <code code="43685-7" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS AND PRECAUTIONS SECTION"/>
               <title>5 WARNINGS AND PRECAUTIONS
</title>
               <effectiveTime value="20230721"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered" styleCode="Disc">
                           <item>
                              <content styleCode="italics">Never share</content> a HUMALOG prefilled pen, cartridge, reusable pen compatible with Lilly 3 mL cartridges, or syringe between patients, even if the needle is changed. (<linkHtml href="#s15">5.1</linkHtml>)
</item>
                           <item>
                              <content styleCode="italics">Hyperglycemia or Hypoglycemia with Changes in Insulin Regimen:</content> Make changes to a patient's insulin regimen (e.g., insulin strength, manufacturer, type, injection site or method of administration) under close medical supervision with increased frequency of blood glucose monitoring. (<linkHtml href="#s16">5.2</linkHtml>)
</item>
                           <item>
                              <content styleCode="italics">Hypoglycemia:</content> May be life-threatening. Monitor blood glucose and increase monitoring frequency with changes to insulin dosage, use of glucose lowering medications, meal pattern, physical activity; in patients with renal or hepatic impairment; and in patients with hypoglycemia unawareness. (<linkHtml href="#s17">5.3</linkHtml>, <linkHtml href="#s38">7</linkHtml>, <linkHtml href="#s51">8.6</linkHtml>, <linkHtml href="#s52">8.7</linkHtml>)
</item>
                           <item>
                              <content styleCode="italics">Hypoglycemia Due to Medication Errors:</content> Accidental mix-ups between insulin products can occur. Instruct patients to check insulin labels before injection. Do not transfer HUMALOG U-200 from the HUMALOG KwikPen to a syringe as overdosage and severe hypoglycemia can result. (<linkHtml href="#s20">5.4</linkHtml>)
</item>
                           <item>
                              <content styleCode="italics">Hypersensitivity Reactions:</content> May be life-threatening. Discontinue HUMALOG, monitor and treat if indicated. (<linkHtml href="#s21">5.5</linkHtml>)
</item>
                           <item>
                              <content styleCode="italics">Hypokalemia:</content> May be life-threatening. Monitor potassium levels in patients at risk of hypokalemia and treat if indicated. (<linkHtml href="#s22">5.6</linkHtml>)
</item>
                           <item>Fluid <content styleCode="italics">Retention and Heart Failure with Concomitant Use of Thiazolidinediones (TZDs):</content> Observe for signs and symptoms of heart failure; consider dosage reduction or discontinuation if heart failure occurs. (<linkHtml href="#s23">5.7</linkHtml>)
</item>
                           <item>
                              <content styleCode="italics">Hyperglycemia and Ketoacidosis Due to Insulin Pump Device Malfunction:</content> Monitor glucose and administer HUMALOG U-100 by subcutaneous injection if pump malfunction occurs. (<linkHtml href="#s24">5.8</linkHtml>)
</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="s15">
                     <id root="a8a40bfa-1238-43ae-b250-d17f3659cd92"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.1 Never Share a HUMALOG Prefilled Pen, Cartridge, Reusable Pen Compatible with Lilly 3 mL Cartridges<sup>1</sup>, or Syringe Between Patients
</title>
                     <text>
                        <paragraph>HUMALOG prefilled pens, cartridges, and reusable pens compatible with Lilly 3 mL cartridges must never be shared between patients, even if the needle is changed. Patients using HUMALOG vials must never share needles or syringes with another person. Sharing poses a risk for transmission of blood-borne pathogens.
</paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
               <component>
                  <section ID="s16">
                     <id root="8e90647e-7cd6-48ab-b589-17695569f57e"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.2 Hyperglycemia or Hypoglycemia with Changes in Insulin Regimen
</title>
                     <text>
                        <paragraph>Changes in an insulin regimen (e.g., insulin strength, manufacturer, type, injection site or method of administration) may affect glycemic control and predispose to hypoglycemia <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s17">5.3</linkHtml>)]</content> or hyperglycemia. Repeated insulin injections into areas of lipodystrophy or localized cutaneous amyloidosis have been reported to result in hyperglycemia; and a sudden change in the injection site (to an unaffected area) has been reported to result in hypoglycemia <content styleCode="italics">[see Adverse Reactions (<linkHtml href="#s25">6</linkHtml>)]</content>.
</paragraph>
                        <paragraph>Make any changes to a patient's insulin regimen under close medical supervision with increased frequency of blood glucose monitoring. Advise patients who have repeatedly injected into areas of lipodystrophy or localized cutaneous amyloidosis to change the injection site to unaffected areas and closely monitor for hypoglycemia. For patients with type 2 diabetes, dosage adjustments of concomitant antidiabetic products may be needed.
</paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
               <component>
                  <section ID="s17">
                     <id root="a4a35795-cde6-458f-a8f4-8a699f7f9d51"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.3 Hypoglycemia
</title>
                     <text>
                        <paragraph>Hypoglycemia is the most common adverse reaction associated with insulins, including HUMALOG. Severe hypoglycemia can cause seizures, may be life-threatening, or cause death. Hypoglycemia can impair concentration ability and reaction time; this may place an individual and others at risk in situations where these abilities are important (e.g., driving or operating other machinery).
</paragraph>
                        <paragraph>Hypoglycemia can happen suddenly, and symptoms may differ in each individual and change over time in the same individual. Symptomatic awareness of hypoglycemia may be less pronounced in patients with longstanding diabetes, in patients with diabetic nerve disease, in patients using medications that block the sympathetic nervous system (e.g., beta-blockers) <content styleCode="italics">[see Drug Interactions (<linkHtml href="#s38">7</linkHtml>)]</content>, or in patients who experience recurrent hypoglycemia.
</paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                     <component>
                        <section ID="s18">
                           <id root="a0c5dda5-6bb7-4020-88f3-3502b9b9e5e9"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Risk Factors for Hypoglycemia</content>
                              </paragraph>
                              <paragraph>The risk of hypoglycemia after an injection is related to the duration of action of the insulin and, in general, is highest when the glucose lowering effect of the insulin is maximal. As with all insulins, the glucose lowering effect time course of HUMALOG may vary in different individuals or at different times in the same individual and depends on many conditions, including the area of injection as well as the injection site blood supply and temperature <content styleCode="italics">[see Clinical Pharmacology (<linkHtml href="#s57">12.2</linkHtml>)]</content>. Other factors which may increase the risk of hypoglycemia include changes in meal pattern (e.g., macronutrient content or timing of meals), changes in level of physical activity, or changes to co-administered medication <content styleCode="italics">[see Drug Interactions (<linkHtml href="#s38">7</linkHtml>)]</content>. Patients with renal or hepatic impairment may be at higher risk of hypoglycemia <content styleCode="italics">[see Use in Specific Populations (<linkHtml href="#s51">8.6</linkHtml>, <linkHtml href="#s52">8.7</linkHtml>)]</content>.
</paragraph>
                           </text>
                           <effectiveTime value="20230721"/>
                        </section>
                     </component>
                     <component>
                        <section ID="s19">
                           <id root="3878dd46-49db-4e5a-b6f6-8fde16fd763e"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Risk Mitigation Strategies for Hypoglycemia</content>
                              </paragraph>
                              <paragraph>Patients and caregivers must be educated to recognize and manage hypoglycemia. Self-monitoring of blood glucose plays an essential role in the prevention and management of hypoglycemia. In patients at higher risk for hypoglycemia and patients who have reduced symptomatic awareness of hypoglycemia, increased frequency of blood glucose monitoring is recommended.
</paragraph>
                           </text>
                           <effectiveTime value="20230721"/>
                        </section>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="s20">
                     <id root="74162ca3-e1ac-43c1-9f76-221901ae821c"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.4 Hypoglycemia Due to Medication Errors
</title>
                     <text>
                        <paragraph>Accidental mix-ups between insulin products have been reported. To avoid medication errors between HUMALOG and other insulins, instruct patients to always check the insulin label before each injection.
</paragraph>
                        <paragraph>Do not transfer HUMALOG U-200 from the HUMALOG KwikPen to a syringe. The markings on the insulin syringe will not measure the dose correctly and can result in overdosage and severe hypoglycemia <content styleCode="italics">[see Dosage and Administration (<linkHtml href="#s3">2.1</linkHtml>) and Warnings and Precautions (<linkHtml href="#s17">5.3</linkHtml>)]</content>.
</paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
               <component>
                  <section ID="s21">
                     <id root="7a4be136-2836-484b-ba8b-ccbfb54ea517"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.5 Hypersensitivity Reactions
</title>
                     <text>
                        <paragraph>Severe, life-threatening, generalized allergy, including anaphylaxis, can occur with insulins, including HUMALOG. If hypersensitivity reactions occur, discontinue HUMALOG; treat per standard of care and monitor until symptoms and signs resolve <content styleCode="italics">[see Adverse Reactions (<linkHtml href="#s26">6.1</linkHtml>)]</content>. HUMALOG is contraindicated in patients who have had hypersensitivity reactions to insulin lispro or any of the excipients in HUMALOG <content styleCode="italics">[see Contraindications (<linkHtml href="#s13">4</linkHtml>)]</content>.
</paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
               <component>
                  <section ID="s22">
                     <id root="37fce90a-1850-4b62-bffe-220b1b10bfdc"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.6 Hypokalemia
</title>
                     <text>
                        <paragraph>All insulins, including HUMALOG, cause a shift in potassium from the extracellular to intracellular space, possibly leading to hypokalemia. Untreated hypokalemia may cause respiratory paralysis, ventricular arrhythmia, and death. Monitor potassium levels in patients at risk for hypokalemia if indicated (e.g., patients using potassium-lowering medications, patients taking medications sensitive to serum potassium concentrations).
</paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
               <component>
                  <section ID="s23">
                     <id root="92e796e5-bf5d-432c-82c9-46048a1b3bc3"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.7 Fluid Retention and Heart Failure with Concomitant Use of PPAR-gamma Agonists
</title>
                     <text>
                        <paragraph>Thiazolidinediones (TZDs), which are peroxisome proliferator-activated receptor (PPAR)-gamma agonists, can cause dose-related fluid retention, particularly when used in combination with insulin. Fluid retention may lead to or exacerbate heart failure. Patients treated with insulin, including HUMALOG, and a PPAR-gamma agonist should be observed for signs and symptoms of heart failure. If heart failure develops, it should be managed according to current standards of care, and discontinuation or dose reduction of the PPAR-gamma agonist must be considered.
</paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
               <component>
                  <section ID="s24">
                     <id root="3d3b3c00-6e65-4982-93f5-3fc917afea24"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.8 Hyperglycemia and Ketoacidosis Due to Insulin Pump Device Malfunction
</title>
                     <text>
                        <paragraph>Malfunction of the insulin pump or insulin infusion set or insulin degradation can rapidly lead to hyperglycemia and ketoacidosis. Prompt identification and correction of the cause of hyperglycemia or ketosis is necessary. Interim subcutaneous injections with HUMALOG may be required. Patients using continuous subcutaneous insulin infusion pump therapy must be trained to administer insulin by injection and have alternate insulin therapy available in case of pump failure <content styleCode="italics">[see How Supplied/Storage and Handling (<linkHtml href="#s78">16.2</linkHtml>) and Patient Counseling Information (<linkHtml href="#s82">17</linkHtml>)]</content>.
</paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s25">
               <id root="095b48ae-94ff-4209-ae3e-cb6a259a9a9d"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>6 ADVERSE REACTIONS
</title>
               <text>
                  <paragraph>The following adverse reactions are discussed elsewhere:
</paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Hypoglycemia <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s17">5.3</linkHtml>)]</content>.
</item>
                     <item>Hypoglycemia Due to Medication Errors <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s20">5.4</linkHtml>)].</content>
                     </item>
                     <item>Hypersensitivity Reactions <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s21">5.5</linkHtml>)].</content>
                     </item>
                     <item>Hypokalemia <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s22">5.6</linkHtml>)]</content>.
</item>
                  </list>
               </text>
               <effectiveTime value="20230721"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>Adverse reactions associated with HUMALOG include hypoglycemia, allergic reactions, injection site reactions, lipodystrophy, pruritus, and rash. (<linkHtml href="#s26">6.1</linkHtml>)
</paragraph>
                        <paragraph>
                           <content styleCode="bold">To report SUSPECTED ADVERSE REACTIONS, contact Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.</content>
                        </paragraph>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="s26">
                     <id root="59f5e6c1-3a46-4252-8f5b-3b342ca0e410"/>
                     <code code="90374-0" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL TRIALS EXPERIENCE SECTION"/>
                     <title>6.1 Clinical Trials Experience
</title>
                     <text>
                        <paragraph>Because clinical trials are conducted under widely varying designs, the adverse reaction rates reported in one clinical trial may not be easily compared with those rates reported in another clinical trial, and may not reflect the rates actually observed in clinical practice.
</paragraph>
                        <paragraph>Common adverse reactions, excluding hypoglycemia, were defined as events that occurred in ≥5% of patients treated with insulin lispro or regular human insulin. The frequencies of adverse reactions during HUMALOG clinical trials in patients with type 1 diabetes mellitus and type 2 diabetes mellitus are listed in the tables below.
</paragraph>
                        <table width="100%">
                           <caption>Table 1: Adverse Reactions That Occurred in ≥5% in Patients with Type 1 Diabetes Mellitus
</caption>
                           <col width="32.223%" align="left"/>
                           <col width="33.889%" align="left"/>
                           <col width="33.889%" align="left"/>
                           <tbody>
                              <tr>
                                 <td align="left" valign="top" styleCode="Toprule Botrule Lrule Rrule"/>
                                 <td align="center" valign="top" styleCode="Toprule Botrule Rrule">
                                    <content styleCode="bold">HUMALOG (%)<br/>(n=81)</content>
                                 </td>
                                 <td align="center" valign="top" styleCode="Toprule Botrule Rrule">
                                    <content styleCode="bold">Regular human insulin (%)<br/>(n=86)</content>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Flu syndrome
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">34.6
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">32.6
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Pharyngitis
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">33.3
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">33.7
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Rhinitis
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">24.7
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">29.1
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Headache
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">29.6
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">22.1
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Pain
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">19.8
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">16.3
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Cough increased
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">17.3
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">17.4
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Infection
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">13.6
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">20.9
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Nausea
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">6.2
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">15.1
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Accidental injury
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">8.6
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">11.6
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Surgical procedure
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">6.2
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">14.0
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Fever
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">6.2
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">11.6
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Abdominal pain
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">7.4
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">8.1
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Asthenia
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">7.4
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">8.1
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Bronchitis
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">7.4
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">7.0
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Diarrhea
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">8.6
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">5.8
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Dysmenorrhea
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">6.2
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">7.0
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Myalgia
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">7.4
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">5.8
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Urinary tract infection
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">6.2
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">4.7
</td>
                              </tr>
                           </tbody>
                        </table>
                        <table width="100%">
                           <caption>Table 2: Adverse Reactions That Occurred in
≥5% in Patients with Type 2 Diabetes Mellitus
</caption>
                           <col width="32.233%" align="left"/>
                           <col width="33.867%" align="left"/>
                           <col width="33.900%" align="left"/>
                           <tbody>
                              <tr>
                                 <td align="left" valign="top" styleCode="Toprule Botrule Lrule Rrule"/>
                                 <td align="center" valign="top" styleCode="Toprule Botrule Rrule">
                                    <content styleCode="bold">HUMALOG (%)<br/>(n=714)</content>
                                 </td>
                                 <td align="center" valign="top" styleCode="Toprule Botrule Rrule">
                                    <content styleCode="bold">Regular human insulin (%)<br/>(n=709)</content>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Headache
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">11.6
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">9.3
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Pain
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">10.8
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">10.0
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Infection
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">10.1
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">7.6
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Pharyngitis
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">6.6
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">8.2
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Rhinitis
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">8.1
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">6.6
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Flu syndrome
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">6.2
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">8.2
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Surgical procedure
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">7.4
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">6.8
</td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                     <effectiveTime value="20230721"/>
                     <component>
                        <section ID="s27">
                           <id root="64ffc524-3ffa-417b-a169-cdffdbe1e96e"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Insulin initiation and intensification of glucose control</content>
                              </paragraph>
                              <paragraph>Intensification or rapid improvement in glucose control has been associated with a transitory, reversible ophthalmologic refraction disorder, worsening of diabetic retinopathy, and acute painful peripheral neuropathy. However, long-term glycemic control decreases the risk of diabetic retinopathy and neuropathy.
</paragraph>
                           </text>
                           <effectiveTime value="20230721"/>
                        </section>
                     </component>
                     <component>
                        <section ID="s28">
                           <id root="fcd3ee00-cc7b-4602-81f5-c7dc8e301648"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Hypoglycemia</content>
                              </paragraph>
                              <paragraph>Hypoglycemia is the most commonly observed adverse reaction in patients using insulin, including HUMALOG.
</paragraph>
                           </text>
                           <effectiveTime value="20230721"/>
                        </section>
                     </component>
                     <component>
                        <section ID="s29">
                           <id root="a1db5e11-e8c8-4b1d-a7ca-c0029d1a025a"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Lipodystrophy</content>
                              </paragraph>
                              <paragraph>Long-term use of insulin, including HUMALOG, can cause lipodystrophy at the site of repeated insulin injections or infusion. Lipodystrophy includes lipohypertrophy (thickening of adipose tissue) and lipoatrophy (thinning of adipose tissue), and may affect insulin absorption <content styleCode="italics">[see Dosage and Administration (<linkHtml href="#s4">2.2</linkHtml>)]</content>.
</paragraph>
                           </text>
                           <effectiveTime value="20230721"/>
                        </section>
                     </component>
                     <component>
                        <section ID="s30">
                           <id root="d55cc73a-d0ad-4902-a48d-7abfd7c4dc48"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Weight gain</content>
                              </paragraph>
                              <paragraph>Weight gain can occur with insulins, including HUMALOG, and has been attributed to the anabolic effects of insulin and the decrease in glucosuria.
</paragraph>
                           </text>
                           <effectiveTime value="20230721"/>
                        </section>
                     </component>
                     <component>
                        <section ID="s31">
                           <id root="d40d998e-549b-40b0-a9c7-ad96e8ceb2cc"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Peripheral Edema</content>
                              </paragraph>
                              <paragraph>Insulins, including HUMALOG, may cause sodium retention and edema, particularly if previously poor metabolic control is improved by intensified insulin therapy.
</paragraph>
                           </text>
                           <effectiveTime value="20230721"/>
                        </section>
                     </component>
                     <component>
                        <section ID="s32">
                           <id root="2faee042-cfe8-44de-bf8d-66dd74b8334c"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Adverse Reactions with Continuous Subcutaneous Insulin Infusion (CSII) — HUMALOG U-100</content>
                              </paragraph>
                              <paragraph>In a 12-week, randomized, crossover study in adult patients with type 1 diabetes (n=39), the rates of catheter occlusions and infusion site reactions were similar for HUMALOG U-100 and regular human insulin treated patients (<content styleCode="italics">see
</content>
                                 <linkHtml href="#t3">Table 3</linkHtml>).
</paragraph>
                              <table width="100%">
                                 <caption>Table 3: Catheter Occlusions and Infusion Site Reactions
</caption>
                                 <col width="33.000%" align="left"/>
                                 <col width="34.000%" align="left"/>
                                 <col width="33.000%" align="left"/>
                                 <tbody>
                                    <tr>
                                       <td align="left" valign="top" styleCode="Toprule Botrule Lrule Rrule"/>
                                       <td align="center" valign="top" styleCode="Toprule Botrule Rrule">HUMALOG U-100<br/>(n=38)
</td>
                                       <td align="center" valign="top" styleCode="Toprule Botrule Rrule">Regular human insulin<br/>(n=39)
</td>
                                    </tr>
                                    <tr>
                                       <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Catheter occlusions/month
</td>
                                       <td align="center" valign="top" styleCode="Botrule Rrule">0.09
</td>
                                       <td align="center" valign="top" styleCode="Botrule Rrule">0.10
</td>
                                    </tr>
                                    <tr>
                                       <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Infusion site reactions
</td>
                                       <td align="center" valign="top" styleCode="Botrule Rrule">2.6% (1/38)
</td>
                                       <td align="center" valign="top" styleCode="Botrule Rrule">2.6% (1/39)
</td>
                                    </tr>
                                 </tbody>
                              </table>
                              <paragraph>In a randomized, 16-week, open-label, parallel design study of pediatric patients with type 1 diabetes, adverse reactions related to infusion-site reactions were similar for insulin lispro and insulin aspart (21% of 100 patients versus 17% of 198 patients, respectively). In both groups, the most frequently reported infusion site reactions were infusion site erythema and infusion site reaction.
</paragraph>
                           </text>
                           <effectiveTime value="20230721"/>
                        </section>
                     </component>
                     <component>
                        <section ID="s33">
                           <id root="f28b28df-974b-45b9-955e-18f96112b4b9"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Allergic Reactions</content>
                              </paragraph>
                           </text>
                           <effectiveTime value="20230721"/>
                           <component>
                              <section ID="s34">
                                 <id root="7be46105-c859-40b8-aecc-a757a9eab03e"/>
                                 <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                                 <text>
                                    <paragraph>
                                       <content styleCode="italics">Local Allergy</content> — As with any insulin, patients taking HUMALOG may experience redness, swelling, or itching at the site of the injection. These minor reactions usually resolve in a few days to a few weeks, but in some occasions, may require discontinuation of HUMALOG.
</paragraph>
                                 </text>
                                 <effectiveTime value="20230721"/>
                              </section>
                           </component>
                           <component>
                              <section ID="s35">
                                 <id root="13c57f94-b267-4e9c-a672-893b8bc1e4ec"/>
                                 <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                                 <text>
                                    <paragraph>
                                       <content styleCode="italics">Systemic Allergy</content> — Severe, life-threatening, generalized allergy, including anaphylaxis, may occur with any insulin, including HUMALOG. Generalized allergy to insulin may cause whole body rash (including pruritus), dyspnea, wheezing, hypotension, tachycardia, or diaphoresis.
</paragraph>
                                    <paragraph>In controlled clinical trials, pruritus (with or without rash) was seen in 17 patients receiving regular human insulin (n=2969) and 30 patients receiving HUMALOG (n=2944).
</paragraph>
                                    <paragraph>Localized reactions and generalized myalgias have been reported with injected metacresol, which is an excipient in HUMALOG <content styleCode="italics">[see Contraindications (<linkHtml href="#s13">4</linkHtml>)]</content>.
</paragraph>
                                 </text>
                                 <effectiveTime value="20230721"/>
                              </section>
                           </component>
                        </section>
                     </component>
                     <component>
                        <section ID="s36">
                           <id root="16aa64c4-eb55-49b2-84a1-804b29c9893a"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Antibody Production</content>
                              </paragraph>
                              <paragraph>In large clinical trials with patients with type 1 (n=509) and type 2 (n=262) diabetes mellitus, anti-insulin antibody (insulin lispro-specific antibodies, insulin-specific antibodies, cross-reactive antibodies) formation was evaluated in patients receiving both regular human insulin and HUMALOG (including patients previously treated with human insulin and naive patients). As expected, the largest increase in the antibody levels occurred in patients new to insulin therapy. The antibody levels peaked by 12 months and declined over the remaining years of the study. These antibodies do not appear to cause deterioration in glycemic control or necessitate an increase in insulin dose. There was no statistically significant relationship between the change in the total daily insulin dose and the change in percent antibody binding for any of the antibody types.
</paragraph>
                           </text>
                           <effectiveTime value="20230721"/>
                        </section>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="s37">
                     <id root="c61acf0c-68c1-44c1-901f-9876ba3f3401"/>
                     <code code="90375-7" codeSystem="2.16.840.1.113883.6.1" displayName="POSTMARKETING EXPERIENCE SECTION"/>
                     <title>6.2 Postmarketing Experience
</title>
                     <text>
                        <paragraph>The following additional adverse reactions have been identified during post-approval use of HUMALOG. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
</paragraph>
                        <paragraph>Medication errors in which other insulins have been accidentally substituted for HUMALOG have been identified during post-approval use.
</paragraph>
                        <paragraph>Localized cutaneous amyloidosis at the injection site has occurred. Hyperglycemia has been reported with repeated insulin injections into areas of localized cutaneous amyloidosis; hypoglycemia has been reported with a sudden change to an unaffected injection site.
</paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s38">
               <id root="3068185b-d7cc-47dd-8ed0-3a4a1d97be25"/>
               <code code="34073-7" codeSystem="2.16.840.1.113883.6.1" displayName="DRUG INTERACTIONS SECTION"/>
               <title>7 DRUG INTERACTIONS
</title>
               <text>
                  <paragraph>The table below includes clinically significant drug interactions with HUMALOG.
</paragraph>
                  <table width="100%">
                     <col width="20.700%" align="left"/>
                     <col width="79.300%" align="left"/>
                     <tbody>
                        <tr>
                           <td colspan="2" align="left" valign="top" styleCode="Toprule Botrule Lrule Rrule">
                              <content styleCode="bold">Drugs That May Increase the Risk of Hypoglycemia</content>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="italics">Drugs:</content>
                           </td>
                           <td align="left" valign="top" styleCode="Botrule Rrule">Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g., octreotide), and sulfonamide antibiotics.
</td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="italics">Intervention:</content>
                           </td>
                           <td align="left" valign="top" styleCode="Botrule Rrule">Dose adjustment and increased frequency of glucose monitoring may be required when HUMALOG is co-administered with these drugs.
</td>
                        </tr>
                        <tr>
                           <td colspan="2" align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Drugs That May Decrease the Blood Glucose Lowering Effect of HUMALOG</content>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="italics">Drugs:</content>
                           </td>
                           <td align="left" valign="top" styleCode="Botrule Rrule">Atypical antipsychotics (e.g., olanzapine and clozapine), corticosteroids, danazol, diuretics, estrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens (e.g., in oral contraceptives), protease inhibitors, somatropin, sympathomimetic agents (e.g., albuterol, epinephrine, terbutaline), and thyroid hormones.
</td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="italics">Intervention:</content>
                           </td>
                           <td align="left" valign="top" styleCode="Botrule Rrule">Dose adjustment and increased frequency of glucose monitoring may be required when HUMALOG is co-administered with these drugs.
</td>
                        </tr>
                        <tr>
                           <td colspan="2" align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Drugs That May Increase or Decrease the Blood Glucose Lowering Effect of HUMALOG</content>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="italics">Drugs:</content>
                           </td>
                           <td align="left" valign="top" styleCode="Botrule Rrule">Alcohol, beta-blockers, clonidine, and lithium salts. Pentamidine may cause hypoglycemia, which may sometimes be followed by hyperglycemia.
</td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="italics">Intervention:</content>
                           </td>
                           <td align="left" valign="top" styleCode="Botrule Rrule">Dose adjustment and increased frequency of glucose monitoring may be required when HUMALOG is co-administered with these drugs.
</td>
                        </tr>
                        <tr>
                           <td colspan="2" align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Drugs That May Blunt Signs and Symptoms of Hypoglycemia</content>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="italics">Drugs:</content>
                           </td>
                           <td align="left" valign="top" styleCode="Botrule Rrule">Beta-blockers, clonidine, guanethidine and reserpine.
</td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="italics">Intervention:</content>
                           </td>
                           <td align="left" valign="top" styleCode="Botrule Rrule">Increased frequency of glucose monitoring may be required when HUMALOG is co-administered with these drugs.
</td>
                        </tr>
                     </tbody>
                  </table>
               </text>
               <effectiveTime value="20230721"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered" styleCode="Disc">
                           <item>
                              <content styleCode="italics">Drugs that may increase the risk of hypoglycemia:</content> antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g., octreotide), and sulfonamide antibiotics (<linkHtml href="#s38">7</linkHtml>).
</item>
                           <item>
                              <content styleCode="italics">Drugs that may decrease the blood glucose lowering effect:</content> atypical antipsychotics, corticosteroids, danazol, diuretics, estrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens (e.g., in oral contraceptives), protease inhibitors, somatropin, sympathomimetic agents (e.g., albuterol, epinephrine, terbutaline), and thyroid hormones (<linkHtml href="#s38">7</linkHtml>).
</item>
                           <item>
                              <content styleCode="italics">Drugs that may increase or decrease the blood glucose lowering effect:</content> alcohol, beta-blockers, clonidine, lithium salts, and pentamidine (<linkHtml href="#s38">7</linkHtml>).
</item>
                           <item>
                              <content styleCode="italics">Drugs that may blunt the signs and symptoms of hypoglycemia:</content> beta-blockers, clonidine, guanethidine, and reserpine (<linkHtml href="#s38">7</linkHtml>).
</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="s39">
               <id root="a69b37eb-c862-490c-8270-433b824fe7f0"/>
               <code code="43684-0" codeSystem="2.16.840.1.113883.6.1" displayName="USE IN SPECIFIC POPULATIONS SECTION"/>
               <title>8 USE IN SPECIFIC POPULATIONS
</title>
               <effectiveTime value="20230721"/>
               <component>
                  <section ID="s40">
                     <id root="a7650541-d91f-44c2-a759-f8726fe9e7f8"/>
                     <code code="42228-7" codeSystem="2.16.840.1.113883.6.1" displayName="PREGNANCY SECTION"/>
                     <title>8.1 Pregnancy
</title>
                     <effectiveTime value="20230721"/>
                     <component>
                        <section ID="s41">
                           <id root="467bd3b4-3f5d-4410-be24-05053f58a6d7"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Risk Summary</content>
                              </paragraph>
                              <paragraph>Published studies with insulin lispro used during pregnancy have not reported an association between insulin lispro and the induction of major birth defects, miscarriage, or adverse maternal or fetal outcomes <content styleCode="italics">(see Data)</content>. There are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy <content styleCode="italics">(see Clinical Considerations)</content>.
</paragraph>
                              <paragraph>Pregnant rats and rabbits were exposed to insulin lispro in animal reproduction studies during organogenesis. No adverse effects on embryo/fetal viability or morphology were observed in offspring of rats exposed to insulin lispro at a dose approximately 3 times the human subcutaneous dose of 1 unit insulin lispro/kg/day. No adverse effects on embryo/fetal development were observed in offspring of rabbits exposed to insulin lispro at doses up to approximately 0.2 times the human subcutaneous dose of 1 unit/kg/day <content styleCode="italics">(see Data)</content>.
</paragraph>
                              <paragraph>The estimated background risk of major birth defects is 6-10% in women with pre-gestational diabetes with a HbA1c &gt;7 and has been reported to be as high as 20-25% in women with a HbA1c &gt;10. The estimated background risk of miscarriage for the indicated population is unknown. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively.
</paragraph>
                           </text>
                           <effectiveTime value="20230721"/>
                        </section>
                     </component>
                     <component>
                        <section ID="s42">
                           <id root="2c921e4f-08b4-4364-9290-e47eb1a017f4"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Clinical Considerations</content>
                              </paragraph>
                           </text>
                           <effectiveTime value="20230721"/>
                           <component>
                              <section ID="s43">
                                 <id root="0a79a854-c02f-4702-9852-f09a6aa82e7e"/>
                                 <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                                 <text>
                                    <paragraph>
                                       <content styleCode="italics">Disease-associated maternal and/or embryo/fetal risk</content>
                                    </paragraph>
                                    <paragraph>Poorly controlled diabetes in pregnancy increases the maternal risk for diabetic ketoacidosis, pre-eclampsia, spontaneous abortions, preterm delivery, and delivery complications. Poorly controlled diabetes increases the fetal risk for major birth defects, stillbirth, and macrosomia related morbidity.
</paragraph>
                                 </text>
                                 <effectiveTime value="20230721"/>
                              </section>
                           </component>
                        </section>
                     </component>
                     <component>
                        <section ID="s44">
                           <id root="68edb887-8ba5-4450-9137-3a3dc41baa8d"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Data</content>
                              </paragraph>
                           </text>
                           <effectiveTime value="20230721"/>
                           <component>
                              <section ID="s45">
                                 <id root="1a056e9d-1ffb-4852-a7f9-8371124c5b6d"/>
                                 <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                                 <text>
                                    <paragraph>
                                       <content styleCode="italics">Human Data</content>
                                    </paragraph>
                                    <paragraph>Published data from retrospective studies and meta-analyses do not report an association with insulin lispro and major birth defects, miscarriage, or adverse maternal or fetal outcomes when insulin lispro is used during pregnancy. However, these studies cannot definitely establish or exclude the absence of any risk because of methodological limitations including small sample size, selection bias, confounding by unmeasured factors, and some lacking comparator groups.
</paragraph>
                                 </text>
                                 <effectiveTime value="20230721"/>
                              </section>
                           </component>
                           <component>
                              <section ID="s46">
                                 <id root="97071b09-71d6-4d1b-946e-ce09dd644ba5"/>
                                 <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                                 <text>
                                    <paragraph>
                                       <content styleCode="italics">Animal Data</content>
                                    </paragraph>
                                    <paragraph>In a combined fertility and embryo-fetal development study, female rats were given subcutaneous insulin lispro injections of 1, 5, and 20 units/kg/day (0.2, 0.8, and 3 times the human subcutaneous dose of 1 unit insulin lispro/kg/day, based on units/body surface area, respectively) from 2 weeks prior to cohabitation through Gestation Day 19. There were no adverse effects on female fertility, implantation, or fetal viability and morphology. However, fetal growth retardation was produced at the 20 units/kg/day-dose as indicated by decreased fetal weight and an increased incidence of fetal runts/litter.
</paragraph>
                                    <paragraph>In an embryo-fetal development study in pregnant rabbits, insulin lispro doses of 0.1, 0.25, and 0.75 unit/kg/day (0.03, 0.08, and 0.2 times the human subcutaneous dose of 1 unit insulin lispro/kg/day, based on units/body surface area, respectively) were injected subcutaneously on Gestation days 7 through 19. There were no adverse effects on fetal viability, weight, and morphology at any dose.
</paragraph>
                                 </text>
                                 <effectiveTime value="20230721"/>
                              </section>
                           </component>
                        </section>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="s47">
                     <id root="f9fe6da1-f708-4f30-8876-899451dcf22b"/>
                     <code code="77290-5" codeSystem="2.16.840.1.113883.6.1" displayName="LACTATION SECTION"/>
                     <title>8.2 Lactation
</title>
                     <effectiveTime value="20230721"/>
                     <component>
                        <section ID="s48">
                           <id root="2adab2cf-c123-46f8-be24-71accd573aaa"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Risk Summary</content>
                              </paragraph>
                              <paragraph>Available data from published literature suggests that exogenous human insulin products, including insulin lispro, are transferred into human milk. There are no adverse reactions reported in breastfed infants in the literature. There are no data on the effects of exogenous human insulin products, including insulin lispro, on milk production. The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for insulin, any potential adverse effects on the breastfed child from HUMALOG or from the underlying maternal condition.
</paragraph>
                           </text>
                           <effectiveTime value="20230721"/>
                        </section>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="s49">
                     <id root="2ed0782e-4c6a-47c8-949c-d922921cb263"/>
                     <code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="PEDIATRIC USE SECTION"/>
                     <title>8.4 Pediatric Use
</title>
                     <text>
                        <paragraph>The safety and effectiveness of HUMALOG to improve glycemic control have been established in pediatric patients with diabetes mellitus. Use of HUMALOG for this indication is supported by evidence from adequate and well-controlled studies in 831 pediatric patients with type 1 diabetes mellitus aged 3 years and older and from studies in adults with diabetes mellitus <content styleCode="italics">[see Adverse Reactions (<linkHtml href="#s26">6.1</linkHtml>), Clinical Pharmacology (<linkHtml href="#s59">12.3</linkHtml>), and Clinical Studies (<linkHtml href="#s70">14</linkHtml>)].</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
               <component>
                  <section ID="s50">
                     <id root="9419535f-8b44-4242-9a02-7c24b1ef967e"/>
                     <code code="34082-8" codeSystem="2.16.840.1.113883.6.1" displayName="GERIATRIC USE SECTION"/>
                     <title>8.5 Geriatric Use
</title>
                     <text>
                        <paragraph>Of the total number of patients (n=2,834) in eight clinical studies of HUMALOG, twelve percent (n=338) were 65 years of age or over. The majority of these patients had type 2 diabetes. HbA<sub>1c</sub> values and hypoglycemia rates did not differ by age. Pharmacokinetic/pharmacodynamic studies to assess the effect of age on the onset of HUMALOG action have not been performed.
</paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
               <component>
                  <section ID="s51">
                     <id root="53271cd8-636d-4b78-bc25-64959880691d"/>
                     <code code="88828-9" codeSystem="2.16.840.1.113883.6.1" displayName="RENAL IMPAIRMENT SUBSECTION"/>
                     <title>8.6 Renal Impairment
</title>
                     <text>
                        <paragraph>Patients with renal impairment may be at increased risk of hypoglycemia and may require more frequent HUMALOG dose adjustment and more frequent blood glucose monitoring <content styleCode="italics">[see Clinical Pharmacology (<linkHtml href="#s59">12.3</linkHtml>)]</content>.
</paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
               <component>
                  <section ID="s52">
                     <id root="de619661-9a75-4d76-bd4e-82eae0308d43"/>
                     <code code="88829-7" codeSystem="2.16.840.1.113883.6.1" displayName="HEPATIC IMPAIRMENT SUBSECTION"/>
                     <title>8.7 Hepatic Impairment
</title>
                     <text>
                        <paragraph>Patients with hepatic impairment may be at increased risk of hypoglycemia and may require more frequent HUMALOG dose adjustment and more frequent blood glucose monitoring <content styleCode="italics">[see Clinical Pharmacology (<linkHtml href="#s59">12.3</linkHtml>)]</content>.
</paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s53">
               <id root="4e65a53e-4385-4f28-b4b9-4f69d4326162"/>
               <code code="34088-5" codeSystem="2.16.840.1.113883.6.1" displayName="OVERDOSAGE SECTION"/>
               <title>10 OVERDOSAGE
</title>
               <text>
                  <paragraph>Excess insulin administration may cause hypoglycemia and hypokalemia. Mild episodes of hypoglycemia usually can be treated with oral glucose. Adjustments in drug dosage, meal patterns, or exercise may be needed. More severe episodes with coma, seizure, or neurologic impairment may be treated with a glucagon product for emergency use or concentrated intravenous glucose. Sustained carbohydrate intake and observation may be necessary because hypoglycemia may recur after apparent clinical recovery. Hypokalemia must be corrected appropriately.
</paragraph>
               </text>
               <effectiveTime value="20230721"/>
            </section>
         </component>
         <component>
            <section ID="s54">
               <id root="0e241510-b2a9-48b2-bca0-16752acdd6fc"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>11 DESCRIPTION
</title>
               <text>
                  <paragraph>Insulin lispro is a rapid-acting human insulin analog produced by recombinant DNA technology utilizing a non-pathogenic laboratory strain of <content styleCode="italics">Escherichia coli</content>. Insulin lispro differs from human insulin in that the amino acid proline at position B28 is replaced by lysine and the lysine in position B29 is replaced by proline. Chemically, it is Lys(B28), Pro(B29) human insulin analog and has the empirical formula C<sub>257</sub>H<sub>383</sub>N<sub>65</sub>O<sub>77</sub>S<sub>6</sub> and a molecular weight of 5.808 kDa, both identical to that of human insulin.
</paragraph>
                  <paragraph>Insulin lispro has the following primary structure:
</paragraph>
                  <renderMultiMedia ID="f01" referencedObject="mm01"/>
                  <paragraph>HUMALOG (insulin lispro) injection is a sterile, clear, and colorless solution for subcutaneous or intravenous use.
</paragraph>
                  <paragraph>Each mL of HUMALOG U-100 contains 100 units of insulin lispro, and the inactive ingredients: dibasic sodium phosphate (1.0 mg), glycerin (16 mg), metacresol (3.15 mg), trace amounts of phenol, zinc oxide (content adjusted to provide 0.0197 mg zinc ion), and Water for Injection, USP.
</paragraph>
                  <paragraph>Each mL of HUMALOG U-200 contains 200 units of insulin lispro, and the inactive ingredients: glycerin (16 mg), metacresol (3.15 mg), trace amounts of phenol, tromethamine (5 mg), zinc oxide (content adjusted to provide 0.046 mg zinc ion), and Water for Injection, USP.
</paragraph>
                  <paragraph>HUMALOG has a pH of 7.0 to 7.8.
</paragraph>
                  <paragraph>Hydrochloric acid 10% and/or sodium hydroxide 10% is added to adjust the pH.
</paragraph>
               </text>
               <effectiveTime value="20230721"/>
               <component>
                  <observationMedia ID="mm01">
                     <text>Primary Structure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-structure-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="s55">
               <id root="f9d19818-31a2-4dff-8522-534c05eae292"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>12 CLINICAL PHARMACOLOGY
</title>
               <effectiveTime value="20230721"/>
               <component>
                  <section ID="s56">
                     <id root="9a745634-612b-4660-9d05-3197288b29df"/>
                     <code code="43679-0" codeSystem="2.16.840.1.113883.6.1" displayName="MECHANISM OF ACTION SECTION"/>
                     <title>12.1 Mechanism of Action
</title>
                     <text>
                        <paragraph>Regulation of glucose metabolism is the primary activity of insulins and insulin analogs, including insulin lispro. Insulins lower blood glucose by stimulating peripheral glucose uptake by skeletal muscle and fat, and by inhibiting hepatic glucose production. Insulins inhibit lipolysis and proteolysis, and enhance protein synthesis.
</paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
               <component>
                  <section ID="s57">
                     <id root="13c25d8b-af83-4a9c-acdc-07e384a8ea06"/>
                     <code code="43681-6" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACODYNAMICS SECTION"/>
                     <title>12.2 Pharmacodynamics
</title>
                     <text>
                        <paragraph>HUMALOG has been shown to be equipotent to human insulin on a molar basis. One unit of HUMALOG has the same glucose-lowering effect as one unit of regular human insulin. Studies in normal volunteers and patients with diabetes demonstrated that HUMALOG has a more rapid onset of action and a shorter duration of activity than regular human insulin when given subcutaneously.
</paragraph>
                        <paragraph>The time course of action of insulin and insulin analogs, such as HUMALOG, may vary considerably in different individuals or within the same individual. The parameters of HUMALOG activity (time of onset, peak time, and duration) as designated in <linkHtml href="#f02">Figure 1</linkHtml> should be considered only as general guidelines. The rate of insulin absorption, and consequently the onset of activity are known to be affected by the site of injection, exercise, and other variables <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s16">5.2</linkHtml>)]</content>.
</paragraph>
                        <renderMultiMedia ID="f02" referencedObject="mm02">
                           <caption>Figure 1: Blood Glucose Levels After Subcutaneous Injection of Regular Human Insulin or HUMALOG (0.2 unit/kg) Immediately Before a High Carbohydrate Meal in 10 Patients with Type 1 Diabetes<sup>a</sup>.
</caption>
                        </renderMultiMedia>
                        <paragraph>
                           <sup>a</sup> Baseline insulin concentration was maintained by infusion of 0.2 mU/min/kg human insulin.
</paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                     <component>
                        <observationMedia ID="mm02">
                           <text>Figure
</text>
                           <value xsi:type="ED" mediaType="image/jpeg">
                              <reference value="humalog-f001-v3.jpg"/>
                           </value>
                        </observationMedia>
                     </component>
                     <component>
                        <section ID="s58">
                           <id root="4ce65278-1540-4708-84c0-d0eaed013beb"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Intravenous Administration of HUMALOG U-100</content> — The glucose lowering effect of intravenously administered HUMALOG was tested in 21 patients with type 1 diabetes. For the study, the patients' usual doses of insulin were held and blood glucose concentrations were allowed to reach a stable range of 200 to 260 mg/dL during a one to three hours run-in phase. The run-in phase was followed by a 6-hour assessment phase. During the assessment phase, patients received intravenous HUMALOG at an initial infusion rate of 0.5 units/hour. The infusion rate of HUMALOG could be adjusted at regular timed intervals to achieve and maintain blood glucose concentrations between 100 to 160 mg/dL.
</paragraph>
                              <paragraph>The mean blood glucose levels during the assessment phase for patients on HUMALOG therapy are summarized below in <linkHtml href="#t4">Table 4</linkHtml>. All patients achieved the targeted glucose range at some point during the 6-hour assessment phase. At the endpoint, blood glucose was within the target range (100 to 160 mg/dL) for 17 of 20 patients treated with HUMALOG. The average time (±SE) required to attain near normoglycemia was 129 ± 14 minutes for HUMALOG.
</paragraph>
                              <table width="100%">
                                 <caption>Table 4: Mean Blood Glucose Concentrations (mg/dL) During Intravenous Infusions of HUMALOG U-100
</caption>
                                 <col width="50.000%" align="left"/>
                                 <col width="50.000%" align="left"/>
                                 <tfoot>
                                    <tr>
                                       <td colspan="2" align="left" valign="top">
                                          <paragraph>
                                             <sup>a</sup> Results shown as mean ± SD
</paragraph>
                                       </td>
                                    </tr>
                                 </tfoot>
                                 <tbody>
                                    <tr>
                                       <td align="center" valign="top" styleCode="Toprule Botrule Lrule Rrule">Time from Start of Infusion (minutes)
</td>
                                       <td align="center" valign="top" styleCode="Toprule Botrule Rrule">Mean Blood Glucose (mg/dL) Intravenous<sup>a</sup>
                                       </td>
                                    </tr>
                                    <tr>
                                       <td align="center" valign="top" styleCode="Botrule Lrule Rrule">0
</td>
                                       <td align="center" valign="top" styleCode="Botrule Rrule">224 ± 16
</td>
                                    </tr>
                                    <tr>
                                       <td align="center" valign="top" styleCode="Botrule Lrule Rrule">30
</td>
                                       <td align="center" valign="top" styleCode="Botrule Rrule">205 ± 21
</td>
                                    </tr>
                                    <tr>
                                       <td align="center" valign="top" styleCode="Botrule Lrule Rrule">60
</td>
                                       <td align="center" valign="top" styleCode="Botrule Rrule">195 ± 20
</td>
                                    </tr>
                                    <tr>
                                       <td align="center" valign="top" styleCode="Botrule Lrule Rrule">120
</td>
                                       <td align="center" valign="top" styleCode="Botrule Rrule">165 ± 26
</td>
                                    </tr>
                                    <tr>
                                       <td align="center" valign="top" styleCode="Botrule Lrule Rrule">180
</td>
                                       <td align="center" valign="top" styleCode="Botrule Rrule">140 ± 26
</td>
                                    </tr>
                                    <tr>
                                       <td align="center" valign="top" styleCode="Botrule Lrule Rrule">240
</td>
                                       <td align="center" valign="top" styleCode="Botrule Rrule">123 ± 20
</td>
                                    </tr>
                                    <tr>
                                       <td align="center" valign="top" styleCode="Botrule Lrule Rrule">300
</td>
                                       <td align="center" valign="top" styleCode="Botrule Rrule">120 ± 27
</td>
                                    </tr>
                                    <tr>
                                       <td align="center" valign="top" styleCode="Botrule Lrule Rrule">360
</td>
                                       <td align="center" valign="top" styleCode="Botrule Rrule">122 ± 25
</td>
                                    </tr>
                                 </tbody>
                              </table>
                              <paragraph>The pharmacodynamics of a single 20 unit dose of HUMALOG U-200 administered subcutaneously were compared to the pharmacodynamics of a single 20 unit dose of HUMALOG U-100 administered subcutaneously in a euglycemic clamp study enrolling healthy subjects. In this study, the overall, maximum, and time to maximum glucose lowering effect were similar between HUMALOG U-200 and HUMALOG U-100. The mean area under the glucose infusion rate curves (measure of overall pharmacodynamic effect) were 125 g and 126 g for HUMALOG U-200 and HUMALOG U-100, respectively. The maximum glucose infusion rate was 534 mg/min and 559 mg/min and the corresponding median time (min, max) to maximum effect were 2.8 h (0.5 h – 6.3 h) and 2.4 h (0.5 h – 4.7 h) for HUMALOG U-200 and HUMALOG U-100, respectively.
</paragraph>
                           </text>
                           <effectiveTime value="20230721"/>
                        </section>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="s59">
                     <id root="abaea596-3946-49c8-9ea0-3c5c74a299a3"/>
                     <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                     <title>12.3 Pharmacokinetics
</title>
                     <effectiveTime value="20230721"/>
                     <component>
                        <section ID="s60">
                           <id root="72d562d7-b4c0-488a-af22-5628365326c8"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Absorption and Bioavailability</content> — Studies in healthy volunteers and patients with diabetes demonstrated that HUMALOG is absorbed more quickly than regular human insulin. In healthy volunteers given subcutaneous doses of HUMALOG ranging from 0.1 to 0.4 unit/kg, peak serum levels were seen 30 to 90 minutes after dosing. When healthy volunteers received equivalent doses of regular human insulin, peak insulin levels occurred between 50 to 120 minutes after dosing. Similar results were seen in patients with type 1 diabetes (<content styleCode="italics">see
</content>
                                 <linkHtml href="#f03">Figure 2</linkHtml>).
</paragraph>
                              <renderMultiMedia ID="f03" referencedObject="mm03">
                                 <caption>Figure 2: Serum HUMALOG and Insulin Levels After Subcutaneous Injection of Regular Human Insulin or HUMALOG (0.2 unit/kg) Immediately Before a High Carbohydrate Meal in 10 Patients with Type 1 Diabetes<sup>a</sup>.
</caption>
                              </renderMultiMedia>
                              <paragraph>
                                 <sup>a</sup> Baseline insulin concentration was maintained by infusion of 0.2 mU/min/kg human insulin.
</paragraph>
                              <paragraph>HUMALOG U-100 was absorbed at a consistently faster rate than regular human insulin in healthy male volunteers given 0.2 unit/kg at abdominal, deltoid, or femoral subcutaneous sites. After HUMALOG was administered in the abdomen, serum drug levels were higher and the duration of action was slightly shorter than after deltoid or thigh administration. Bioavailability of HUMALOG is similar to that of regular human insulin. The absolute bioavailability after subcutaneous injection ranges from 55% to 77% with doses between 0.1 to 0.2 unit/kg, inclusive.
</paragraph>
                              <paragraph>The results of a study in healthy subjects demonstrated that HUMALOG U-200 is bioequivalent to HUMALOG U-100 following administration of a single 20 unit dose.
</paragraph>
                              <paragraph>The mean observed area under the serum insulin concentration-time curve from time zero to infinity was 2360 pmol hr/L and 2390 pmol hr/L for HUMALOG U-200 and HUMALOG U-100, respectively. The corresponding mean peak serum insulin concentration was 795 pmol/L and 909 pmol/L for HUMALOG U-200 and HUMALOG U-100, respectively. The median time to maximum concentration was 1.0 hour for both formulations.
</paragraph>
                           </text>
                           <effectiveTime value="20230721"/>
                           <component>
                              <observationMedia ID="mm03">
                                 <text>Figure
</text>
                                 <value xsi:type="ED" mediaType="image/jpeg">
                                    <reference value="humalog-f003-v2.jpg"/>
                                 </value>
                              </observationMedia>
                           </component>
                        </section>
                     </component>
                     <component>
                        <section ID="s61">
                           <id root="d4823be0-d305-44b7-a800-9aff4d1f788b"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Distribution</content> — When administered intravenously as bolus injections of 0.1 and 0.2 U/kg dose in two separate groups of healthy subjects, the mean volume of distribution of HUMALOG appeared to decrease with increase in dose (1.55 and 0.72 L/kg, respectively) in contrast to that of regular human insulin for which, the volume of distribution was comparable across the two dose groups (1.37 and 1.12 L/kg for 0.1 and 0.2 U/kg dose, respectively).
</paragraph>
                           </text>
                           <effectiveTime value="20230721"/>
                        </section>
                     </component>
                     <component>
                        <section ID="s62">
                           <id root="5f6245bd-8f79-4ac2-833a-ddcf78cd6433"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Metabolism</content> — Human metabolism studies have not been conducted. However, animal studies indicate that the metabolism of HUMALOG is identical to that of regular human insulin.
</paragraph>
                           </text>
                           <effectiveTime value="20230721"/>
                        </section>
                     </component>
                     <component>
                        <section ID="s63">
                           <id root="93c016ea-ef09-4651-8684-de814357373f"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Elimination</content> — After subcutaneous administration of HUMALOG, the t<sub>1/2</sub> is shorter than that of regular human insulin (1 versus 1.5 hours, respectively). When administered intravenously, HUMALOG and regular human insulin demonstrated similar dose-dependent clearance, with a mean clearance of 21.0 mL/min/kg and 21.4 mL/min/kg, respectively (0.1 unit/kg dose), and 9.6 mL/min/kg and 9.4 mL/min/kg, respectively (0.2 unit/kg dose). Accordingly, HUMALOG demonstrated a mean t<sub>1/2</sub> of 0.85 hours (51 minutes) and 0.92 hours (55 minutes), respectively for 0.1 unit/kg and 0.2 unit/kg doses, and regular human insulin mean t<sub>1/2</sub> was 0.79 hours (47 minutes) and 1.28 hours (77 minutes), respectively for 0.1 unit/kg and 0.2 unit/kg doses.
</paragraph>
                           </text>
                           <effectiveTime value="20230721"/>
                        </section>
                     </component>
                     <component>
                        <section ID="s64">
                           <id root="225fdda1-78a7-438e-8013-afee896ea2b6"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Specific Populations</content>
                              </paragraph>
                              <paragraph>The effects of age, gender, race, obesity, pregnancy, or smoking on the pharmacokinetics of HUMALOG have not been studied.
</paragraph>
                           </text>
                           <effectiveTime value="20230721"/>
                        </section>
                     </component>
                     <component>
                        <section ID="s65">
                           <id root="647ca161-1d66-4a52-9afd-b98c304ee3c2"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Renal Impairment</content> — Type 2 diabetic patients with varying degree of renal impairment showed no difference in pharmacokinetics of regular insulin and HUMALOG. However, the sensitivity of the patients to insulin did change, with an increased response to insulin as the renal function declined. Some studies with human insulin have shown increased circulating levels of insulin in patients with renal impairment <content styleCode="italics">[see Use in Specific Populations (<linkHtml href="#s51">8.6</linkHtml>)].</content>
                              </paragraph>
                           </text>
                           <effectiveTime value="20230721"/>
                        </section>
                     </component>
                     <component>
                        <section ID="s66">
                           <id root="48005ec4-eff7-43c2-ab5e-a4dc891491f2"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="italics">Hepatic Impairment</content> — Type 2 diabetic patients with impaired hepatic function showed no effect on the pharmacokinetics of HUMALOG as compared to patients with no hepatic dysfunction. However, some studies with human insulin have shown increased circulating levels of insulin in patients with liver failure <content styleCode="italics">[see Use in Specific Populations (<linkHtml href="#s52">8.7</linkHtml>)].</content>
                              </paragraph>
                           </text>
                           <effectiveTime value="20230721"/>
                        </section>
                     </component>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s67">
               <id root="bfab3e4e-a70c-4438-bbe5-a155ee5c9dbb"/>
               <code code="43680-8" codeSystem="2.16.840.1.113883.6.1" displayName="NONCLINICAL TOXICOLOGY SECTION"/>
               <title>13 NONCLINICAL TOXICOLOGY
</title>
               <effectiveTime value="20230721"/>
               <component>
                  <section ID="s68">
                     <id root="40a207ff-096a-4a0d-a0e5-1f705e70ca3f"/>
                     <code code="34083-6" codeSystem="2.16.840.1.113883.6.1" displayName="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION"/>
                     <title>13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility
</title>
                     <text>
                        <paragraph>Standard 2-year carcinogenicity studies in animals have not been performed. In Fischer 344 rats, a 12-month repeat-dose toxicity study was conducted with insulin lispro at subcutaneous doses of 20 and 200 units/kg/day (approximately 3 and 32 times the human subcutaneous dose of 1 unit/kg/day, based on units/body surface area). Insulin lispro did not produce important target organ toxicity including mammary tumors at any dose.
</paragraph>
                        <paragraph>Insulin lispro was not mutagenic in the following genetic toxicity assays: bacterial mutation, unscheduled DNA synthesis, mouse lymphoma, chromosomal aberration and micronucleus assays.
</paragraph>
                        <paragraph>Male fertility was not compromised when male rats given subcutaneous insulin lispro injections of 5 and 20 units/kg/day (0.8 and 3 times the human subcutaneous dose of 1 unit/kg/day, based on units/body surface area) for 6 months were mated with untreated female rats. In a combined fertility, perinatal, and postnatal study in male and female rats given 1, 5, and 20 units/kg/day subcutaneously (0.2, 0.8, and 3 times the human subcutaneous dose of 1 unit/kg/day, based on units/body surface area), mating and fertility were not adversely affected in either gender at any dose.
</paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
               <component>
                  <section ID="s69">
                     <id root="b1ed2222-1d14-463d-ad69-6b1fd1f04315"/>
                     <code code="34091-9" codeSystem="2.16.840.1.113883.6.1" displayName="ANIMAL PHARMACOLOGY &amp; OR TOXICOLOGY SECTION"/>
                     <title>13.2 Animal Toxicology and/or Pharmacology
</title>
                     <text>
                        <paragraph>In standard biological assays in fasted rabbits, 0.2 unit/kg of insulin lispro injected subcutaneously had the same glucose-lowering effect and had a more rapid onset of action as 0.2 unit/kg of regular human insulin.
</paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s70">
               <id root="530d8dd7-bb4f-4f0e-880d-9ac66a03083f"/>
               <code code="34092-7" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL STUDIES SECTION"/>
               <title>14 CLINICAL STUDIES
</title>
               <text>
                  <paragraph>The safety and efficacy of HUMALOG U-100 were studied in pediatric and adult patients with type 1 diabetes (n=789) and adult patients with type 2 diabetes (n=722).
</paragraph>
               </text>
               <effectiveTime value="20230721"/>
               <component>
                  <section ID="s71">
                     <id root="a41e8131-e1ab-415d-a09e-b3f5770339ac"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>14.1 Type 1 Diabetes – Adults and Pediatric Patients Aged 12 years and Older
</title>
                     <text>
                        <paragraph>A 12-month, randomized, parallel, open-label, active-controlled study was conducted in patients with type 1 diabetes to assess the safety and efficacy of HUMALOG (n=81) compared with Humulin<sup>®</sup> R [insulin human injection (100 units/mL)] (n=86). HUMALOG was administered by subcutaneous injection immediately prior to meals and Humulin R was administered 30 to 45 minutes before meals. Humulin<sup>®</sup> U [ULTRALENTE<sup>®</sup> human insulin (rDNA origin) extended zinc suspension] was administered once or twice daily as the basal insulin. There was a 2- to 4-week run-in period with Humulin R and Humulin U before randomization. Most patients were Caucasian (97%). Forty-seven percent of the patients were male. The mean age was 31 years (range 12 to 70 years). Glycemic control, the total daily doses of HUMALOG and Humulin R, and the incidence of severe hypoglycemia (as determined by the number of events that were not self-treated) were similar in the two treatment groups. There were no episodes of diabetic ketoacidosis in either treatment group.
</paragraph>
                        <table width="100%">
                           <caption>Table 5: Type 1 Diabetes Mellitus – Adults and Pediatric Patients Aged 12 years and Older
</caption>
                           <col width="60.833%" align="left"/>
                           <col width="20.833%" align="left"/>
                           <col width="18.333%" align="left"/>
                           <tfoot>
                              <tr>
                                 <td colspan="3" align="left" valign="top">
                                    <paragraph>
                                       <sup>a</sup> Values are Mean ± SD
</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="3" align="left" valign="top">
                                    <paragraph>
                                       <sup>b</sup> Severe hypoglycemia refers to hypoglycemia for which patients were not able to self-treat.
</paragraph>
                                 </td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr>
                                 <td align="left" valign="top" styleCode="Toprule Botrule Lrule Rrule">Treatment Duration<br/>Treatment in Combination with:
</td>
                                 <td colspan="2" align="center" valign="top" styleCode="Toprule Botrule Rrule">12 months<br/>Humulin U
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule"/>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">HUMALOG
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">Humulin R
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">N
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">81
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">86
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Baseline HbA<sub>1c</sub> (%)<sup>a</sup>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">8.2 ± 1.4
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">8.3 ± 1.7
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Change from baseline HbA<sub>1c</sub> (%)<sup>a</sup>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">-0.1 ± 0.9
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.1 ± 1.1
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Treatment Difference in HbA<sub>1c</sub> Mean (95% confidence interval)
</td>
                                 <td colspan="2" align="center" valign="top" styleCode="Botrule Rrule">0.4 (0.0, 0.8)
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Baseline short-acting insulin dose (units/kg/day)
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.3 ± 0.1
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.3 ± 0.1
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">End-of-Study short-acting insulin dose (units/kg/day)
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.3 ± 0.1
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.3 ± 0.1
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Change from baseline short-acting insulin dose (units/kg/day)
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.0 ± 0.1
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.0 ± 0.1
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Baseline Body weight (kg)
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">72 ± 12.7
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">71 ± 11.3
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Weight change from baseline (kg)
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">1.4 ± 3.6
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">1.0 ± 2.6
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Patients with severe hypoglycemia (n, %)<sup>b</sup>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">14 (17%)
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">18 (21%)
</td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
               <component>
                  <section ID="s72">
                     <id root="d40002e4-52e4-4ecf-8f29-1c31616f76c8"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>14.2 Type 1 Diabetes – Pediatric Patients
</title>
                     <text>
                        <paragraph>An 8-month, crossover study of pediatric patients with type 1 diabetes (n=463), aged 9 to 19 years, compared two subcutaneous multiple-dose treatment regimens: HUMALOG or Humulin R, both administered with Humulin N (NPH human insulin) as the basal insulin. HUMALOG achieved glycemic control comparable to Humulin R, as measured by HbA<sub>1c</sub> (<content styleCode="italics">see
</content>
                           <linkHtml href="#t6">Table 6</linkHtml>), and both treatment groups had a comparable incidence of hypoglycemia. In a 9-month, crossover study of pediatric patients (n=60) with type 1 diabetes, aged 3 to 11 years, HUMALOG administered immediately before meals, HUMALOG administered immediately after meals and Humulin R administered 30 minutes before meals resulted in similar glycemic control, as measured by HbA<sub>1c</sub>, and incidence of hypoglycemia, regardless of treatment group.
</paragraph>
                        <table width="100%">
                           <caption>Table 6: Pediatric Subcutaneous Administration of HUMALOG in Type 1 Diabetes
</caption>
                           <col width="60.000%" align="left"/>
                           <col width="14.175%" align="left"/>
                           <col width="13.325%" align="left"/>
                           <col width="12.500%" align="left"/>
                           <tfoot>
                              <tr>
                                 <td colspan="4" align="left" valign="top">
                                    <paragraph>
                                       <sup>a</sup> Values are Mean ± SD
</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" align="left" valign="top">
                                    <paragraph>
                                       <sup>b</sup> Severe hypoglycemia refers to hypoglycemia that required glucagon or glucose injection or resulted in coma.
</paragraph>
                                 </td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr>
                                 <td align="left" valign="top" styleCode="Toprule Botrule Lrule Rrule"/>
                                 <td align="center" valign="top" styleCode="Toprule Botrule Rrule"/>
                                 <td colspan="2" align="center" valign="top" styleCode="Toprule Botrule Rrule">End point
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule"/>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">Baseline
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">HUMALOG<br/>+<br/>NPH
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">Humulin R<br/>+<br/>NPH
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">HbA<sub>1c</sub> (%)<sup>a</sup>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">8.6 ± 1.5
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">8.7 ± 1.5
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">8.7 ± 1.6
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Change from baseline HbA<sub>1c</sub> (%)<sup>a</sup>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">—
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.1 ± 1.1
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.1 ± 1.3
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Short-acting insulin dose (units/kg/day)<sup>a</sup>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.5 ± 0.2
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.5 ± 0.2
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.5 ± 0.2
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Change from baseline short-acting insulin dose (units/kg/day)<sup>a</sup>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">—
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.01 ± 0.1
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">-0.01 ± 0.1
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Body weight (kg)<sup>a</sup>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">59.1 ± 13.1
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">61.1 ± 12.7
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">61.4 ± 12.9
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Weight change from baseline (kg)<sup>a</sup>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">—
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">2.0 ± 3.1
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">2.3 ± 3.0
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Patients with severe hypoglycemia (n, %)<sup>b</sup>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">—
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">5 (1.1%)
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">5 (1.1%)
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Diabetic ketoacidosis (n, %)
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">—
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">11 (2.4%)
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">9 (1.9%)
</td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
               <component>
                  <section ID="s73">
                     <id root="f68920a6-8ad7-4451-835e-edebe1769794"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>14.3 Type 1 Diabetes – Adults Continuous Subcutaneous Insulin Infusion
</title>
                     <text>
                        <paragraph>To evaluate the administration of HUMALOG U-100 via external insulin pumps, two open-label, crossover design studies were performed in patients with type 1 diabetes. One study involved 39 patients, ages 19 to 58 years, treated for 24 weeks with HUMALOG or regular human insulin. After 12 weeks of treatment, the mean HbA<sub>1c</sub> values decreased from 7.8% to 7.2% in the HUMALOG-treated patients and from 7.8% to 7.5% in the regular human insulin-treated patients. Another study involved 60 patients (mean age 39, range 15 to 58 years) treated for 24 weeks with either HUMALOG or buffered regular human insulin. After 12 weeks of treatment, the mean HbA<sub>1c</sub> values decreased from 7.7% to 7.4% in the HUMALOG-treated patients and remained unchanged from 7.7% in the buffered regular human insulin-treated patients. Rates of hypoglycemia were comparable between treatment groups in both studies.
</paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
               <component>
                  <section ID="s74">
                     <id root="89f7a9d9-5cff-4938-a289-4d282dfbb743"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>14.4 Type 1 Diabetes – Pediatric Continuous Subcutaneous Insulin Infusion
</title>
                     <text>
                        <paragraph>A randomized, 16-week, open-label, parallel design, study of pediatric patients with type 1 diabetes (n=298) aged 4 to 18 years compared two subcutaneous infusion regimens administered via an external insulin pump: insulin aspart (n=198) or HUMALOG U-100 (n=100). These two treatments resulted in comparable changes from baseline in HbA<sub>1c</sub> and comparable rates of hypoglycemia after 16 weeks of treatment (<content styleCode="italics">see
</content>
                           <linkHtml href="#t7">Table 7</linkHtml>). Infusion site reactions were similar between groups.
</paragraph>
                        <table width="100%">
                           <caption>Table 7: Pediatric Insulin Pump Study in Type 1 Diabetes (16 weeks; n=298)
</caption>
                           <col width="60.833%" align="left"/>
                           <col width="20.833%" align="left"/>
                           <col width="18.333%" align="left"/>
                           <tfoot>
                              <tr>
                                 <td colspan="3" align="left" valign="top">
                                    <paragraph>
                                       <sup>a</sup> Values are Mean ± SD
</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="3" align="left" valign="top">
                                    <paragraph>
                                       <sup>b</sup> Severe hypoglycemia refers to hypoglycemia associated with central nervous system symptoms and requiring the intervention of another person or hospitalization.
</paragraph>
                                 </td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr>
                                 <td align="left" valign="top" styleCode="Toprule Botrule Lrule Rrule"/>
                                 <td align="center" valign="top" styleCode="Toprule Botrule Rrule">HUMALOG
</td>
                                 <td align="center" valign="top" styleCode="Toprule Botrule Rrule">Aspart
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">N
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">100
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">198
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Baseline HbA<sub>1c</sub> (%)<sup>a</sup>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">8.2 ± 0.8
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">8.0 ± 0.9
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Change from Baseline HbA<sub>1c</sub> (%)
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">-0.1 ± 0.7
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">-0.1 ± 0.8
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Treatment Difference in HbA<sub>1c</sub>, Mean (95% confidence interval)
</td>
                                 <td colspan="2" align="center" valign="top" styleCode="Botrule Rrule">0.1 (-0.3, 0.1)
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Baseline insulin dose (units/kg/24 hours)<sup>a</sup>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.9 ± 0.3
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.9 ± 0.3
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">End-of-Study insulin dose (units/kg/24 hours)<sup>a</sup>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.9 ± 0.2
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.9 ± 0.2
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Patients with severe hypoglycemia (n, %)<sup>b</sup>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">8 (8%)
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">19 (10%)
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Diabetic ketoacidosis (n, %)
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0 (0)
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">1 (0.5%)
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Baseline body weight (kg)<sup>a</sup>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">55.5 ± 19.0
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">54.1 ± 19.7
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Weight Change from baseline (kg)<sup>a</sup>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">1.6 ± 2.1
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">1.8 ± 2.1
</td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
               <component>
                  <section ID="s75">
                     <id root="db17ebfe-0ab1-4b11-a6d9-414315cb4d63"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>14.5 Type 2 Diabetes – Adults
</title>
                     <text>
                        <paragraph>A 6-month randomized, crossover, open-label, active-controlled study was conducted in insulin-treated patients with type 2 diabetes (n=722) to assess the safety and efficacy of HUMALOG for 3 months followed by Humulin R for 3 months or the reverse sequence. HUMALOG was administered by subcutaneous injection immediately before meals and Humulin R was administered 30 to 45 minutes before meals. Humulin<sup>®</sup> N [NPH human insulin (rDNA origin) isophane suspension] or Humulin U was administered once or twice daily as the basal insulin. All patients participated in a 2- to 4-week run-in period with Humulin R and Humulin N or Humulin U. Most of the patients were Caucasian (88%), and the numbers of men and women in each group were approximately equal. The mean age was 58.6 years (range 23.8 to 85 years). The average body mass index (BMI) was 28.2 kg/m<sup>2</sup>. During the study, the majority of patients used Humulin N (84%) compared with Humulin U (16%) as their basal insulin. The reductions from baseline in HbA<sub>1c</sub> and the incidence of severe hypoglycemia (as determined by the number of events that were not self-treated) were similar between the two treatments from the combined groups (<content styleCode="italics">see
</content>
                           <linkHtml href="#t8">Table 8</linkHtml>).
</paragraph>
                        <table width="100%">
                           <caption>Table 8: Type 2 Diabetes Mellitus — Adults
</caption>
                           <col width="60.000%" align="left"/>
                           <col width="14.175%" align="left"/>
                           <col width="13.325%" align="left"/>
                           <col width="12.500%" align="left"/>
                           <tfoot>
                              <tr>
                                 <td colspan="4" align="left" valign="top">
                                    <paragraph>
                                       <sup>a</sup> Values are Mean ± SD
</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" align="left" valign="top">
                                    <paragraph>
                                       <sup>b</sup> Severe hypoglycemia refers to hypoglycemia for which patients were not able to self-treat.
</paragraph>
                                 </td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr>
                                 <td align="left" valign="top" styleCode="Toprule Botrule Lrule Rrule"/>
                                 <td align="center" valign="top" styleCode="Toprule Botrule Rrule"/>
                                 <td colspan="2" align="center" valign="top" styleCode="Toprule Botrule Rrule">End point
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule"/>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">Baseline
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">HUMALOG<br/>+<br/>Basal
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">Humulin R<br/>+<br/>Basal
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">HbA<sub>1c</sub> (%)<sup>a</sup>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">8.9 ± 1.7
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">8.2 ± 1.3
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">8.2 ± 1.4
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Change from baseline HbA<sub>1c</sub> (%)<sup>a</sup>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">—
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">-0.7 ± 1.4
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">-0.7 ± 1.3
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Short-acting insulin dose (units/kg/day)<sup>a</sup>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.3 ± 0.2
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.3 ± 0.2
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.3 ± 0.2
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Change from baseline short-acting insulin dose (units/kg/day)<sup>a</sup>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">—
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.0 ± 0.1
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.0 ± 0.1
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Body weight (kg)<sup>a</sup>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">80 ± 15
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">81 ± 15
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">81 ± 15
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Weight change from baseline
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">—
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.8 ± 2.7
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">0.9 ± 2.6
</td>
                              </tr>
                              <tr>
                                 <td align="left" valign="top" styleCode="Botrule Lrule Rrule">Patients with severe hypoglycemia (n, %)<sup>b</sup>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">—
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">15 (2%)
</td>
                                 <td align="center" valign="top" styleCode="Botrule Rrule">16 (2%)
</td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s76">
               <id root="755fac15-a415-4d8a-86ac-bc89e9b82c98"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>16 HOW SUPPLIED/STORAGE AND HANDLING
</title>
               <text>
                  <paragraph>Product:    50090-1375</paragraph>
                  <paragraph>NDC:    50090-1375-0   10 mL in a VIAL   /  1  in a  CARTON </paragraph>
                  <paragraph>Product:    50090-1663</paragraph>
                  <paragraph>NDC:    50090-1663-0   3 mL in a SYRINGE   /  5  in a  CARTON </paragraph>
               </text>
               <effectiveTime value="20250401"/>
            </section>
         </component>
         <component>
            <section ID="s82">
               <id root="c0dc3cfd-135a-4de0-9b15-802fb7989fea"/>
               <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
               <title>17 PATIENT COUNSELING INFORMATION
</title>
               <text>
                  <paragraph>
                     <content styleCode="italics">Advise the patient to read the FDA-approved patient labeling</content> (Patient Information and Instructions for Use).
</paragraph>
               </text>
               <effectiveTime value="20230802"/>
               <component>
                  <section ID="s83">
                     <id root="cb4c2d25-ee63-4e29-805b-f3a5d364cdc6"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Never Share a HUMALOG Prefilled Pen, Cartridge, Reusable Pen Compatible with Lilly 3 mL Cartridges, or Syringe Between Patients</content>
                        </paragraph>
                        <paragraph>Advise patients that they must never share a HUMALOG prefilled pen, cartridge, or reusable pen compatible with Lilly 3 mL cartridges with another person, even if the needle is changed. Advise patients using HUMALOG vials not to share needles or syringes with another person. Sharing poses a risk for transmission of blood-borne pathogens <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s15">5.1</linkHtml>)]</content>.
</paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
               <component>
                  <section ID="s84">
                     <id root="dfc96242-b4c8-43c3-b49b-e412b40edb88"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Hyperglycemia or Hypoglycemia</content>
                        </paragraph>
                        <paragraph>Instruct patients on self-management procedures including glucose monitoring, proper injection technique, and management of hypoglycemia and hyperglycemia, especially at initiation of HUMALOG therapy. Instruct patients on handling of special situations such as intercurrent conditions (illness, stress, or emotional disturbances), an inadequate or skipped insulin dose, inadvertent administration of an increased insulin dose, inadequate food intake, and skipped meals. Instruct patients on the management of hypoglycemia.
</paragraph>
                        <paragraph>Inform patients that their ability to concentrate and react may be impaired as a result of hypoglycemia. Advise patients who have frequent hypoglycemia or reduced or absent warning signs of hypoglycemia to use caution when driving or operating machinery <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s17">5.3</linkHtml>)]</content>.
</paragraph>
                        <paragraph>Advise patients that changes in insulin regimen can predispose to hyperglycemia or hypoglycemia and that changes in insulin regimen should be made under close medical supervision <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s16">5.2</linkHtml>)]</content>.
</paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
               <component>
                  <section ID="s85">
                     <id root="a7a5746e-7479-4be9-bffd-bf9ffca31594"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Hypoglycemia due to Medication Errors</content>
                        </paragraph>
                        <paragraph>Instruct patients to always check the insulin container label before each injection to avoid mix-ups between insulin products <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s20">5.4</linkHtml>)]</content>.
</paragraph>
                        <paragraph>Inform patients that HUMALOG U-200 contains 2 times as much insulin per mL as HUMALOG U-100. The HUMALOG U-200 KwikPen dose window shows the number of units of HUMALOG U-200 to be injected so no dose conversion is required <content styleCode="italics">[see Dosage and Administration (<linkHtml href="#s3">2.1</linkHtml>)].</content>
                        </paragraph>
                        <paragraph>Instruct patients to NOT transfer HUMALOG U-200 from the HUMALOG U-200 KwikPen to a syringe. The markings on the syringe will not measure the dose correctly and this can result in overdosage and severe hypoglycemia. <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s20">5.4</linkHtml>)].</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
               <component>
                  <section ID="s86">
                     <id root="d543d7bf-42e8-4d84-9bdf-517c6fc26c93"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Hypersensitivity Reactions</content>
                        </paragraph>
                        <paragraph>Advise patients that hypersensitivity reactions have occurred with HUMALOG. Inform patients on the symptoms of hypersensitivity reactions <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s21">5.5</linkHtml>)]</content>.
</paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
               <component>
                  <section ID="s87">
                     <id root="abad3bc2-3992-4354-a138-e8ec6b318eeb"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Administration Instruction for HUMALOG U-200</content>
                        </paragraph>
                        <paragraph>Instruct patients to NOT mix HUMALOG U-200 with any other insulin.
</paragraph>
                     </text>
                     <effectiveTime value="20230721"/>
                  </section>
               </component>
               <component>
                  <section ID="s88">
                     <id root="17734db4-146c-4fe0-b752-9954faa1d23e"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Instructions For Patients Using Continuous Subcutaneous Insulin Pumps</content>
                        </paragraph>
                        <list listType="unordered" styleCode="Disc">
                           <item>Do not use HUMALOG U-200 in a subcutaneous insulin pump.
</item>
                           <item>Train patients in intensive insulin therapy with multiple injections and in the function of their pump and pump accessories.
</item>
                           <item>Instruct patients to follow healthcare provider recommendations when setting pump basal rates and bolus settings.
</item>
                           <item>Refer to the continuous subcutaneous infusion pump user manual to see if HUMALOG can be used with the pump. See recommended reservoir and infusion sets in the insulin pump user manual.
</item>
                           <item>Instruct patients to replace insulin in the reservoir at least every 7 days, or according to the pump user manual, whichever is shorter; infusion sets and infusion set insertion sites should be changed in accordance with the manufacturers' user manual. By following this schedule, patients avoid insulin degradation, infusion set occlusion, and loss of the insulin preservative.
</item>
                           <item>Instruct patients to discard insulin exposed to temperatures higher than 98.6°F (37°C). The temperature of the insulin may exceed ambient temperature when the pump housing, cover, tubing or sport case is exposed to sunlight or radiant heat.
</item>
                           <item>Instruct patients to inform healthcare provider and select a new site for infusion if infusion site becomes erythematous, pruritic, or thickened.
</item>
                           <item>Instruct patients on the risk of rapid hyperglycemia and ketosis due to pump malfunction, infusion set occlusion, leakage, disconnection or kinking, and degraded insulin. Instruct patients on the risk of hypoglycemia from pump malfunction. If these problems cannot be promptly corrected, instruct patients to resume therapy with subcutaneous insulin injection and contact their healthcare provider <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s14">5</linkHtml>) and How Supplied/Storage and Handling (<linkHtml href="#s78">16.2</linkHtml>)]</content>.
</item>
                        </list>
                        <paragraph>Manufactured by:<br/>Eli Lilly and Company<br/>Indianapolis, IN 46285, USA<br/>US License Number 1891
</paragraph>
                        <paragraph>
                           <sup>1</sup> 3 mL cartridge is for use in compatible insulin delivery devices, including HumaPen<sup>®</sup> Luxura<sup>®</sup> HD
</paragraph>
                        <paragraph>Humalog<sup>®</sup>, Humalog KwikPen<sup>®</sup>, Humalog Tempo Penä, Humalog<sup>®</sup> Junior KwikPen<sup>®</sup>, HumaPen<sup>®</sup>, HumaPen<sup>®</sup> Luxura<sup>®</sup> and HumaPen<sup>®</sup> Luxura<sup>®</sup> HD are trademarks of Eli Lilly and Company.
</paragraph>
                        <paragraph>www.humalog.com<br/>Copyright © 1996, 2023, Eli Lilly and Company. All rights reserved.
</paragraph>
                        <paragraph>LOG-0011-USPI-20230802
</paragraph>
                     </text>
                     <effectiveTime value="20230802"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s89">
               <id root="997e0e7c-0772-48e2-a30b-05eee1edad00"/>
               <code code="42230-3" codeSystem="2.16.840.1.113883.6.1" displayName="SPL PATIENT PACKAGE INSERT SECTION"/>
               <title>U-100 Patient Package Insert</title>
               <text>
                  <table width="100%">
                     <col width="50.000%" align="left"/>
                     <col width="25.000%" align="left"/>
                     <col width="25.000%" align="left"/>
                     <tfoot>
                        <tr>
                           <td colspan="2" align="left" valign="top">
                              <paragraph>This Patient Information has been approved by the U.S. Food and Drug Administration 
</paragraph>
                           </td>
                           <td align="right" valign="top">
                              <paragraph>Revised: July 2023
</paragraph>
                           </td>
                        </tr>
                     </tfoot>
                     <tbody>
                        <tr>
                           <td colspan="3" align="center" valign="top" styleCode="Toprule Botrule Lrule Rrule">
                              <content styleCode="bold">PATIENT INFORMATION</content>
                              <br/>
                              <content styleCode="bold">HUMALOG</content>
                              <content styleCode="bold">
                                 <sup>®
</sup>
                              </content>
                              <content styleCode="bold">(HU-ma-log)<br/>(insulin lispro)<br/>injection, for subcutaneous or intravenous use</content>
                              <br/>
                              <content styleCode="bold">100 units per mL</content>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Do not share your Humalog prefilled pens, cartridges, reusable pen compatible with Lilly 3 mL cartridges, needles, or syringes with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.</content>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">What is HUMALOG?</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>HUMALOG is a man-made fast-acting insulin used to control high blood sugar in adults and children with diabetes mellitus.
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Who should not take HUMALOG?</content>
                              <br/>
                              <content styleCode="bold">Do not take HUMALOG if you:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>are having an episode of low blood sugar (hypoglycemia).
</item>
                                 <item>have an allergy to HUMALOG or any of the ingredients in HUMALOG. See the end of this Patient Information leaflet for a complete list of ingredients in HUMALOG.
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Lrule Rrule">
                              <content styleCode="bold">What should I tell my healthcare provider before taking HUMALOG?</content>
                              <br/>
                              <content styleCode="bold">Before taking HUMALOG, tell your healthcare provider about all of your medical conditions, including if you:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>have kidney or liver problems.
</item>
                                 <item>take any other medicines, especially ones called TZDs (thiazolidinediones).
</item>
                                 <item>have heart failure or other heart problems. If you have heart failure, it may get worse while you take TZDs with HUMALOG.
</item>
                                 <item>are pregnant or plan to become pregnant. Talk with your healthcare provider about the best way to control your blood sugar if you plan to become pregnant or while you are pregnant.
</item>
                                 <item>are breastfeeding or plan to breastfeed. Talk with your healthcare provider about the best way to feed your baby while taking HUMALOG.
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Tell your healthcare provider about all the medicines you take,</content> including prescription and over-the-counter medicines, vitamins, and herbal supplements.<br/>
                              <content styleCode="bold">Before you start taking HUMALOG, talk to your healthcare provider about low blood sugar and how to manage it.</content>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Lrule Rrule">
                              <content styleCode="bold">How should I take HUMALOG?</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Read the <content styleCode="bold">Instructions for Use</content> that comes with your HUMALOG.
</item>
                                 <item>Take HUMALOG exactly as your healthcare provider tells you to. Your healthcare provider should tell you how much HUMALOG to take and when to take it.
</item>
                                 <item>
                                    <content styleCode="bold">HUMALOG starts acting fast. Inject HUMALOG within 15 minutes before or right after you eat a meal.</content>
                                 </item>
                                 <item>Know the type, strength and amount of insulin you take. <content styleCode="bold">Do not</content> change the type or amount of insulin you take unless your healthcare provider tells you to. The amount of insulin and the best time for you to take your insulin may need to change if you take different types of insulin.
</item>
                                 <item>Check your insulin label each time you give your injection to make sure you are taking the correct insulin.
</item>
                                 <item>Inject HUMALOG under the skin (subcutaneously) of your stomach area, buttocks, upper legs or upper arms, or by continuous infusion under the skin (subcutaneously) through an insulin pump into an area of your body recommended in the instructions that come with your insulin pump.
</item>
                                 <item>
                                    <content styleCode="bold">Change (rotate) your injection sites within the area you choose with each dose</content> to reduce your risk of getting lipodystrophy (pits in skin or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the injection sites.<list listType="unordered" styleCode="Circle">
                                       <item>
                                          <content styleCode="bold">Do not</content> use the exact same spot for each injection.
</item>
                                       <item>
                                          <content styleCode="bold">Do not</content> inject where the skin has pits, is thickened, or has lumps.
</item>
                                       <item>
                                          <content styleCode="bold">Do not</content> inject where the skin is tender, bruised, scaly or hard, or into scars or damaged skin.
</item>
                                    </list>
                                 </item>
                                 <item>
                                    <content styleCode="bold">Always use a new needle for each injection to help prevent infections and blocked needles. Do not reuse or share your needles with other people. You may give other people a serious infection or get a serious infection from them.</content>
                                 </item>
                                 <item>
                                    <content styleCode="bold">Check your blood sugar levels.</content> Ask your healthcare provider what your blood sugars should be and when you should check your blood sugar levels.<br/>
                                 </item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Keep HUMALOG and all medicines out of the reach of children.</content>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Your dose of HUMALOG may need to change because of a:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>change in physical activity or exercise, weight gain or loss, increased stress, illness, change in diet, or because of other medicines you take.
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">What should I avoid while taking HUMALOG?</content>
                              <br/>
                              <content styleCode="bold">While taking HUMALOG do not:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>drive or operate heavy machinery, until you know how HUMALOG affects you.
</item>
                                 <item>drink alcohol or take prescription or over-the-counter medicines that contain alcohol.
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Lrule Rrule">
                              <content styleCode="bold">What are the possible side effects of HUMALOG?</content>
                              <br/>
                              <content styleCode="bold">HUMALOG may cause serious side effects that can lead to death, including:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>
                                    <content styleCode="bold">low blood sugar (hypoglycemia).</content> Signs and symptoms of low blood sugar may include:
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Lrule">
                              <list listType="unordered" styleCode="Circle">
                                 <item>dizziness or light-headedness
</item>
                                 <item>sweating
</item>
                                 <item>confusion
</item>
                                 <item>headache
</item>
                                 <item>blurred vision
</item>
                              </list>
                           </td>
                           <td colspan="2" align="left" valign="top" styleCode="Rrule">
                              <list listType="unordered" styleCode="Circle">
                                 <item>slurred speech
</item>
                                 <item>shakiness
</item>
                                 <item>fast heartbeat
</item>
                                 <item>anxiety, irritability or mood changes
</item>
                                 <item>hunger
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Lrule Rrule">Your healthcare provider may prescribe a glucagon product for emergency use so that someone else can give you glucagon if your blood sugar becomes too low (severe hypoglycemia) and you are unable to take sugar by mouth.<br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>
                                    <content styleCode="bold">serious allergic reactions (whole body allergic reaction). Get medical help right away, if you have any of these signs or symptoms of a severe allergic reaction:</content>
                                 </item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Lrule">
                              <list listType="unordered" styleCode="Circle">
                                 <item>a rash over your whole body
</item>
                                 <item>trouble breathing
</item>
                                 <item>a fast heartbeat
</item>
                              </list>
                           </td>
                           <td colspan="2" align="left" valign="top" styleCode="Rrule">
                              <list listType="unordered" styleCode="Circle">
                                 <item>sweating
</item>
                                 <item>feel faint
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Lrule Rrule">
                              <list listType="unordered" styleCode="Disc">
                                 <item>
                                    <content styleCode="bold">low potassium in your blood (hypokalemia).</content>
                                 </item>
                                 <item>
                                    <content styleCode="bold">heart failure.</content> Taking certain diabetes pills called thiazolidinediones or “TZDs” with HUMALOG may cause heart failure in some people. This can happen even if you have never had heart failure or heart problems before. If you already have heart failure it may get worse while you take TZDs with HUMALOG. Your healthcare provider should monitor you closely while you are taking TZDs with HUMALOG. Tell your healthcare provider if you have any new or worse symptoms of heart failure including:
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Lrule">
                              <list listType="unordered" styleCode="Circle">
                                 <item>shortness of breath
</item>
                                 <item>swelling of your ankles or feet
</item>
                              </list>
                           </td>
                           <td colspan="2" align="left" valign="top" styleCode="Rrule">
                              <list listType="unordered" styleCode="Circle">
                                 <item>sudden weight gain
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Lrule Rrule">Treatment with TZDs and HUMALOG may need to be adjusted or stopped by your healthcare provider if you have new or worse heart failure.<br/>
                              <content styleCode="bold">Get emergency medical help if you have:</content>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Lrule">
                              <list listType="unordered" styleCode="Disc">
                                 <item>trouble breathing
</item>
                                 <item>shortness of breath
</item>
                                 <item>fast heartbeat
</item>
                                 <item>swelling of your face, tongue, or throat
</item>
                              </list>
                           </td>
                           <td colspan="2" align="left" valign="top" styleCode="Rrule">
                              <list listType="unordered" styleCode="Disc">
                                 <item>sweating
</item>
                                 <item>extreme drowsiness
</item>
                                 <item>dizziness
</item>
                                 <item>confusion
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Lrule Rrule">
                              <content styleCode="bold">The most common side effects of HUMALOG include:</content>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Lrule">
                              <list listType="unordered" styleCode="Disc">
                                 <item>low blood sugar (hypoglycemia)
</item>
                                 <item>reactions at your injection site
</item>
                                 <item>skin thickening or pits at the injection site<br/>(lipodystrophy)
</item>
                              </list>
                           </td>
                           <td colspan="2" align="left" valign="top" styleCode="Rrule">
                              <list listType="unordered" styleCode="Disc">
                                 <item>weight gain
</item>
                                 <item>swelling in your hands or feet
</item>
                                 <item>itching
</item>
                                 <item>rash
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">These are not all the possible side effects of HUMALOG.</content> Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
</td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">General information about the safe and effective use of HUMALOG.</content>
                              <br/>Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not take HUMALOG for a condition for which it was not prescribed. Do not give HUMALOG to other people, even if they have the same symptoms that you have. It may harm them.<br/>This Patient Information leaflet summarizes the most important information about HUMALOG. If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for information about HUMALOG that is written for health professionals.
</td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">What are the ingredients in HUMALOG?</content>
                              <br/>
                              <content styleCode="bold">Active ingredient:</content> insulin lispro<br/>
                              <content styleCode="bold">Inactive ingredients:</content> dibasic sodium phosphate, glycerin, hydrochloric acid, metacresol, trace amounts of phenol, sodium hydroxide, zinc oxide (zinc ion), and Water for Injection, USP.<br/>Humalog<sup>®</sup> is a registered trademark of Eli Lilly and Company.<br/>Manufactured by: Eli Lilly and Company, Indianapolis, IN 46285, USA, US License Number 1891<br/>Copyright © 1996, 2023, Eli Lilly and Company. All rights reserved.<br/>For more information, go to www.humalog.com or call 1-800-545-5979.
</td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>LOG-0007-PPI-20230721
</paragraph>
               </text>
               <effectiveTime value="20230721"/>
            </section>
         </component>
         <component>
            <section ID="s90">
               <id root="48c6f199-5ab9-4458-a1b8-0f6e04d83c49"/>
               <code code="59845-8" codeSystem="2.16.840.1.113883.6.1" displayName="INSTRUCTIONS FOR USE SECTION"/>
               <title>U-100 Vial Instructions for Use</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">INSTRUCTIONS FOR USE</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">HUMALOG</content>
                     <content styleCode="bold">
                        <sup>®
</sup>
                     </content>
                     <content styleCode="bold">(HU-ma-log)<br/>(insulin lispro)<br/>injection, for subcutaneous use</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">3 mL or 10 mL multiple-dose vial (100 units per mL, U-100)</content>
                  </paragraph>
                  <paragraph>Read this Instructions for Use before you start taking HUMALOG and each time you get a new vial. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.
</paragraph>
                  <paragraph>
                     <content styleCode="bold">Do not share your needles or syringes with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Supplies needed to give your injection</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>a multiple-dose HUMALOG vial
</item>
                     <item>a U-100 insulin syringe and needle
</item>
                     <item>2 alcohol swabs
</item>
                     <item>gauze
</item>
                     <item>1 sharps container for throwing away used needles and syringes. See <content styleCode="bold">“<linkHtml href="#p01">Disposing of used needles and syringes</linkHtml>”</content> at the end of these instructions.
</item>
                  </list>
                  <table width="100%" styleCode="Noautorules">
                     <col width="21.850%" align="left"/>
                     <col width="78.150%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="center" valign="middle">
                              <content styleCode="bold">Vial</content>
                           </td>
                           <td align="center" valign="middle">
                              <content styleCode="bold">Syringe</content>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" valign="middle">
                              <renderMultiMedia ID="f04" referencedObject="mm04"/>
                           </td>
                           <td align="center" valign="middle">
                              <renderMultiMedia ID="f05" referencedObject="mm05"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">Preparing your HUMALOG dose</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Wash your hands with soap and water.
</item>
                     <item>Check the HUMALOG label to make sure you are taking the right type of insulin. This is especially important if you use more than 1 type of insulin.
</item>
                     <item>HUMALOG should look clear and colorless. <content styleCode="bold">Do not</content> use HUMALOG if it is thick, cloudy, or colored, or if you see lumps or particles in it.
</item>
                     <item>
                        <content styleCode="bold">Do not</content> use HUMALOG past the expiration date printed on the label or 28 days after you first use it.
</item>
                     <item>
                        <content styleCode="bold">Always use a new syringe and needle for each injection to prevent infections and blocked needles. Do not reuse or share your syringes or needles with other people. You may give other people a serious infection or get a serious infection from them.</content>
                     </item>
                  </list>
                  <table width="100%">
                     <col width="53.250%" align="left"/>
                     <col width="46.750%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top" styleCode="Toprule Botrule Lrule Rrule">
                              <content styleCode="bold">Step 1:</content>
                              <br/>If you are using a new vial, pull off the plastic Protective Cap, but <content styleCode="bold">do not</content> remove the Rubber Stopper.
</td>
                           <td align="center" valign="top" styleCode="Toprule Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f06" referencedObject="mm06"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Step 2:</content>
                              <br/>Wipe the Rubber Stopper with an alcohol swab.
</td>
                           <td align="center" valign="top" styleCode="Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f07" referencedObject="mm07"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Step 3:</content>
                              <br/>Remove the Needle Shield from the syringe by pulling the Needle Shield straight off. Hold the syringe with the needle pointing up. Pull down on the Plunger until the Plunger Tip reaches the line for the number of units for your prescribed dose.
</td>
                           <td align="center" valign="top" styleCode="Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f08" referencedObject="mm08"/>(Example Dose: 20 units shown)<br/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Step 4:</content>
                              <br/>Push the needle through the Rubber Stopper of the vial.
</td>
                           <td align="center" valign="top" styleCode="Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f09" referencedObject="mm09"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Step 5:</content>
                              <br/>Push the Plunger all the way in. This puts air into the vial.
</td>
                           <td align="center" valign="top" styleCode="Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f10" referencedObject="mm10"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Lrule Rrule">
                              <content styleCode="bold">Step 6:</content>
                              <br/>Turn the vial and syringe upside down and slowly pull the Plunger down until the Plunger Tip is a few units past the line for your prescribed dose.
</td>
                           <td align="center" valign="top" styleCode="Rrule">
                              <br/>
                              <renderMultiMedia ID="f11" referencedObject="mm11"/>(Example Dose: 20 units <br/>Plunger is shown at 24 units)
</td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">If there are air bubbles, tap the syringe gently a few times to let any air bubbles rise to the top.
</td>
                           <td align="center" valign="top" styleCode="Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f12" referencedObject="mm12"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Step 7:</content>
                              <br/>Slowly push the Plunger up until the Plunger Tip reaches the line for your prescribed dose.<br/>Check the syringe to make sure that you have the right dose.
</td>
                           <td align="center" valign="top" styleCode="Botrule Rrule">
                              <renderMultiMedia ID="f13" referencedObject="mm13"/>(Example Dose: 20 units shown)
</td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Step 8:</content>
                              <br/>Pull the syringe out of the Rubber Stopper of the vial.
</td>
                           <td align="center" valign="top" styleCode="Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f14" referencedObject="mm14"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">If you use HUMALOG with NPH insulin:</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>NPH insulin is the <content styleCode="bold">only</content> type of insulin that can be mixed with HUMALOG. Do not mix HUMALOG with any other type of insulin.
</item>
                     <item>HUMALOG should be drawn up into the syringe first, before you draw up your NPH insulin. Talk to your healthcare provider if you are not sure about the right way to mix HUMALOG and NPH insulin.
</item>
                     <item>Give your injection right away.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Giving your HUMALOG injection with a syringe</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Inject your insulin exactly as your healthcare provider has shown you. Your healthcare provider should tell you if you should pinch the skin before injecting.
</item>
                     <item>
                        <content styleCode="bold">HUMALOG starts acting fast,</content> so give your injection within 15 minutes before or right after you eat a meal.
</item>
                     <item>Change (rotate) your injection sites within the area you choose for each dose to reduce your risk of getting lipodystrophy (pits in skin or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the injection sites.
</item>
                     <item>
                        <content styleCode="bold">Do not</content> inject where the skin has pits, is thickened, or has lumps.
</item>
                     <item>
                        <content styleCode="bold">Do not</content> inject where the skin is tender, bruised, scaly or hard, or into scars or damaged skin.
</item>
                  </list>
                  <table width="100%">
                     <col width="53.750%" align="left"/>
                     <col width="46.250%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top" styleCode="Toprule Botrule Lrule Rrule">
                              <content styleCode="bold">Step 9:</content>
                              <br/>Choose your injection site.<br/>HUMALOG is injected under the skin (subcutaneously) of your stomach area (abdomen), buttocks, upper legs or upper arms.<br/>Wipe the skin with an alcohol swab. Let the injection site dry before you inject your dose.
</td>
                           <td align="center" valign="top" styleCode="Toprule Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f15" referencedObject="mm15"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Step 10:</content>
                              <br/>Insert the needle into your skin.
</td>
                           <td align="center" valign="top" styleCode="Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f16" referencedObject="mm16"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Step 11:</content>
                              <br/>Push down on the Plunger to inject your dose.<br/>The needle should stay in your skin for at least 5 seconds to make sure you have injected all of your insulin dose.
</td>
                           <td align="center" valign="top" styleCode="Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f17" referencedObject="mm17"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Step 12:</content>
                              <br/>Pull the needle out of your skin.<br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>If you see blood after you take the needle out of your skin, press the injection site with a piece of gauze or an alcohol swab. <content styleCode="bold">Do not</content> rub the area.
</item>
                                 <item>
                                    <content styleCode="bold">Do not</content> recap the needle. Recapping the needle can lead to a needle stick injury.
</item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f18" referencedObject="mm18"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">Giving your HUMALOG using an insulin pump</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>HUMALOG should be given into an area of your body recommended in the instructions that come with your insulin pump.
</item>
                     <item>Change your infusion set and rotate the infusion set insertion site according to the manufacturer's user manual.
</item>
                     <item>Change (rotate) your insertion sites within the area you choose for each insertion to reduce your risk of getting lipodystrophy (pits in skin or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the insertion sites. <content styleCode="bold">Do not</content> insert into the exact same spot for each insertion. <content styleCode="bold">Do not</content> insert where the skin has pits, is thickened, or has lumps. <content styleCode="bold">Do not</content> insert where the skin is tender, bruised, scaly or hard, or into scars or damaged skin.
</item>
                     <item>Change the insulin in the reservoir at least every 7 days or according to the pump user manual, whichever is shorter, even if you have not used all of the insulin.
</item>
                     <item>
                        <content styleCode="bold">Do not</content> dilute or mix HUMALOG with any other type of insulin in your insulin pump.
</item>
                     <item>See your insulin pump manual for instructions or talk to your healthcare provider.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Disposing of used needles and syringes</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Put your used needles and syringes in a FDA-cleared sharps disposal container right away after use. <content styleCode="bold">Do not</content> throw away (dispose of) loose needles and syringes in your household trash.
</item>
                     <item>If you do not have a FDA-cleared sharps disposal container, you may use a household container that is:<list listType="unordered" styleCode="Disc">
                           <item>
                              <caption>-
</caption>made of a heavy-duty plastic,
</item>
                           <item>
                              <caption>-
</caption>can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out,
</item>
                           <item>
                              <caption>-
</caption>upright and stable during use,
</item>
                           <item>
                              <caption>-
</caption>leak-resistant, and
</item>
                           <item>
                              <caption>-
</caption>properly labeled to warn of hazardous waste inside the container.
</item>
                        </list>
                     </item>
                     <item>When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used needles and syringes. For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA's website at: http://www.fda.gov/safesharpsdisposal.
</item>
                     <item>
                        <content styleCode="bold">Do not</content> dispose of your used sharps disposal container in your household trash unless your community guidelines permit this. <content styleCode="bold">Do not</content> recycle your used sharps disposal container.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">How should I store HUMALOG?</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">All unopened vials:</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Store all unopened vials in the refrigerator at 36°F to 46°F (2°C to 8°C).
</item>
                     <item>
                        <content styleCode="bold">Do not</content> freeze. <content styleCode="bold">Do not</content> use if HUMALOG has been frozen.
</item>
                     <item>Keep away from heat and out of direct light.
</item>
                     <item>Unopened vials can be used until the expiration date on the carton and label, if they have been stored in the refrigerator.
</item>
                     <item>Unopened vials should be thrown away after 28 days, if they are stored at room temperature.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">After vials have been opened:</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Store opened vials in the refrigerator or at room temperature up to 86°F (30°C) for up to 28 days.
</item>
                     <item>Keep vials away from heat and out of direct light.
</item>
                     <item>Throw away all opened vials after 28 days of use, even if there is insulin left in the vial.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">HUMALOG in an insulin pump:</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Throw away HUMALOG in the pump reservoir if it has been exposed to temperatures higher than 98.6°F (37°C).
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Keep HUMALOG vials, syringes, needles and all medicines out of the reach of children.</content>
                  </paragraph>
                  <paragraph>If you have any questions or problems with your HUMALOG, contact Lilly at 1-800-Lilly-Rx (1-800-545-5979) or call your healthcare provider for help. For more information on HUMALOG and insulin, go to <content styleCode="underline">www.humalog.com</content>.
</paragraph>
                  <paragraph>Manufactured by:<br/>Eli Lilly and Company<br/>Indianapolis, IN 46285, USA<br/>US License Number 1891
</paragraph>
                  <paragraph>This Instructions for Use has been approved by the U.S. Food and Drug Administration.
</paragraph>
                  <paragraph>Revised: July 2023
</paragraph>
                  <paragraph>
                     <renderMultiMedia ID="f19" referencedObject="mm19"/>
                  </paragraph>
                  <paragraph>Scan this code to launch the humalog.com website
</paragraph>
                  <paragraph>Humalog<sup>®</sup> is a registered trademark of Eli Lilly and Company.
</paragraph>
                  <paragraph>Copyright © 1996, 2023, Eli Lilly and Company. All rights reserved.
</paragraph>
                  <paragraph>LOGVL-0009-IFU-20230721
</paragraph>
               </text>
               <effectiveTime value="20230721"/>
               <component>
                  <observationMedia ID="mm04">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-vial-ifu-1-v6.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm05">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-vial-ifu-2-v3.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm06">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-vial-ifu-3.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm07">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-vial-ifu-4.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm08">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-vial-ifu-5.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm09">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-vial-ifu-6.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm10">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-vial-ifu-7.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm11">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-vial-ifu-8.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm12">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-vial-ifu-9.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm13">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-vial-ifu-10.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm14">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-vial-ifu-11.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm15">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-vial-ifu-12-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm16">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-vial-ifu-13.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm17">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-vial-ifu-14.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm18">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-vial-ifu-15.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm19">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-QR.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="s92">
               <id root="87ae54e1-f058-4b84-b6ac-d28b654fbd15"/>
               <code code="59845-8" codeSystem="2.16.840.1.113883.6.1" displayName="INSTRUCTIONS FOR USE SECTION"/>
               <title>KwikPen U-100 Instructions for Use</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">INSTRUCTIONS FOR USE</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">HUMALOG (HU-ma-log) KwikPen</content>
                     <content styleCode="bold">
                        <sup>®</sup>
                     </content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">(insulin lispro)</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">injection, for subcutaneous use</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">3 mL single-patient-use pen (100 units per mL)</content>
                  </paragraph>
                  <renderMultiMedia ID="f36" referencedObject="mm36"/>
                  <paragraph>Read the Instructions for Use before you start taking HUMALOG<sup>®</sup> and each time you get another KwikPen<sup>®</sup>. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.
</paragraph>
                  <paragraph>
                     <content styleCode="bold">Do not share your HUMALOG KwikPen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.</content>
                  </paragraph>
                  <paragraph>HUMALOG KwikPen (“Pen”) is a disposable single-patient-use prefilled pen containing 300 units of HUMALOG. You can give yourself more than 1 dose from the Pen. Each turn (click) of the Dose Knob dials 1 unit of insulin. You can give from 1 to 60 units in a single injection. <content styleCode="bold">If your dose is more than 60 units, you will need to give yourself more than 1 injection.</content> The Plunger only moves a little with each injection, and you may not notice that it moves. The Plunger will only reach the end of the cartridge when you have used all 300 units in the Pen.
</paragraph>
                  <paragraph>
                     <content styleCode="bold">People who are blind or have vision problems should not use the Pen without help from a person trained to use the Pen.</content>
                  </paragraph>
                  <renderMultiMedia ID="f37" referencedObject="mm37"/>
                  <paragraph>
                     <content styleCode="bold">How to recognize your HUMALOG KwikPen</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Pen color: Dark blue
</item>
                     <item>Dose Knob: Dark blue
</item>
                     <item>Labels: White label with burgundy stripe
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Supplies you will need to give your injection</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>HUMALOG KwikPen
</item>
                     <item>KwikPen compatible Needle (Becton, Dickinson and Company Pen Needles recommended)
</item>
                     <item>Alcohol swab
</item>
                     <item>Gauze
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Preparing your Pen</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Wash your hands with soap and water.
</item>
                     <item>Check your Pen to make sure you are taking the right type of insulin. This is especially important if you use more than 1 type of insulin.
</item>
                     <item>
                        <content styleCode="bold">Do not</content> use your Pen past the expiration date printed on the Label or for more than 28 days after you first start using the Pen.
</item>
                     <item>
                        <content styleCode="bold">Always use a new needle for each injection to help prevent infections and blocked needles. Do not reuse or share your needles with other people. You may give other people a serious infection or get a serious infection from them.</content>
                     </item>
                  </list>
                  <table width="100%">
                     <col width="51.300%" align="left"/>
                     <col width="48.700%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top" styleCode="Toprule Botrule">
                              <content styleCode="bold">Step 1:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Pull the Pen Cap straight off.<list listType="unordered" styleCode="Disc">
                                       <item>
                                          <caption>-
</caption>
                                          <content styleCode="bold">Do not</content> remove the Pen Label.
</item>
                                    </list>
                                 </item>
                                 <item>Wipe the Rubber Seal with an alcohol swab.
</item>
                              </list>
                              <br/>
                              <content styleCode="bold">Step 2:</content>
                              <list listType="unordered" styleCode="Disc">
                                 <item>
                                    <content styleCode="bold">Check the liquid in the Pen.</content>
                                    <br/>HUMALOG should look clear and colorless. <content styleCode="bold">Do not</content> use if it is cloudy, colored, or has particles or clumps in it.<br/>
                                 </item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Toprule Botrule">
                              <br/>
                              <renderMultiMedia ID="f38" referencedObject="mm38"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 3:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>
                                    <content styleCode="bold">Select a new Needle.</content>
                                 </item>
                                 <item>Pull off the Paper Tab from the Outer Needle Shield.
</item>
                              </list>
                           </td>
                           <td align="center" valign="middle" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f39" referencedObject="mm39"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 4:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Push the capped Needle straight onto the Pen and twist the Needle on until it is tight.
</item>
                              </list>
                           </td>
                           <td align="center" valign="middle" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f40" referencedObject="mm40"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 5:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Pull off the Outer Needle Shield. <content styleCode="bold">Do not</content> throw it away.
</item>
                                 <item>Pull off the Inner Needle Shield and throw it away.
</item>
                              </list>
                           </td>
                           <td align="center" valign="middle" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f41" referencedObject="mm41"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">Priming your Pen</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Prime before each injection.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Priming your Pen means removing the air from the Needle and Cartridge that may collect during normal use and ensures that the Pen is working correctly.
</item>
                     <item>If you <content styleCode="bold">do not</content> prime before each injection, you may get too much or too little insulin.
</item>
                  </list>
                  <table width="100%">
                     <col width="51.300%" align="left"/>
                     <col width="48.700%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top" styleCode="Toprule Botrule">
                              <content styleCode="bold">Step 6:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>To prime your Pen, turn the Dose Knob to select 2 units.
</item>
                              </list>
                           </td>
                           <td align="center" valign="middle" styleCode="Toprule Botrule">
                              <br/>
                              <renderMultiMedia ID="f42" referencedObject="mm42"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 7:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Hold your Pen with the Needle pointing up. Tap the Cartridge Holder gently to collect air bubbles at the top.
</item>
                              </list>
                           </td>
                           <td align="center" valign="middle" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f43" referencedObject="mm43"/>
                           </td>
                        </tr>
                        <tr>
                           <td rowspan="2" align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 8:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Continue holding your Pen with Needle pointing up. Push the Dose Knob in until it stops, and “0” is seen in the Dose Window. Hold the Dose Knob in and <content styleCode="bold">count to 5 slowly</content>.<br/>
                                    <br/>You should see insulin at the tip of the Needle.
											<list listType="unordered" styleCode="Disc">
                                       <item>
                                          <caption>-
</caption>If you <content styleCode="bold">do not</content> see insulin, repeat priming steps 6 to 8, no more than 4 times.
</item>
                                       <item>
                                          <caption>-
</caption>If you <content styleCode="bold">still do not</content> see insulin, change the Needle and repeat priming steps 6 to 8.
</item>
                                    </list>
                                 </item>
                              </list>Small air bubbles are normal and will not affect your dose.<br/>
                           </td>
                           <td align="center" valign="middle">
                              <br/>
                              <renderMultiMedia ID="f44" referencedObject="mm44"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" valign="middle" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f45" referencedObject="mm45"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">Selecting your dose</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>You can give from 1 to 60 units in a single injection.
</item>
                     <item>If your dose is more than 60 units, you will need to give more than 1 injection.<list listType="unordered" styleCode="Disc">
                           <item>
                              <caption>-
</caption>If you need help with dividing up your dose the right way, ask your healthcare provider.
</item>
                           <item>
                              <caption>-
</caption>Use a new Needle for each injection and repeat the priming step.
</item>
                        </list>
                     </item>
                  </list>
                  <table width="100%">
                     <col width="49.700%" align="left"/>
                     <col width="50.300%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top" styleCode="Toprule Botrule">
                              <content styleCode="bold">Step 9:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Turn the Dose Knob to select the number of units you need to inject. The Dose Indicator should line up with your dose.<list listType="unordered" styleCode="Disc">
                                       <item>
                                          <caption>-
</caption>The Pen dials 1 unit at a time.
</item>
                                       <item>
                                          <caption>-
</caption>The Dose Knob clicks as you turn it.
</item>
                                       <item>
                                          <caption>-
</caption>
                                          <content styleCode="bold">Do not</content> dial your dose by counting the clicks. You may dial the wrong dose. This may lead to you getting too much insulin or not enough insulin.
</item>
                                       <item>
                                          <caption>-
</caption>The dose can be corrected by turning the Dose Knob in either direction until the correct dose lines up with the Dose Indicator.
</item>
                                       <item>
                                          <caption>-
</caption>The <content styleCode="bold">even</content> numbers (for example, 12) are printed on the dial.
</item>
                                       <item>
                                          <caption>-
</caption>The <content styleCode="bold">odd</content> numbers, (for example, 25) after the number 1, are shown as full lines.
</item>
                                    </list>
                                 </item>
                                 <item>
                                    <content styleCode="bold">Always check the number in the Dose Window to make sure you have dialed the correct dose.</content>
                                 </item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Toprule Botrule">
                              <br/>
                              <renderMultiMedia ID="f46" referencedObject="mm46"/>
                              <br/>
                              <renderMultiMedia ID="f47" referencedObject="mm47"/>(Example: 12 units shown in the Dose Window)<br/>
                              <br/>
                              <br/>
                              <renderMultiMedia ID="f48" referencedObject="mm48"/>(Example: 25 units shown in the Dose Window)
</td>
                        </tr>
                     </tbody>
                  </table>
                  <list listType="unordered" styleCode="Disc">
                     <item>The Pen will not let you dial more than the number of units left in the Pen.
</item>
                     <item>If you need to inject more than the number of units left in the Pen, you may either:<list listType="unordered" styleCode="Disc">
                           <item>
                              <caption>-
</caption>inject the amount left in your Pen and then use a new Pen to give the rest of your dose, <content styleCode="bold">or</content>
                           </item>
                           <item>
                              <caption>-
</caption>get a new Pen and inject the full dose.
</item>
                        </list>
                     </item>
                     <item>It is normal to see a small amount of insulin left in the Pen that you can not inject.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Giving your injection</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Inject your insulin as your healthcare provider has shown you.
</item>
                     <item>Change (rotate) your injection sites within the area you choose for each dose to reduce your risk of getting lipodystrophy (pits in skin or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the injection sites.
</item>
                     <item>
                        <content styleCode="bold">Do not</content> inject where the skin has pits, is thickened, or has lumps.
</item>
                     <item>
                        <content styleCode="bold">Do not</content> inject where the skin is tender, bruised, scaly or hard, or into scars or damaged skin.
</item>
                     <item>
                        <content styleCode="bold">Do not</content> try to change your dose while injecting.
</item>
                  </list>
                  <table width="100%">
                     <col width="51.300%" align="left"/>
                     <col width="48.700%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top" styleCode="Toprule Botrule">
                              <content styleCode="bold">Step 10:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Choose your injection site.<br/>HUMALOG is injected under the skin (subcutaneously) of your stomach area, buttocks, upper legs or upper arms.
</item>
                                 <item>Wipe your skin with an alcohol swab, and let your skin dry before you inject your dose.
</item>
                              </list>
                           </td>
                           <td align="center" valign="middle" styleCode="Toprule Botrule">
                              <br/>
                              <renderMultiMedia ID="f49" referencedObject="mm49"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 11:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Insert the Needle into your skin.
</item>
                                 <item>Push the Dose Knob all the way in.
</item>
                                 <item>Continue to hold the Dose Knob in and <content styleCode="bold">slowly count to 5</content> before removing the Needle.<br/>
                                    <renderMultiMedia ID="f50" referencedObject="mm50"/>
                                    <content styleCode="bold">Do not</content> try to inject your insulin by turning the Dose Knob. You will <content styleCode="bold">not</content> receive your insulin by turning the Dose Knob.<br/>
                                 </item>
                              </list>
                           </td>
                           <td align="center" valign="middle" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f51" referencedObject="mm51"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 12:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Pull the Needle out of your skin.<br/>A drop of insulin at the Needle tip is normal. It will not affect your dose.
</item>
                                 <item>Check the number in the Dose Window.<list listType="unordered" styleCode="Disc">
                                       <item>
                                          <caption>-
</caption>If you see “0” in the Dose Window, you have received the full amount you dialed.
</item>
                                       <item>
                                          <caption>-
</caption>If you do not see “0” in the Dose Window, do not redial. Insert the Needle into your skin and finish your injection.
</item>
                                       <item>
                                          <caption>-
</caption>If you <content styleCode="bold">still</content> do not think you received the full amount you dialed for your injection, <content styleCode="bold">do not start over or repeat the injection.</content> Monitor your blood glucose as instructed by your healthcare provider.
</item>
                                       <item>
                                          <caption>-
</caption>If you normally need to give 2 injections for your full dose, be sure to give your second injection.
</item>
                                    </list>
                                 </item>
                              </list>The Plunger only moves a little with each injection, and you may not notice that it moves.<br/>If you see blood after you take the Needle out of your skin, press the injection site lightly with a piece of gauze or an alcohol swab. <content styleCode="bold">Do not</content> rub the area.<br/>
                           </td>
                           <td align="center" valign="top" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f52" referencedObject="mm44"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">After your injection</content>
                  </paragraph>
                  <table width="100%">
                     <col width="51.300%" align="left"/>
                     <col width="48.700%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top" styleCode="Toprule Botrule">
                              <content styleCode="bold">Step 13:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Carefully replace the Outer Needle Shield.
</item>
                              </list>
                           </td>
                           <td align="center" valign="middle" styleCode="Toprule Botrule">
                              <br/>
                              <renderMultiMedia ID="f53" referencedObject="mm53"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 14:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Unscrew the capped Needle and throw it away (see <content styleCode="bold">Disposing of Pens and Needles</content> section).
</item>
                                 <item>
                                    <content styleCode="bold">Do not</content> store the Pen with the Needle attached to prevent leaking, blocking the Needle, and air from entering the Pen.
</item>
                              </list>
                           </td>
                           <td align="center" valign="middle" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f54" referencedObject="mm54"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 15:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Replace the Pen Cap by lining up the Cap Clip with the Dose Indicator and pushing straight on.
</item>
                              </list>
                           </td>
                           <td align="center" valign="middle" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f55" referencedObject="mm55"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">Disposing of Pens and Needles</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>The used Pen may be discarded in your household trash after you have removed the needle.
</item>
                     <item>Put your used needles in a FDA-cleared sharps disposal container right away after use. Do not throw away (dispose of) loose needles in your household trash.
</item>
                     <item>If you do not have a FDA-cleared sharps disposal container, you may use a household container that is:<list listType="unordered" styleCode="Disc">
                           <item>
                              <caption>-
</caption>made of a heavy-duty plastic,
</item>
                           <item>
                              <caption>-
</caption>can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out,
</item>
                           <item>
                              <caption>-
</caption>upright and stable during use,
</item>
                           <item>
                              <caption>-
</caption>leak-resistant, and
</item>
                           <item>
                              <caption>-
</caption>properly labeled to warn of hazardous waste inside the container.
</item>
                        </list>
                     </item>
                     <item>When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used needles and syringes. For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA's website at: http://www.fda.gov/safesharpsdisposal
</item>
                     <item>Do not dispose of your used sharps disposal container in your household trash unless your community guidelines permit this. Do not recycle your used sharps disposal container.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Storing your Pen</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Unused Pens</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Store unused Pens in the refrigerator at 36°F to 46°F (2°C to 8°C).
</item>
                     <item>
                        <content styleCode="bold">Do not</content> freeze your insulin. <content styleCode="bold">Do not</content> use if it has been frozen.
</item>
                     <item>Unused Pens may be used until the expiration date printed on the Label, if the Pen has been kept in the refrigerator.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">In-use Pen</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Store the Pen you are currently using at room temperature [up to 86°F (30°C)]. Keep away from heat and light.
</item>
                     <item>Throw away the HUMALOG Pen you are using after 28 days, even if it still has insulin left in it.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">General information about the safe and effective use of your Pen</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>
                        <content styleCode="bold">Keep your Pen and needles out of the reach of children.</content>
                     </item>
                     <item>
                        <content styleCode="bold">Do not</content> use your Pen if any part looks broken or damaged.
</item>
                     <item>Always carry an extra Pen in case yours is lost or damaged.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Troubleshooting</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>If you can not remove the Pen Cap, gently twist the cap back and forth, and then pull the cap straight off.
</item>
                     <item>If the Dose Knob is hard to push:<list listType="unordered" styleCode="Disc">
                           <item>
                              <caption>-
</caption>Pushing the Dose Knob more slowly will make it easier to inject.
</item>
                           <item>
                              <caption>-
</caption>Your Needle may be blocked. Put on a new Needle and prime the Pen.
</item>
                           <item>
                              <caption>-
</caption>You may have dust, food, or liquid inside the Pen. Throw the Pen away and get a new Pen.
</item>
                        </list>
                     </item>
                  </list>
                  <paragraph>If you have any questions or problems with your HUMALOG KwikPen, contact Lilly at 1-800-LillyRx (1-800-545-5979) or call your healthcare provider for help. For more information on HUMALOG KwikPen and insulin, go to <content styleCode="underline">www.humalog.com</content>.
</paragraph>
                  <paragraph>Manufactured by:<br/>Eli Lilly and Company<br/>Indianapolis, IN 46285, USA<br/>US License Number 1891
</paragraph>
                  <paragraph>This Instructions for Use has been approved by the U.S. Food and Drug Administration.
</paragraph>
                  <paragraph>Revised: July 2023
</paragraph>
                  <paragraph>
                     <renderMultiMedia ID="f56" referencedObject="mm56"/>
                  </paragraph>
                  <paragraph>Scan this code to launch (www.humalog.com)
</paragraph>
                  <paragraph>HUMALOG<sup>®</sup> and HUMALOG KwikPen<sup>®</sup> are registered trademarks of Eli Lilly and Company.
</paragraph>
                  <paragraph>Copyright © 2007, 2023, Eli Lilly and Company. All rights reserved.
</paragraph>
                  <table width="100%">
                     <col width="100.000%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top" styleCode="Toprule Botrule Lrule Rrule">
                              <content styleCode="bold">HUMALOG KwikPen</content> meets the current dose accuracy and functional requirements of ISO 11608-1.
</td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>LOGKP-0009-IFU-20230721
</paragraph>
               </text>
               <effectiveTime value="20230721"/>
               <component>
                  <observationMedia ID="mm36">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u100-ifu-1-v4.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm37">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u100-ifu-2-v4.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm38">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u100-ifu-3-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm39">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u100-ifu-4-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm40">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u100-ifu-5-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm41">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u100-ifu-6-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm42">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u100-ifu-7-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm43">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u100-ifu-8-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm44">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u100-ifu-9-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm45">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u100-ifu-10-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm46">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u100-ifu-11-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm47">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u100-ifu-12-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm48">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u100-ifu-13-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm49">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-inj-sites-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm50">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-5sec-clock.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm51">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u100-ifu-16-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm53">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u100-ifu-18-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm54">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u100-ifu-19-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm55">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u100-ifu-20-v3.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm56">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-QR.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="s93">
               <id root="8a910095-85b1-4045-83fa-9d97d111fc78"/>
               <code code="59845-8" codeSystem="2.16.840.1.113883.6.1" displayName="INSTRUCTIONS FOR USE SECTION"/>
               <title>Junior KwikPen U-100 Vial Instructions for Use</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">INSTRUCTIONS FOR USE</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">HUMALOG</content>
                     <content styleCode="bold">
                        <sup>®
</sup>
                     </content>
                     <content styleCode="bold">(HU-ma-log) Junior KwikPen</content>
                     <content styleCode="bold">
                        <sup>®</sup>
                     </content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">(insulin lispro)</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">injection, for subcutaneous use</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">3 mL single-patient-use pen (100 units per mL)</content>
                  </paragraph>
                  <renderMultiMedia ID="f57" referencedObject="mm57"/>
                  <paragraph>Read the Instructions for Use before you start taking HUMALOG and each time you get another HUMALOG<sup>®</sup> Junior KwikPen<sup>®</sup>. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.
</paragraph>
                  <paragraph>
                     <content styleCode="bold">Do not share your HUMALOG Junior KwikPen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.</content>
                  </paragraph>
                  <paragraph>HUMALOG Junior KwikPen (“Pen”) is a disposable single-patient-use prefilled pen containing 300 units of HUMALOG.
</paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>You can give yourself more than 1 dose from the Pen.
</item>
                     <item>Each turn of the Dose Knob dials 0.5 (½) unit of insulin. You can give from 0.5 (½) to 30 units in a single injection.
</item>
                     <item>If your dose is more than 30 units, you will need to give yourself more than 1 injection.
</item>
                     <item>The Plunger only moves a little with each injection, and you may not notice that it moves. The Plunger will only reach the end of the cartridge when you have used all 300 units in the Pen.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">People who are blind or have vision problems should not use the Pen without help from a person trained to use the Pen.</content>
                  </paragraph>
                  <renderMultiMedia ID="f58" referencedObject="mm58"/>
                  <paragraph>
                     <content styleCode="bold">How to recognize your HUMALOG Junior KwikPen:</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Pen color:        Blue
</item>
                     <item>Dose Knob:        Blue, with raised ridges on end and side
</item>
                     <item>Label:        White with an orange color bar and orange-to-yellow color band
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Supplies needed to give your injection:</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>HUMALOG Junior KwikPen
</item>
                     <item>KwikPen compatible Needle (BD [Becton, Dickinson and Company] Pen Needles recommended)
</item>
                     <item>Alcohol swab
</item>
                     <item>Gauze
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Preparing your Pen</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Wash your hands with soap and water.
</item>
                     <item>Check the Pen to make sure you are taking the right type of insulin. This is especially important if you use more than 1 type of insulin.
</item>
                     <item>
                        <content styleCode="bold">Do not</content> use your Pen past the expiration date printed on the Label or for more than 28 days after you first start using the Pen.
</item>
                     <item>
                        <content styleCode="bold">Always use a new needle for each injection to help prevent infections and blocked needles. Do not reuse or share your needles with other people. You may give other people a serious infection or get a serious infection from them.</content>
                     </item>
                  </list>
                  <table width="100%">
                     <col width="56.000%" align="left"/>
                     <col width="44.000%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top" styleCode="Toprule Botrule Lrule Rrule">
                              <content styleCode="bold">Step 1:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Pull the Pen Cap straight off.<list listType="unordered" styleCode="Disc">
                                       <item>
                                          <caption>–
</caption>
                                          <content styleCode="bold">Do not</content> remove the Pen Label.
</item>
                                    </list>
                                 </item>
                                 <item>Wipe the Rubber Seal with an alcohol swab.
</item>
                              </list>
                              <content styleCode="bold">Step 2:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Check the liquid in the Pen.<br/>HUMALOG should look clear and colorless. <content styleCode="bold">Do not</content> use if it is cloudy, colored, or has particles or clumps in it.
</item>
                              </list>
                           </td>
                           <td align="center" valign="middle" styleCode="Toprule Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f59" referencedObject="mm59"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Step 3:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Select a new Needle.
</item>
                                 <item>Pull off the Paper Tab from the Outer Needle Shield.
</item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f60" referencedObject="mm60"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Step 4:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Push the capped Needle straight onto the Pen and twist the Needle on until it is tight.
</item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f61" referencedObject="mm61"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Step 5:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Pull off the Outer Needle Shield. <content styleCode="bold">Do not</content> throw it away.
</item>
                                 <item>Pull off the Inner Needle Shield and throw it away.
</item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f62" referencedObject="mm62"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">Priming your Pen</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Prime before each injection.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Priming your Pen means removing the air from the Needle and Cartridge that may collect during normal use and ensures that the Pen is working correctly.
</item>
                     <item>If you <content styleCode="bold">do not</content> prime before each injection, you may get too much or too little insulin.
</item>
                  </list>
                  <table width="100%">
                     <col width="56.000%" align="left"/>
                     <col width="44.000%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top" styleCode="Toprule Botrule Lrule Rrule">
                              <content styleCode="bold">Step 6:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>To prime your Pen, turn the Dose Knob to select 2 units.<br/>
                                 </item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Toprule Botrule Rrule">
                              <br/>
                              <br/>
                              <renderMultiMedia ID="f63" referencedObject="mm63"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Step 7:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Hold your Pen with the Needle pointing up. Tap the Cartridge Holder gently to collect air bubbles at the top.
</item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f64" referencedObject="mm64"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Step 8:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Continue holding your Pen with Needle pointing up. Push the Dose Knob in until it stops, and “0” is seen in the Dose Window. Hold the Dose Knob in and <content styleCode="bold">count to 5 slowly</content>.
											<br/>
                                    <br/>
											You should see insulin at the tip of the Needle.
											<list listType="unordered" styleCode="Disc">
                                       <item>
                                          <caption>-
</caption>If you <content styleCode="bold">do not</content> see insulin, repeat priming steps 6 to 8, no more than 4 times.
</item>
                                       <item>
                                          <caption>-
</caption>If you <content styleCode="bold">still do not</content> see insulin, change the Needle and repeat priming steps 6 to 8.
</item>
                                    </list>
                                 </item>
                              </list>Small air bubbles are normal and will not affect your dose.<br/>
                           </td>
                           <td align="center" valign="middle" styleCode="Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f65" referencedObject="mm65"/>
                              <br/>
                              <renderMultiMedia ID="f66" referencedObject="mm66"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">Selecting your dose</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>You can give from 0.5 (½) to 30 units in a single injection.
</item>
                     <item>If your dose is more than 30 units, you will need to give more than 1 injection.<list listType="unordered" styleCode="Disc">
                           <item>
                              <caption>–
</caption>
If you need help with dividing up your dose the right way, ask your healthcare provider.
</item>
                           <item>
                              <caption>–
</caption>
You must use a new Needle for each injection and repeat the priming step.
</item>
                        </list>
                     </item>
                  </list>
                  <table width="100%">
                     <col width="56.000%" align="left"/>
                     <col width="44.000%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top" styleCode="Toprule Botrule Lrule Rrule">
                              <content styleCode="bold">Step 9:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Turn the Dose Knob to select the number of units you need to inject. The Dose Indicator should line up with your dose.<list listType="unordered" styleCode="Disc">
                                       <item>
                                          <caption>–
</caption>
The Pen dials 0.5 (½) unit at a time.
</item>
                                       <item>
                                          <caption>–
</caption>
The Dose Knob clicks as you turn it.
</item>
                                       <item>
                                          <caption>–
</caption>
                                          <content styleCode="bold">Do not</content> dial your dose by counting the clicks. You may dial the wrong dose. This may lead to you getting too much insulin or not enough insulin.
</item>
                                       <item>
                                          <caption>–
</caption>
The dose can be corrected by turning the Dose Knob in either direction until the correct dose lines up with the Dose Indicator.
</item>
                                       <item>
                                          <caption>–
</caption>
The <content styleCode="bold">whole unit</content> numbers (for example, 4) are printed on the dial.
</item>
                                       <item>
                                          <caption>–
</caption>
The <content styleCode="bold">half units</content> are shown as lines between the whole unit numbers.
</item>
                                    </list>
                                 </item>
                                 <item>
                                    <content styleCode="bold">Always check the number in the Dose Window to make sure you have dialed the correct dose.</content>
                                 </item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Toprule Botrule Rrule">
                              <br/>
                              <br/>
                              <renderMultiMedia ID="f67" referencedObject="mm67"/>
                              <br/>
                              <renderMultiMedia ID="f68" referencedObject="mm68"/>
                              <br/>Example: 4 units shown in the Dose Window<br/>
                              <br/>
                              <br/>
                              <renderMultiMedia ID="f69" referencedObject="mm69"/>Example: 10.5 (10 ½) units shown in the Dose Window
</td>
                        </tr>
                     </tbody>
                  </table>
                  <list listType="unordered" styleCode="Disc">
                     <item>The Pen will not let you dial more than the number of units left in the Pen.
</item>
                     <item>If you need to inject more than the number of units left in the Pen, you may either:<list listType="unordered" styleCode="Disc">
                           <item>
                              <caption>–
</caption>
inject the amount left in your Pen and then use a new Pen to give the rest of your dose, <content styleCode="bold">or</content>
                           </item>
                           <item>
                              <caption>–
</caption>
get a new Pen and inject the full dose.
</item>
                        </list>
                     </item>
                     <item>It is normal to see a small amount of insulin left in the Pen that you can not inject.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Giving your injection</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Inject your insulin as your healthcare provider has shown you.
</item>
                     <item>Change (rotate) your injection sites within the area you choose for each dose to reduce your risk of getting lipodystrophy (pits in skin or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the injection sites.
</item>
                     <item>
                        <content styleCode="bold">Do not</content> inject where the skin has pits, is thickened, or has lumps.
</item>
                     <item>
                        <content styleCode="bold">Do not</content> inject where the skin is tender, bruised, scaly or hard, or into scars or damaged skin.
</item>
                     <item>
                        <content styleCode="bold">Do not</content> try to change your dose while injecting.
</item>
                  </list>
                  <table width="100%">
                     <col width="41.700%" align="left"/>
                     <col width="14.875%" align="left"/>
                     <col width="10%" align="left"/>
                     <col width="43.350%" align="left"/>
                     <tbody>
                        <tr>
                           <td colspan="2" align="left" valign="top" styleCode="Toprule Botrule Lrule Rrule">
                              <content styleCode="bold">Step 10:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Choose your injection site.<br/>HUMALOG is injected under the skin (subcutaneously) of your stomach area, buttocks, upper legs or upper arms.
</item>
                                 <item>Wipe your skin with an alcohol swab, and let your skin dry before you inject your dose.
</item>
                              </list>
                           </td>
                           <td align="left" valign="top" styleCode="Toprule Botrule Lrule"/>
                           <td align="center" valign="middle" styleCode="Toprule Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f70" referencedObject="mm70"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" align="left" valign="top" styleCode="Lrule Rrule">
                              <content styleCode="bold">Step 11:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Insert the Needle into your skin.
</item>
                                 <item>Push the Dose Knob all the way in.
</item>
                              </list>
                           </td>
                           <td align="left" valign="top" styleCode="Lrule"/>
                           <td rowspan="2" align="center" valign="middle" styleCode="Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f72" referencedObject="mm72"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule">
                              <list listType="unordered" styleCode="Disc">
                                 <item>Continue to hold the Dose Knob in and <content styleCode="bold">slowly count to 5</content> before removing the Needle.
</item>
                              </list>
                              <content styleCode="bold">Do not</content> try to inject your insulin by turning the Dose Knob. You will <content styleCode="bold">not</content> receive your insulin by turning the Dose Knob.<br/>
                           </td>
                           <td align="center" valign="top" styleCode="Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f71" referencedObject="mm71"/>
                           </td>
                           <td align="center" valign="top" styleCode="Botrule"/>
                        </tr>
                        <tr>
                           <td colspan="2" align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Step 12:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Pull the Needle out of your skin.<list listType="unordered" styleCode="Disc">
                                       <item>
                                          <caption>–
</caption>
A drop of insulin at the Needle tip is normal. It will not affect your dose.
</item>
                                    </list>
                                 </item>
                                 <item>Check the number in the Dose Window<list listType="unordered" styleCode="Disc">
                                       <item>
                                          <caption>–
</caption>
If you see “0” in the Dose window, you have received the full amount you dialed.
</item>
                                       <item>
                                          <caption>–
</caption>
If you do not see “0” in the Dose window, <content styleCode="bold">do not</content> redial. Insert the Needle into your skin and finish your injection.
</item>
                                       <item>
                                          <caption>–
</caption>
If you <content styleCode="bold">still</content> do not think you received the full amount you dialed for your injection, <content styleCode="bold">do not start over or repeat that injection</content>. Monitor your blood glucose as instructed by your healthcare provider.
</item>
                                       <item>
                                          <caption>–
</caption>
If you normally need to give 2 injections for your full dose, be sure to give your second injection.
</item>
                                    </list>
                                 </item>
                              </list>The Plunger only moves a little with each injection and you may not notice that it moves.<br/>If you see blood after you take the Needle out of your skin, press the injection site lightly with a piece of gauze or an alcohol swab. <content styleCode="bold">Do not</content> rub the area.<br/>
                           </td>
                           <td colspan="2" align="center" valign="top" styleCode="Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f73" referencedObject="mm73"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">After your injection</content>
                  </paragraph>
                  <table width="100%">
                     <col width="56.000%" align="left"/>
                     <col width="44.000%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top" styleCode="Toprule Botrule Lrule Rrule">
                              <content styleCode="bold">Step 13:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Carefully replace the Outer Needle Shield.
</item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Toprule Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f74" referencedObject="mm74"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Step 14:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Unscrew the capped Needle and throw it away (see <content styleCode="bold">Disposing of Pens and Needles</content> section).
</item>
                                 <item>Do not store the Pen with the Needle attached to prevent leaking, blocking the Needle, and air from entering the Pen.
</item>
                              </list>
                           </td>
                           <td align="center" valign="middle" styleCode="Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f75" referencedObject="mm75"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Step 15:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Replace the Pen Cap by lining up the Cap Clip with the Dose Indicator and pushing straight on.
</item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Botrule Rrule">
                              <br/>
                              <renderMultiMedia ID="f76" referencedObject="mm76"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">Disposing of Pens and Needles</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>The used Pen may be discarded in your household trash after you have removed the needle.
</item>
                     <item>Put your used Needles in a FDA-cleared sharps disposal container right away after use. <content styleCode="bold">Do not</content> throw away (dispose of) loose needles in your household trash.
</item>
                     <item>If you do not have a FDA-cleared sharps disposal container, you may use a household container that is:<list listType="unordered" styleCode="Disc">
                           <item>
                              <caption>–
</caption>
made of a heavy-duty plastic,
</item>
                           <item>
                              <caption>–
</caption>
can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out,
</item>
                           <item>
                              <caption>–
</caption>
upright and stable during use,
</item>
                           <item>
                              <caption>–
</caption>
leak-resistant, and
</item>
                           <item>
                              <caption>–
</caption>
properly labeled to warn of hazardous waste inside the container.
</item>
                        </list>
                     </item>
                     <item>When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used needles. For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA's website at: http://www.fda.gov/safesharpsdisposal
</item>
                     <item>Do not dispose of your used sharps disposal container in your household trash unless your community guidelines permit this. Do not recycle the container.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Storing your Pen</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Unused Pens</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Store unused Pens in the refrigerator at 36°F to 46°F (2°C to 8°C).
</item>
                     <item>
                        <content styleCode="bold">Do not</content> freeze your insulin. <content styleCode="bold">Do not</content> use if it has been frozen.
</item>
                     <item>Unused Pens may be used until the expiration date printed on the Label, if the Pen has been kept in the refrigerator.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">In-use Pen</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Store the Pen you are currently using at room temperature [up to 86°F (30°C)]. Keep away from heat and light.
</item>
                     <item>Throw away the HUMALOG Pen you are using after 28 days, even if it still has insulin left in it.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">General information about the safe and effective use of your Pen</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>
                        <content styleCode="bold">Keep your Pen and Needles out of the sight and reach of children.</content>
                     </item>
                     <item>
                        <content styleCode="bold">Do not</content> use your Pen if any part looks broken or damaged.
</item>
                     <item>Always carry an extra Pen in case yours is lost or damaged.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Troubleshooting</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>If you can not remove the Pen Cap, gently twist the cap back and forth, and then pull the cap straight off.
</item>
                     <item>If the Dose Knob is hard to push:<list listType="unordered" styleCode="Disc">
                           <item>
                              <caption>–
</caption>
Pushing the Dose Knob more slowly will make it easier to inject.
</item>
                           <item>
                              <caption>–
</caption>
Your Needle may be blocked. Put on a new Needle and prime the Pen.
</item>
                           <item>
                              <caption>–
</caption>
You may have dust, food, or liquid inside the Pen. Throw the Pen away and get a new Pen.
</item>
                        </list>
                     </item>
                  </list>
                  <paragraph>If you have any questions or problems with your HUMALOG Junior KwikPen, contact Lilly at 1-800-LillyRx (1-800-545-5979) or call your healthcare provider for help. For more information on HUMALOG Junior KwikPen and insulin, go to <content styleCode="underline">www.humalog.com</content>.
</paragraph>
                  <paragraph>Manufactured by:<br/>Eli Lilly and Company<br/>Indianapolis, IN 46285, USA<br/>US License Number 1891
</paragraph>
                  <paragraph>
                     <content styleCode="italics">This Instructions for Use has been approved by the U.S. Food and Drug Administration.</content>
                  </paragraph>
                  <paragraph>Revised: July 2023
</paragraph>
                  <paragraph>Scan this code to launch (www.humalog.com)
</paragraph>
                  <paragraph>
                     <renderMultiMedia ID="f77" referencedObject="mm77"/>
                  </paragraph>
                  <paragraph>HUMALOG<sup>®</sup> and HUMALOG<sup>®</sup> Junior KwikPen<sup>®</sup> are trademarks of Eli Lilly and Company.
</paragraph>
                  <paragraph>Copyright © 2017, 2023, Eli Lilly and Company. All rights reserved.
</paragraph>
                  <table width="100%">
                     <col width="100.000%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top" styleCode="Toprule Botrule Lrule Rrule">
                              <content styleCode="bold">HUMALOG Junior KwikPen</content> meets the current dose accuracy and functional requirements of ISO 11608-1.
</td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>LOGJRKP-0004-IFU-20230721
</paragraph>
               </text>
               <effectiveTime value="20230721"/>
               <component>
                  <observationMedia ID="mm57">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-jr-ifu-1-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm58">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-jr-ifu-2-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm59">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-jr-ifu-3-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm60">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-jr-ifu-4-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm61">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-jr-ifu-5-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm62">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-jr-ifu-6-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm63">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-jr-ifu-7-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm64">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-jr-ifu-8-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm65">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-jr-ifu-9-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm66">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-jr-ifu-10-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm67">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-jr-ifu-11-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm68">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-jr-ifu-12-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm69">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-jr-ifu-13-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm70">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-inj-sites-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm71">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-5sec-clock.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm72">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-jr-ifu-14-v3.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm73">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-jr-ifu-15-v3.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm74">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-jr-ifu-16-v3.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm75">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-jr-ifu-17-v3.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm76">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-jr-ifu-18-v3.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm77">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-QR.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="s94">
               <id root="b3a5e586-8db7-4bca-bcbc-648a6d05e256"/>
               <code code="59845-8" codeSystem="2.16.840.1.113883.6.1" displayName="INSTRUCTIONS FOR USE SECTION"/>
               <title>Tempo Pen U-100 Instructions for Use</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">INSTRUCTIONS FOR USE</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">HUMALOG</content>
                     <content styleCode="bold">
                        <sup>®
</sup>
                     </content>
                     <content styleCode="bold">(HU-ma-log) Tempo Pen™</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">(insulin lispro)</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">injection, for subcutaneous use</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">3 mL single-patient-use pen, (100 units per mL)</content>
                  </paragraph>
                  <renderMultiMedia ID="f78" referencedObject="mm78"/>
                  <paragraph>Read the Instructions for Use before you start taking HUMALOG and each time you get another HUMALOG Tempo Pen. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.
</paragraph>
                  <paragraph>
                     <content styleCode="bold">Do not share your HUMALOG Tempo Pen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.</content>
                  </paragraph>
                  <paragraph>HUMALOG Tempo Pen (“Pen”) is a disposable single-patient-use prefilled pen containing 300 units of HUMALOG. You can give yourself more than 1 dose from the Pen. Each turn (click) of the Dose Knob dials 1 unit of insulin. You can give from 1 to 60 units in a single injection. <content styleCode="bold">If your dose is more than 60 units, you will need to give yourself more than 1 injection.</content> The Plunger only moves a little with each injection, and you may not notice that it moves. The Plunger will only reach the end of the cartridge when you have used all 300 units in the Pen.
</paragraph>
                  <paragraph>
                     <content styleCode="bold">People who are blind or have vision problems should not use the Pen without help from a person trained to use the Pen.</content>
                  </paragraph>
                  <paragraph>This HUMALOG Tempo Pen contains a component that allows for data connectivity when used with a compatible transmitter.
</paragraph>
                  <renderMultiMedia ID="f79" referencedObject="mm79"/>
                  <paragraph>
                     <content styleCode="bold">How to recognize your HUMALOG Tempo Pen</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Pen color: Dark blue
</item>
                     <item>Dose Knob: Burgundy
</item>
                     <item>Labels: White label with burgundy stripe
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Supplies you will need to give your injection</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>HUMALOG Tempo Pen
</item>
                     <item>Tempo Pen compatible Needle (Becton, Dickinson and Company Pen Needles recommended)
</item>
                     <item>Alcohol swab
</item>
                     <item>Gauze
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Preparing your Pen</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Wash your hands with soap and water.
</item>
                     <item>Check your Pen to make sure you are taking the right type of insulin. This is especially important if you use more than 1 type of insulin.
</item>
                     <item>
                        <content styleCode="bold">Do not</content> use your Pen past the expiration date printed on the Label or for more than 28 days after you first start using the Pen.
</item>
                     <item>
                        <content styleCode="bold">Always use a new needle for each injection to help prevent infections and blocked needles. Do not reuse or share your needles with other people. You may give other people a serious infection or get a serious infection from them.</content>
                     </item>
                  </list>
                  <table width="100%">
                     <col width="51.300%" align="left"/>
                     <col width="48.700%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top" styleCode="Toprule Botrule">
                              <content styleCode="bold">Step 1:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Pull the Pen Cap straight off.<list listType="unordered" styleCode="Disc">
                                       <item>
                                          <caption>-
</caption>
                                          <content styleCode="bold">Do not</content> remove the Pen Label.
</item>
                                    </list>
                                 </item>
                                 <item>Wipe the Rubber Seal with an alcohol swab.
</item>
                              </list>
                              <br/>
                              <content styleCode="bold">Step 2:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>
                                    <content styleCode="bold">Check the liquid in the Pen.<br/>
                                    </content>HUMALOG should look clear and colorless. <content styleCode="bold">Do not</content> use if it is cloudy, colored, or has particles or clumps in it.
</item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Toprule Botrule">
                              <br/>
                              <renderMultiMedia ID="f80" referencedObject="mm80"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 3:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>
                                    <content styleCode="bold">Select a new Needle.</content>
                                 </item>
                                 <item>Pull off the Paper Tab from the Outer Needle Shield.
</item>
                              </list>
                           </td>
                           <td align="center" valign="middle" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f81" referencedObject="mm81"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 4:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Push the capped Needle straight onto the Pen and twist the Needle on until it is tight.
</item>
                              </list>
                           </td>
                           <td align="center" valign="middle" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f82" referencedObject="mm82"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 5:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Pull off the Outer Needle Shield. <content styleCode="bold">Do not</content> throw it away.
</item>
                                 <item>Pull off the Inner Needle Shield and throw it away.
</item>
                              </list>
                           </td>
                           <td align="center" valign="middle" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f83" referencedObject="mm83"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">Priming your Pen</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Prime before each injection.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Priming your Pen means removing the air from the Needle and Cartridge that may collect during normal use and ensures that the Pen is working correctly.
</item>
                     <item>If you <content styleCode="bold">do not</content> prime before each injection, you may get too much or too little insulin.
</item>
                  </list>
                  <table width="100%">
                     <col width="51.300%" align="left"/>
                     <col width="48.700%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top" styleCode="Toprule Botrule">
                              <content styleCode="bold">Step 6:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>To prime your Pen, turn the Dose Knob to <content styleCode="bold">select 2 units</content>.
</item>
                              </list>
                           </td>
                           <td align="center" valign="middle" styleCode="Toprule Botrule">
                              <br/>
                              <renderMultiMedia ID="f84" referencedObject="mm84"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 7:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Hold your Pen with the Needle pointing up. Tap the Cartridge Holder gently to collect air bubbles at the top.
</item>
                              </list>
                           </td>
                           <td align="center" valign="middle" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f85" referencedObject="mm85"/>
                           </td>
                        </tr>
                        <tr>
                           <td rowspan="2" align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 8:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Continue holding your Pen with the Needle pointing up. Push the Dose Knob in until it stops, and “0” is seen in the Dose Window. Hold the Dose Knob in and <content styleCode="bold">count to 5 slowly</content>.<br/>
                                    <br/>You should see insulin at the tip of the Needle.
											<list listType="unordered" styleCode="Disc">
                                       <item>
                                          <caption>-
</caption>If you <content styleCode="bold">do not</content> see insulin, repeat priming steps 6 to 8, but no more than 4 times.
</item>
                                       <item>
                                          <caption>-
</caption>If you <content styleCode="bold">still do not</content> see insulin, change the Needle and repeat priming steps 6 to 8.<br/>
                                       </item>
                                    </list>
                                 </item>
                              </list>Small air bubbles are normal and will not affect your dose.
</td>
                           <td align="center" valign="middle">
                              <br/>
                              <renderMultiMedia ID="f86" referencedObject="mm86"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" valign="middle" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f87" referencedObject="mm87"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">Selecting your dose</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>You can give from 1 to 60 units in a single injection.
</item>
                     <item>If your dose is more than 60 units, you will need to give more than 1 injection.<list listType="unordered" styleCode="Disc">
                           <item>
                              <caption>-
</caption>If you need help with dividing up your dose the right way, ask your healthcare provider.
</item>
                           <item>
                              <caption>-
</caption>Use a new Needle for each injection and repeat the priming step.
</item>
                        </list>
                     </item>
                  </list>
                  <table width="100%">
                     <col width="50.000%" align="left"/>
                     <col width="50.000%" align="left"/>
                     <tbody>
                        <tr>
                           <td rowspan="3" align="left" valign="top" styleCode="Toprule Botrule">
                              <content styleCode="bold">Step 9:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Turn the Dose Knob to select the number of units you need to inject. The Dose Indicator should line up with your dose.<list listType="unordered" styleCode="Disc">
                                       <item>
                                          <caption>-
</caption>The Pen dials 1 unit at a time.
</item>
                                       <item>
                                          <caption>-
</caption>The Dose Knob clicks as you turn it.
</item>
                                       <item>
                                          <caption>-
</caption>
                                          <content styleCode="bold">Do not</content> dial your dose by counting the clicks. You may dial the wrong dose. This may lead to you getting too much insulin or not enough insulin.
</item>
                                       <item>
                                          <caption>-
</caption>The dose can be corrected by turning the Dose Knob in either direction until the correct dose lines up with the Dose Indicator.
</item>
                                       <item>
                                          <caption>-
</caption>The <content styleCode="bold">even</content> numbers (for example, 12) are printed on the dial.
</item>
                                       <item>
                                          <caption>-
</caption>The <content styleCode="bold">odd</content> numbers, (for example, 25) after the number 1, are shown as full lines.
</item>
                                    </list>
                                 </item>
                                 <item>
                                    <content styleCode="bold">Always check the number in the Dose Window to make sure you have dialed the correct dose.</content>
                                 </item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Toprule">
                              <br/>
                              <renderMultiMedia ID="f88" referencedObject="mm88"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" valign="top">
                              <br/>
                              <renderMultiMedia ID="f89" referencedObject="mm89"/>(Example: 12 units shown in the Dose Window)<br/>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" valign="top" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f90" referencedObject="mm90"/>(Example: 25 units shown in the Dose Window)
</td>
                        </tr>
                     </tbody>
                  </table>
                  <list listType="unordered" styleCode="Disc">
                     <item>The Pen will not let you dial more than the number of units left in the Pen.
</item>
                     <item>If you need to inject more than the number of units left in the Pen, you may either:<list listType="unordered" styleCode="Disc">
                           <item>
                              <caption>-
</caption>inject the amount left in your Pen and then use a new Pen to give the rest of your dose, <content styleCode="bold">or</content>
                           </item>
                           <item>
                              <caption>-
</caption>get a new Pen and inject the full dose.
</item>
                        </list>
                     </item>
                     <item>It is normal to see a small amount of insulin left in the Pen that you cannot inject.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Giving your injection</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Inject your insulin as your healthcare provider has shown you.
</item>
                     <item>Change (rotate) your injection sites within the area you choose for each dose to reduce your risk of getting lipodystrophy (pits in skin or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the injection sites.
</item>
                     <item>
                        <content styleCode="bold">Do not</content> inject where the skin has pits, is thickened, or has lumps.
</item>
                     <item>
                        <content styleCode="bold">Do not</content> inject where the skin is tender, bruised, scaly or hard, or into scars or damaged skin.
</item>
                     <item>
                        <content styleCode="bold">Do not</content> try to change your dose while injecting.
</item>
                  </list>
                  <table width="100%">
                     <col width="51.300%" align="left"/>
                     <col width="48.700%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top" styleCode="Toprule Botrule">
                              <content styleCode="bold">Step 10:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Choose your injection site.<br/>HUMALOG is injected under the skin (subcutaneously) of your stomach area, buttocks, upper legs or upper arms.
</item>
                                 <item>Wipe your skin with an alcohol swab, and let your skin dry before you inject your dose.
</item>
                              </list>
                           </td>
                           <td align="center" valign="middle" styleCode="Toprule Botrule">
                              <br/>
                              <renderMultiMedia ID="f91" referencedObject="mm91"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 11:</content>
                              <br/> Insert the Needle into your skin.<br/> Push the Dose Knob all the way in.<br/> Continue to hold the Dose Knob in and <content styleCode="bold">slowly count to 5</content> before removing the Needle.<br/>
                              <br/>
                              <renderMultiMedia ID="f92" referencedObject="mm92"/>
                              <content styleCode="bold">Do not</content> try to inject your insulin by turning the Dose Knob. You will <content styleCode="bold">not</content> receive your insulin by turning the Dose Knob.
</td>
                           <td align="center" valign="middle" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f93" referencedObject="mm93"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 12:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Pull the Needle out of your skin.<br/>A drop of insulin at the Needle tip is normal. It will not affect your dose.
</item>
                                 <item>Check the number in the Dose Window.<list listType="unordered" styleCode="Disc">
                                       <item>
                                          <caption>-
</caption>If you see “0” in the Dose Window, you have received the full amount you dialed.
</item>
                                       <item>
                                          <caption>-
</caption>If you do not see “0” in the Dose Window, do not redial. Insert the Needle into your skin and finish your injection.
</item>
                                       <item>
                                          <caption>-
</caption>If you <content styleCode="bold">still</content> do not think you received the full amount you dialed for your injection, <content styleCode="bold">do not start over or repeat the injection.</content> Monitor your blood sugar (glucose) as instructed by your healthcare provider.
</item>
                                       <item>
                                          <caption>-
</caption>If you normally need to give 2 injections for your full dose, be sure to give your second injection.
</item>
                                    </list>
                                 </item>
                              </list>The Plunger only moves a little with each injection, and you may not notice that it moves.<br/>If you see blood after you take the Needle out of your skin, press the injection site lightly with a piece of gauze or an alcohol swab. <content styleCode="bold">Do not</content> rub the area.<br/>
                           </td>
                           <td align="center" valign="top" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f94" referencedObject="mm94"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">After your injection</content>
                  </paragraph>
                  <table width="100%">
                     <col width="51.300%" align="left"/>
                     <col width="48.700%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top" styleCode="Toprule Botrule">
                              <content styleCode="bold">Step 13:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Carefully replace the Outer Needle Shield.
</item>
                              </list>
                           </td>
                           <td align="center" valign="middle" styleCode="Toprule Botrule">
                              <br/>
                              <renderMultiMedia ID="f95" referencedObject="mm95"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 14:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Unscrew the capped Needle and throw it away (see <content styleCode="bold">Disposing of Pens and Needles</content> section).
</item>
                                 <item>
                                    <content styleCode="bold">Do not</content> store the Pen with the Needle attached to prevent leaking, blocking the Needle, and air from entering the Pen.
</item>
                              </list>
                           </td>
                           <td align="center" valign="middle" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f96" referencedObject="mm96"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 15:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Replace the Pen Cap by lining up the Cap Clip with the Dose Indicator and pushing straight on.
</item>
                              </list>
                           </td>
                           <td align="center" valign="middle" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f97" referencedObject="mm97"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">Disposing of Pens and Needles</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>The used Pen may be discarded in your household trash after you have removed the needle.
</item>
                     <item>Put your used needles in a FDA-cleared sharps disposal container right away after use. Do not throw away (dispose of) loose needles in your household trash.
</item>
                     <item>If you do not have a FDA-cleared sharps disposal container, you may use a household container that is:<list listType="unordered" styleCode="Disc">
                           <item>
                              <caption>-
</caption>made of a heavy-duty plastic,
</item>
                           <item>
                              <caption>-
</caption>can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out,
</item>
                           <item>
                              <caption>-
</caption>upright and stable during use,
</item>
                           <item>
                              <caption>-
</caption>leak-resistant, and
</item>
                           <item>
                              <caption>-
</caption>properly labeled to warn of hazardous waste inside the container.
</item>
                        </list>
                     </item>
                     <item>When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used needles and syringes. For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA's website at: http://www.fda.gov/safesharpsdisposal
</item>
                     <item>Do not dispose of your used sharps disposal container in your household trash unless your community guidelines permit this. Do not recycle your used sharps disposal container.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Storing your Pen</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Unopened Pens</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Store unopened Pens in the refrigerator at 36°F to 46°F (2°C to 8°C).
</item>
                     <item>
                        <content styleCode="bold">Do not</content> freeze your insulin. <content styleCode="bold">Do not</content> use if it has been frozen.
</item>
                     <item>Unopened Pens may be used until the expiration date printed on the Label, if the Pen has been kept in the refrigerator.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">In-use Pen</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Store the Pen you are currently using at room temperature [up to 86°F (30°C)]. Keep away from heat and light.
</item>
                     <item>Throw away the HUMALOG Tempo Pen you are using after 28 days, even if it still has insulin left in it.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">General information about the safe and effective use of your Pen</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>
                        <content styleCode="bold">Keep your Pen and needles out of the reach of children.</content>
                     </item>
                     <item>
                        <content styleCode="bold">Do not</content> use your Pen if any part looks broken or damaged.
</item>
                     <item>Always carry an extra Pen in case yours is lost or damaged.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Troubleshooting</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>If you cannot remove the Pen Cap, gently twist the cap back and forth, and then pull the cap straight off.
</item>
                     <item>If the Dose Knob is hard to push:<list listType="unordered" styleCode="Disc">
                           <item>
                              <caption>-
</caption>Pushing the Dose Knob more slowly will make it easier to inject.
</item>
                           <item>
                              <caption>-
</caption>Your Needle may be blocked. Put on a new Needle and prime the Pen.
</item>
                           <item>
                              <caption>-
</caption>You may have dust, food, or liquid inside the Pen. Throw the Pen away and get a new Pen.
</item>
                        </list>
                     </item>
                  </list>
                  <paragraph>If you have any questions or problems with your HUMALOG Tempo Pen, contact Lilly at 1-800-LillyRx (1-800-545-5979) or call your healthcare provider for help. For more information on HUMALOG Tempo Pen and insulin, go to <content styleCode="underline">www.humalog.com</content>.
</paragraph>
                  <paragraph>Manufactured by:<br/>Eli Lilly and Company<br/>Indianapolis, IN 46285, USA<br/>US License Number 1891
</paragraph>
                  <paragraph>This Instructions for Use has been approved by the U.S. Food and Drug Administration.
</paragraph>
                  <paragraph>Revised: July 2023
</paragraph>
                  <paragraph>Scan this code to launch (www.humalog.com)
</paragraph>
                  <paragraph>
                     <renderMultiMedia ID="f98" referencedObject="mm98"/>
                  </paragraph>
                  <paragraph>HUMALOG<sup>®</sup> is a registered trademark and TEMPO PEN<sup>TM</sup> is a trademark of Eli Lilly and Company.
</paragraph>
                  <paragraph>Copyright © 2019, 2023, Eli Lilly and Company. All rights reserved.
</paragraph>
                  <table width="100%">
                     <col width="100.000%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top" styleCode="Toprule Botrule Lrule Rrule">
                              <content styleCode="bold">HUMALOG Tempo Pen</content> meets the current dose accuracy and functional requirements of ISO 11608-1.
</td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>LOGTP-0002-IFU-20230721
</paragraph>
               </text>
               <effectiveTime value="20230721"/>
               <component>
                  <observationMedia ID="mm78">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-tp-ifu-1-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm79">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-tp-ifu-2-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm80">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-tp-ifu-3-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm81">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-jr-ifu-4-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm82">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-jr-ifu-5-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm83">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-jr-ifu-6-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm84">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-tp-ifu-4-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm85">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-jr-ifu-8-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm86">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-tp-ifu-5-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm87">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-tp-ifu-6-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm88">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-tp-ifu-7-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm89">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-tp-ifu-8-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm90">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-tp-ifu-9-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm91">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-inj-sites-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm92">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-5sec-clock.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm93">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-tp-ifu-11-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm94">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-tp-ifu-12-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm95">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u100-ifu-18-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm96">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u100-ifu-19-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm97">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-tp-ifu-13-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm98">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-QR.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="s95">
               <id root="3c9ce1a4-fa77-4f57-ad06-753059f65f8a"/>
               <code code="42230-3" codeSystem="2.16.840.1.113883.6.1" displayName="SPL PATIENT PACKAGE INSERT SECTION"/>
               <title>U-200 Patient Package Insert</title>
               <text>
                  <table width="100%">
                     <col width="50.000%" align="left"/>
                     <col width="25.000%" align="left"/>
                     <col width="25.000%" align="left"/>
                     <tfoot>
                        <tr>
                           <td colspan="2" align="left" valign="top">
                              <paragraph>This Patient Information has been approved by the U.S. Food and Drug Administration 
</paragraph>
                           </td>
                           <td align="right" valign="top">
                              <paragraph>Revised: July 2023
</paragraph>
                           </td>
                        </tr>
                     </tfoot>
                     <tbody>
                        <tr>
                           <td colspan="3" align="center" valign="top" styleCode="Toprule Botrule Lrule Rrule">
                              <content styleCode="bold">PATIENT INFORMATION</content>
                              <br/>
                              <content styleCode="bold">HUMALOG</content>
                              <content styleCode="bold">
                                 <sup>®
</sup>
                              </content>
                              <content styleCode="bold">(HU-ma-log) KwikPen</content>
                              <content styleCode="bold">
                                 <sup>®</sup>
                              </content>
                              <br/>
                              <content styleCode="bold">(insulin lispro)</content>
                              <br/>
                              <content styleCode="bold">injection, for subcutaneous use</content>
                              <br/>
                              <content styleCode="bold">200 units per mL</content>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Do not share your HUMALOG KwikPen or needles with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.</content>
                              <br/>
                              <content styleCode="bold">What is HUMALOG?</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>HUMALOG is a rapid-acting man-made insulin used to control high blood sugar in adults and children with diabetes mellitus.
</item>
                                 <item>This single-patient-use HUMALOG U-200 KwikPen (“Pen”) contains <content styleCode="bold">2</content> times as much insulin (200 units per mL) in 1 mL as HUMALOG U-100 KwikPen (100 units per mL).
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Who should not take HUMALOG?</content>
                              <br/>
                              <content styleCode="bold">Do not take HUMALOG if you:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>are having an episode of low blood sugar (hypoglycemia).
</item>
                                 <item>have an allergy to insulin lispro or any of the ingredients in HUMALOG. See the end of this Patient Information leaflet for a complete list of ingredients in HUMALOG.
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Lrule Rrule">
                              <content styleCode="bold">What should I tell my healthcare provider before taking HUMALOG?</content>
                              <br/>
                              <content styleCode="bold">Before taking HUMALOG, tell your healthcare provider about all your medical conditions, including if you:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>have liver or kidney problems.
</item>
                                 <item>take any other medicines, especially ones called TZDs (thiazolidinediones).
</item>
                                 <item>have heart failure or other heart problems. If you have heart failure, it may get worse while you take TZDs with HUMALOG.
</item>
                                 <item>are pregnant or plan to become pregnant. Talk to your healthcare provider about the best way to control your blood sugar if you plan to become pregnant or while you are pregnant.
</item>
                                 <item>are breastfeeding or plan to breastfeed. Talk with your healthcare provider about the best way to feed your baby while taking HUMALOG.
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Tell your healthcare provider about all the medicines you take,</content> including prescription and over-the-counter medicines, vitamins, and herbal supplements.<br/>
                              <content styleCode="bold">Before you start taking HUMALOG, talk to your healthcare provider about low blood sugar and how to manage it.</content>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Lrule Rrule">
                              <content styleCode="bold">How should I use HUMALOG KwikPen?</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Read the detailed <content styleCode="bold">Instructions for Use</content> that comes with your HUMALOG KwikPen.
</item>
                                 <item>Use HUMALOG KwikPen exactly as your healthcare provider tells you to. Your healthcare provider should tell you how much HUMALOG to take and when to take it.
</item>
                                 <item>Know the type, strength and amount of insulin you take. <content styleCode="bold">Do not</content> change the type or amount of insulin you take unless your healthcare provider tells you to. The amount of insulin and the best time for you to take your insulin may need to change if you take different types of insulin.
</item>
                                 <item>Check your insulin label each time you give your injection to make sure you are taking the correct insulin.
</item>
                                 <item>HUMALOG comes in a KwikPen which is a disposable single-patient-use prefilled pen that you must use to give your HUMALOG. The dose window on your pen shows your dose of HUMALOG. <content styleCode="bold">Do not</content> make any dose changes unless your healthcare provider tells you to.
</item>
                                 <item>
                                    <content styleCode="bold">Do not</content> use a syringe to remove HUMALOG from your KwikPen disposable prefilled pen.
</item>
                                 <item>
                                    <content styleCode="bold">Do not</content> re-use needles. Always use a new needle for each injection. Re-use of needles increases your risk of having blocked needles, which may cause you to get the wrong dose of HUMALOG. Using a new needle for each injection also lowers your risk of getting an infection. If your needle is blocked, follow the instructions in the <content styleCode="bold">“General information about the safe and effective use of your Pen”</content> section of the Instructions for Use.
</item>
                                 <item>
                                    <content styleCode="bold">HUMALOG is a rapid-acting insulin. Inject HUMALOG within 15 minutes before or right after eating a meal.</content>
                                 </item>
                                 <item>Inject HUMALOG under the skin (subcutaneously) of your stomach area, buttocks, upper legs or upper arms. <content styleCode="bold">Do not</content> use HUMALOG KwikPen (“Pen”) in an insulin pump or inject HUMALOG KwikPen into your vein (intravenously).
</item>
                                 <item>
                                    <content styleCode="bold">Change (rotate) your injection sites within the area you choose with each dose</content> to reduce your risk of getting lipodystrophy (pits in skin or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the injection sites.<list listType="unordered" styleCode="Circle">
                                       <item>
                                          <content styleCode="bold">Do not</content> use the exact same spot for each injection.
</item>
                                       <item>
                                          <content styleCode="bold">Do not</content> inject where the skin has pits, is thickened, or has lumps.
</item>
                                       <item>
                                          <content styleCode="bold">Do not</content> inject where the skin is tender, bruised, scaly or hard, or into scars or damaged skin.
</item>
                                    </list>
                                 </item>
                                 <item>
                                    <content styleCode="bold">Do not</content> mix the HUMALOG in the HUMALOG KwikPen with any other type of insulin or liquid medicine.
</item>
                                 <item>
                                    <content styleCode="bold">Check your blood sugar levels.</content> Ask your healthcare provider what your blood sugar should be and when you should check your blood sugar levels.
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Keep HUMALOG KwikPen and all medicines out of reach of children.</content>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">Your dose of HUMALOG may need to change because of a:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>change in physical activity or exercise, weight gain or loss, increased stress, illness, change in diet, or because of other medicines you take.
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">What should I avoid while using HUMALOG KwikPen?</content>
                              <br/>
                              <content styleCode="bold">While using HUMALOG KwikPen do not:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>drive or operate heavy machinery, until you know how HUMALOG KwikPen affects you
</item>
                                 <item>drink alcohol or take prescription or over-the-counter medicines that contain alcohol
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Lrule Rrule">
                              <content styleCode="bold">What are the possible side effects of HUMALOG?</content>
                              <br/>
                              <content styleCode="bold">HUMALOG may cause serious side effects that can lead to death, including:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>
                                    <content styleCode="bold">low blood sugar (hypoglycemia).</content> Signs and symptoms of low blood sugar may include:
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Lrule">
                              <list listType="unordered" styleCode="Circle">
                                 <item>dizziness or light-headedness
</item>
                                 <item>sweating
</item>
                                 <item>confusion
</item>
                                 <item>headache
</item>
                                 <item>blurred vision
</item>
                              </list>
                           </td>
                           <td colspan="2" align="left" valign="top" styleCode="Rrule">
                              <list listType="unordered" styleCode="Circle">
                                 <item>slurred speech
</item>
                                 <item>shakiness
</item>
                                 <item>fast heartbeat
</item>
                                 <item>anxiety, irritability or mood changes
</item>
                                 <item>hunger
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Lrule Rrule">Your healthcare provider may prescribe a glucagon product for emergency use so that someone else can give you glucagon if your blood sugar becomes too low (severe hypoglycemia) and you are unable to take sugar by mouth.<br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>
                                    <content styleCode="bold">severe allergic reaction (whole body reaction). Get medical help right away, if you have any of these signs or symptoms of a severe allergic reaction:</content>
                                 </item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Lrule">
                              <list listType="unordered" styleCode="Circle">
                                 <item>a rash over your whole body
</item>
                                 <item>trouble breathing
</item>
                              </list>
                           </td>
                           <td colspan="2" align="left" valign="top" styleCode="Rrule">
                              <list listType="unordered" styleCode="Circle">
                                 <item>a fast heartbeat
</item>
                                 <item>sweating
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Lrule Rrule">
                              <list listType="unordered" styleCode="Disc">
                                 <item>
                                    <content styleCode="bold">low potassium in your blood (hypokalemia).</content>
                                 </item>
                                 <item>
                                    <content styleCode="bold">heart failure.</content> Taking certain diabetes pills called thiazolidinediones or “TZDs” with HUMALOG may cause heart failure in some people. This can happen even if you have never had heart failure or heart problems before. If you already have heart failure it may get worse while you take TZDs with HUMALOG. Your healthcare provider should monitor you closely while you are taking TZDs with HUMALOG. Tell your healthcare provider if you have any new or worse symptoms of heart failure including:
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Lrule">
                              <list listType="unordered" styleCode="Circle">
                                 <item>shortness of breath
</item>
                                 <item>swelling of your ankles or feet
</item>
                              </list>
                           </td>
                           <td colspan="2" align="left" valign="top" styleCode="Rrule">
                              <list listType="unordered" styleCode="Circle">
                                 <item>sudden weight gain
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Lrule Rrule">Treatment with TZDs and HUMALOG may need to be adjusted or stopped by your healthcare provider if you have new or worse heart failure.<br/>
                              <content styleCode="bold">Get emergency medical help if you have:</content>
                              <br/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Lrule">
                              <list listType="unordered" styleCode="Disc">
                                 <item>trouble breathing
</item>
                                 <item>shortness of breath
</item>
                                 <item>fast heartbeat
</item>
                                 <item>swelling of your face, tongue, or throat
</item>
                              </list>
                           </td>
                           <td colspan="2" align="left" valign="top" styleCode="Rrule">
                              <list listType="unordered" styleCode="Disc">
                                 <item>sweating
</item>
                                 <item>extreme drowsiness
</item>
                                 <item>dizziness
</item>
                                 <item>confusion
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Lrule Rrule">
                              <content styleCode="bold">The most common side effects of HUMALOG include:</content>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Lrule">
                              <list listType="unordered" styleCode="Disc">
                                 <item>low blood sugar (hypoglycemia)
</item>
                                 <item>reactions at your injection site
</item>
                                 <item>skin thickening or pits at the injection site <br/>(lipodystrophy)
</item>
                              </list>
                           </td>
                           <td colspan="2" align="left" valign="top" styleCode="Rrule">
                              <list listType="unordered" styleCode="Disc">
                                 <item>weight gain
</item>
                                 <item>swelling in your hands or feet
</item>
                                 <item>itching
</item>
                                 <item>rash
</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">These are not all of the possible side effects of HUMALOG.</content> Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
</td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">General Information about the safe and effective use of HUMALOG KwikPen.</content>
                              <br/>Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not take HUMALOG for a condition for which it was not prescribed. Do not give HUMALOG to other people, even if they have the same symptoms that you have. It may harm them.<br/>This Patient Information leaflet summarizes the most important information about HUMALOG KwikPen. If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for information about HUMALOG that is written for healthcare professionals.
</td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left" valign="top" styleCode="Botrule Lrule Rrule">
                              <content styleCode="bold">What are the ingredients in HUMALOG U-200?</content>
                              <br/>
                              <content styleCode="bold">Active ingredient:</content> insulin lispro.<br/>
                              <content styleCode="bold">Inactive ingredient:</content> glycerin, metacresol, trace amounts of phenol, tromethamine, zinc oxide (zinc ion), and Water for Injection, USP.<br/>Humalog<sup>®</sup> and Humalog KwikPen<sup>®</sup> are registered trademarks of Eli Lilly and Company.<br/>Manufactured by: Eli Lilly and Company, Indianapolis, IN 46285, USA, US License Number 1891<br/>Copyright © 2015, 2023, Eli Lilly and Company. All rights reserved.<br/>For more information, go to www.humalog.com or call 1-800-545-5979.
</td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>LOG200-0004-PPI-20230721
</paragraph>
               </text>
               <effectiveTime value="20230721"/>
            </section>
         </component>
         <component>
            <section ID="s96">
               <id root="a76c0c80-ba91-46d2-a24a-17d10661988d"/>
               <code code="59845-8" codeSystem="2.16.840.1.113883.6.1" displayName="INSTRUCTIONS FOR USE SECTION"/>
               <title>KwikPen U-200 Instructions for Use</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">INSTRUCTIONS FOR USE</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">HUMALOG (HU-ma-log) KwikPen</content>
                     <content styleCode="bold">
                        <sup>®</sup>
                     </content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">(insulin lispro)</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">injection, for subcutaneous use</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">3 mL single-patient-use pen (200 units per mL)</content>
                  </paragraph>
                  <renderMultiMedia ID="f99" referencedObject="mm99"/>
                  <renderMultiMedia ID="f100" referencedObject="mm100"/>
                  <paragraph>Read the Instructions for Use before you start taking HUMALOG<sup>®</sup> and each time you get another KwikPen<sup>®</sup>. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.
</paragraph>
                  <paragraph>
                     <content styleCode="bold">Do not share your HUMALOG KwikPen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.</content>
                  </paragraph>
                  <paragraph>HUMALOG KwikPen 200 units/mL (“Pen”) is a disposable single-patient-use prefilled pen containing 600 units of HUMALOG. You can give yourself more than 1 dose from the Pen. Each turn (click) of the Dose Knob dials 1 unit of insulin. You can give from 1 to 60 units in a single injection. <content styleCode="bold">If your dose is more than 60 units, you will need to give yourself more than 1 injection.</content> The Plunger only moves a little with each injection, and you may not notice that it moves. The Plunger will only reach the end of the cartridge when you have used all 600 units in the Pen.
</paragraph>
                  <paragraph>
                     <content styleCode="bold">Inject HUMALOG 200 units/mL only with your Pen. Do not transfer insulin from your Pen to a syringe. Syringes will not measure 200 units/mL insulin correctly. A severe overdose can result, causing very low blood sugar which may put your life in danger.</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">People who are blind or have vision problems should not use the Pen without help from a person trained to use the Pen.</content>
                  </paragraph>
                  <renderMultiMedia ID="f101" referencedObject="mm101"/>
                  <paragraph>
                     <content styleCode="bold">How to recognize your HUMALOG 200 units/mL KwikPen</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Pen color: Dark grey
</item>
                     <item>Dose Knob: Dark grey with burgundy ring on the end
</item>
                     <item>Label: Burgundy label with “200 units per mL (U-200)” in white stripe and a grey and burgundy checker board design.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Supplies needed to give your injection</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>HUMALOG KwikPen
</item>
                     <item>KwikPen compatible Needle (Becton, Dickinson and Company Pen Needles recommended)
</item>
                     <item>Alcohol swab
</item>
                     <item>Gauze
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Preparing your Pen</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Wash your hands with soap and water.
</item>
                     <item>Check your Pen to make sure you are taking the right type of insulin. This is especially important if you use more than 1 type of insulin.
</item>
                     <item>
                        <content styleCode="bold">Do not</content> use your Pen past the expiration date printed on the Label or for more than 28 days after you first start using the Pen.
</item>
                     <item>
                        <content styleCode="bold">Always use a new needle for each injection to help prevent infections and blocked needles. Do not reuse or share your needles with other people. You may give other people a serious infection or get a serious infection from them.</content>
                     </item>
                  </list>
                  <table width="100%">
                     <col width="50.000%" align="left"/>
                     <col width="50.000%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top" styleCode="Toprule">
                              <content styleCode="bold">Step 1:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Pull the Pen Cap straight off.<list listType="unordered" styleCode="Disc">
                                       <item>
                                          <caption>-
</caption>
                                          <content styleCode="bold">Do not</content> remove the Pen Label.
</item>
                                    </list>
                                 </item>
                                 <item>Wipe the Rubber Seal with an alcohol swab.
</item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Toprule">
                              <br/>
                              <renderMultiMedia ID="f102" referencedObject="mm102"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 2:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>
                                    <content styleCode="bold">Check the liquid in the Pen.<br/>
                                    </content>HUMALOG should look clear and colorless. <content styleCode="bold">Do not</content> use if it is cloudy, colored, or has particles or clumps in it.
</item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Botrule"/>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 3:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Select a new Needle.
</item>
                                 <item>Pull off the Paper Tab from the Outer Needle Shield.
</item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f103" referencedObject="mm103"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 4:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Push the capped Needle straight onto the Pen and twist the Needle on until it is tight.
</item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Botrule">
                              <renderMultiMedia ID="f104" referencedObject="mm104"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 5:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Pull off the Outer Needle Shield. <content styleCode="bold">Do not</content> throw it away.
</item>
                                 <item>Pull off the Inner Needle Shield and throw it away.
</item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f105" referencedObject="mm105"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">Priming your Pen</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Prime before each injection.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Priming your Pen means removing the air from the Needle and Cartridge that may collect during normal use and ensures that the Pen is working correctly.
</item>
                     <item>If you <content styleCode="bold">do not</content> prime before each injection, you may get too much or too little insulin.
</item>
                  </list>
                  <table width="100%">
                     <col width="49.950%" align="left"/>
                     <col width="50.050%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top" styleCode="Toprule Botrule">
                              <content styleCode="bold">Step 6:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>To prime your Pen, turn the Dose Knob to <content styleCode="bold">select 2 units</content>.
</item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Toprule Botrule">
                              <br/>
                              <renderMultiMedia ID="f106" referencedObject="mm106"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 7:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Hold your Pen with the Needle pointing up. Tap the Cartridge Holder gently to collect air bubbles at the top.
</item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f107" referencedObject="mm107"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 8:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Continue holding your Pen with Needle pointing up. Push the Dose Knob in until it stops, and “<content styleCode="bold">0</content>” is seen in the Dose Window. Hold the Dose Knob in and <content styleCode="bold">count to 5 slowly</content>.<br/>
                                    <br/>You should see insulin at the tip of the Needle.
											<list listType="unordered" styleCode="Disc">
                                       <item>
                                          <caption>-
</caption>If you <content styleCode="bold">do not</content> see insulin, repeat priming steps 6 to 8, no more than 8 times.
</item>
                                       <item>
                                          <caption>-
</caption>If you <content styleCode="bold">still do not</content> see insulin, change the Needle and repeat priming steps 6 to 8.
</item>
                                    </list>
                                 </item>
                              </list>Small air bubbles are normal and will not affect your dose.<br/>
                           </td>
                           <td align="center" valign="top" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f108" referencedObject="mm108"/>
                              <br/>
                              <renderMultiMedia ID="f109" referencedObject="mm109"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">Selecting your dose</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">This Pen has been made to deliver the dose that is shown in the Dose Window. Dial your usual dose as instructed by your healthcare provider.</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>You can give from 1 to 60 units in a single injection.
</item>
                     <item>If your dose is more than 60 units, you will need to give more than 1 injection.<list listType="unordered" styleCode="Disc">
                           <item>
                              <caption>-
</caption>If you need help with dividing up your dose the right way, ask your healthcare provider.
</item>
                           <item>
                              <caption>-
</caption>Use a new Needle for each injection and repeat the priming step.
</item>
                        </list>
                     </item>
                  </list>
                  <table width="100%">
                     <col width="50.000%" align="left"/>
                     <col width="50.000%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top" styleCode="Toprule Botrule">
                              <content styleCode="bold">Step 9:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Turn the Dose Knob to select the number of units you need to inject. The Dose Indicator should line up with your dose.<list listType="unordered" styleCode="Disc">
                                       <item>
                                          <caption>-
</caption>The Pen dials 1 unit at a time.
</item>
                                       <item>
                                          <caption>-
</caption>The Dose Knob clicks as you turn it.
</item>
                                       <item>
                                          <caption>-
</caption>
                                          <content styleCode="bold">Do not</content> dial your dose by counting the clicks. You may dial the wrong dose. This may lead to you getting to much insulin or not enough insulin.
</item>
                                       <item>
                                          <caption>-
</caption>The dose can be corrected by turning the Dose Knob in either direction until the correct dose lines up with the Dose Indicator.
</item>
                                       <item>
                                          <caption>-
</caption>The <content styleCode="bold">even</content> numbers (for example, 12) are printed on the dial.
</item>
                                       <item>
                                          <caption>-
</caption>The <content styleCode="bold">odd</content> numbers, (for example, 25) after the number 1, are shown as full lines.
</item>
                                    </list>
                                 </item>
                                 <item>
                                    <content styleCode="bold">Always check the number in the Dose Window to make sure you have dialed the correct dose.</content>
                                 </item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Toprule Botrule">
                              <br/>
                              <renderMultiMedia ID="f110" referencedObject="mm110"/>
                              <br/>
                              <renderMultiMedia ID="f111" referencedObject="mm111"/>(Example: 12 units shown in the Dose Window)<br/>
                              <br/>
                              <br/>
                              <renderMultiMedia ID="f112" referencedObject="mm112"/>(Example: 25 units shown in the Dose Window)
</td>
                        </tr>
                     </tbody>
                  </table>
                  <list listType="unordered" styleCode="Disc">
                     <item>The Pen will not let you dial more than the number of units left in the Pen.
</item>
                     <item>If you need to inject more than the number of units left in the Pen, you may either:<list listType="unordered" styleCode="Disc">
                           <item>
                              <caption>-
</caption>inject the amount left in your Pen and then use a new Pen to give the rest of your dose, <br/>
                              <content styleCode="bold">or</content>
                           </item>
                           <item>
                              <caption>-
</caption>get a new Pen and inject the full dose.
</item>
                        </list>
                     </item>
                     <item>It is normal to see a small amount of insulin left in the Pen that you can not inject. <content styleCode="bold">Do not transfer this to a syringe. Severe overdose can result.</content>
                     </item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Giving your injection</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Inject your insulin as your healthcare provider has shown you.
</item>
                     <item>Change (rotate) your injection sites within the area you choose for each  dose to reduce your risk of getting lipodystrophy (pits in skin or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the injection sites.
</item>
                     <item>
                        <content styleCode="bold">Do not</content> use the exact same spot for each injection.
</item>
                     <item>
                        <content styleCode="bold">Do not</content> inject where the skin has pits, is thickened, or has lumps.
</item>
                     <item>
                        <content styleCode="bold">Do not</content> inject where the skin is tender, bruised, scaly or hard, or into scars or damaged skin.
</item>
                     <item>
                        <content styleCode="bold">Do not</content> try to change your dose while injecting.
</item>
                  </list>
                  <table width="100%">
                     <col width="34.900%" align="left"/>
                     <col width="15.067%" align="left"/>
                     <col width="50.033%" align="left"/>
                     <tbody>
                        <tr>
                           <td colspan="2" align="left" valign="top" styleCode="Toprule Botrule">
                              <content styleCode="bold">Step 10:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Choose your injection site.<br/>HUMALOG is injected under the skin (subcutaneously) of your stomach area, buttocks, upper legs or upper arms.
</item>
                                 <item>Wipe your skin with an alcohol swab, and let your skin dry before you inject your dose.
</item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Toprule Botrule">
                              <br/>
                              <renderMultiMedia ID="f113" referencedObject="mm113"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" align="left" valign="top">
                              <content styleCode="bold">Step 11:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Insert the Needle into your skin.
</item>
                                 <item>Push the Dose Knob all the way in.
</item>
                              </list>
                           </td>
                           <td rowspan="3" align="center" valign="middle" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f115" referencedObject="mm115"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top">
                              <list listType="unordered" styleCode="Disc">
                                 <item>Continue to hold the Dose Knob in and <content styleCode="bold">slowly count to 5</content> before removing the Needle.
</item>
                              </list>
                           </td>
                           <td align="center" valign="top">
                              <br/>
                              <renderMultiMedia ID="f114" referencedObject="mm114"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Do not</content> try to inject your insulin by turning the Dose Knob. You will <content styleCode="bold">not</content> receive your insulin by turning the Dose Knob.
</td>
                        </tr>
                        <tr>
                           <td colspan="2" align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 12:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Pull the Needle out of your skin.<list listType="unordered" styleCode="Disc">
                                       <item>
                                          <caption>-
</caption>A drop of insulin at the Needle tip is normal. It will not affect your dose.
</item>
                                    </list>
                                 </item>
                                 <item>Check the number in the Dose Window<list listType="unordered" styleCode="Disc">
                                       <item>
                                          <caption>-
</caption>If you see “0” in the Dose Window, you have received the full amount you dialed.
</item>
                                       <item>
                                          <caption>-
</caption>If you do not see “0” in the Dose Window, <content styleCode="bold">do not</content> redial. Insert the Needle into your skin and finish your injection.
</item>
                                       <item>
                                          <caption>-
</caption>If you <content styleCode="bold">still</content> do not think you received the full amount you dialed for your injection, <content styleCode="bold">do not start over or repeat the injection.</content> Monitor your blood glucose as instructed by your healthcare provider.
</item>
                                       <item>
                                          <caption>-
</caption>If you normally need to give 2 injections for your full dose, be sure to give your second injection.
</item>
                                    </list>
                                 </item>
                              </list>The Plunger only moves a little with each injection, and you may not notice that it moves.<br/>If you see blood after you take the Needle out of your skin, press the injection site lightly with a piece of gauze or an alcohol swab. <content styleCode="bold">Do not</content> rub the area.<br/>
                           </td>
                           <td align="center" valign="top" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f116" referencedObject="mm109"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">After your injection</content>
                  </paragraph>
                  <table width="100%">
                     <col width="50.000%" align="left"/>
                     <col width="50.000%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top" styleCode="Toprule Botrule">
                              <content styleCode="bold">Step 13:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Carefully replace the Outer Needle Shield.
</item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Toprule Botrule">
                              <br/>
                              <renderMultiMedia ID="f117" referencedObject="mm117"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 14:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Unscrew the capped Needle and throw it away (see <content styleCode="bold">Disposing of Pens and Needles</content> section).
</item>
                                 <item>
                                    <content styleCode="bold">Do not</content> store the Pen with the Needle attached to prevent leaking, blocking the Needle, and air from entering the Pen.
</item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f118" referencedObject="mm118"/>
                           </td>
                        </tr>
                        <tr>
                           <td align="left" valign="top" styleCode="Botrule">
                              <content styleCode="bold">Step 15:</content>
                              <br/>
                              <list listType="unordered" styleCode="Disc">
                                 <item>Replace the Pen Cap by lining up the Cap Clip with the Dose Indicator and pushing straight on.
</item>
                              </list>
                           </td>
                           <td align="center" valign="top" styleCode="Botrule">
                              <br/>
                              <renderMultiMedia ID="f119" referencedObject="mm119"/>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>
                     <content styleCode="bold">Disposing of Pens and Needles</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>The used Pen may be discarded in your household trash after you have removed the needle.
</item>
                     <item>Put your used needles in a FDA-cleared sharps disposal container right away after use. <content styleCode="bold">Do not</content> throw away (dispose of) loose needles in your household trash.
</item>
                     <item>If you do not have a FDA-cleared sharps disposal container, you may use a household container that is:<list listType="unordered" styleCode="Disc">
                           <item>
                              <caption>-
</caption>made of a heavy-duty plastic,
</item>
                           <item>
                              <caption>-
</caption>can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out,
</item>
                           <item>
                              <caption>-
</caption>upright and stable during use,
</item>
                           <item>
                              <caption>-
</caption>leak-resistant, and
</item>
                           <item>
                              <caption>-
</caption>properly labeled to warn of hazardous waste inside the container.
</item>
                        </list>
                     </item>
                     <item>When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used needles and syringes. For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA's website at: http://www.fda.gov/safesharpsdisposal
</item>
                     <item>Do not dispose of your used sharps disposal container in your household trash unless your community guidelines permit this. Do not recycle your used sharps disposal container.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Storing your Pen</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Unused Pens</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Store unused Pens in the refrigerator at 36°F to 46°F (2°C to 8°C).
</item>
                     <item>
                        <content styleCode="bold">Do not</content> freeze your insulin. <content styleCode="bold">Do not</content> use if it has been frozen.
</item>
                     <item>Unused Pens may be used until the expiration date printed on the Label, if the Pen has been kept in the refrigerator.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">In-use Pen</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Store the Pen you are currently using at room temperature [up to 86°F (30°C)]. Keep away from heat and light.
</item>
                     <item>Throw away the HUMALOG Pen you are using after 28 days, even if it still has insulin left in it.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">General information about the safe and effective use of your Pen</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>
                        <content styleCode="bold">Keep your Pen and needles out of the sight and reach of children.</content>
                     </item>
                     <item>
                        <content styleCode="bold">Do not</content> use your Pen if any part looks broken or damaged.
</item>
                     <item>Always carry an extra Pen in case yours is lost or damaged.
</item>
                  </list>
                  <paragraph>
                     <content styleCode="bold">Troubleshooting</content>
                  </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>If you can not remove the Pen Cap, gently twist the cap back and forth, and then pull the cap straight off.
</item>
                     <item>If the Dose Knob is hard to push:<list listType="unordered" styleCode="Disc">
                           <item>
                              <caption>-
</caption>Pushing the Dose Knob more slowly will make it easier to inject.
</item>
                           <item>
                              <caption>-
</caption>Your Needle may be blocked. Put on a new Needle and prime the Pen.
</item>
                           <item>
                              <caption>-
</caption>You may have dust, food, or liquid inside the Pen. Throw the Pen away and get a new Pen.
</item>
                        </list>
                     </item>
                  </list>
                  <paragraph>If you have any questions or problems with your HUMALOG KwikPen, contact Lilly at 1-800-LillyRx (1-800-545-5979) or call your healthcare provider for help. For more information on HUMALOG KwikPen and insulin, go to <content styleCode="underline">www.humalog.com</content>.
</paragraph>
                  <paragraph>Manufactured by:<br/>Eli Lilly and Company<br/>Indianapolis, IN 46285, USA<br/>US License Number 1891
</paragraph>
                  <paragraph>
                     <content styleCode="italics">This Instructions for Use has been approved by the U.S. Food and Drug Administration.</content>
                  </paragraph>
                  <paragraph>Revised: July 2023
</paragraph>
                  <paragraph>
                     <renderMultiMedia ID="f120" referencedObject="mm120"/>
                  </paragraph>
                  <paragraph>Scan this code to launch (www.humalog.com)
</paragraph>
                  <paragraph>HUMALOG<sup>®</sup> and HUMALOG KwikPen<sup>®</sup> are trademarks of Eli Lilly and Company.
</paragraph>
                  <paragraph>Copyright © 2015, 2023, Eli Lilly and Company. All rights reserved.
</paragraph>
                  <table width="100%">
                     <col width="100.000%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top" styleCode="Toprule Botrule Lrule Rrule">
                              <content styleCode="bold">HUMALOG KwikPen</content> meets the current dose accuracy and functional requirements of ISO 11608-1.
</td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>LOGKP200-0005-IFU-20230721
</paragraph>
               </text>
               <effectiveTime value="20230721"/>
               <component>
                  <observationMedia ID="mm99">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u200-ifu-1-v4.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm100">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u200-ifu-2-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm101">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u200-ifu-3-v4.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm102">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u200-ifu-4-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm103">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u200-ifu-5-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm104">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u200-ifu-6-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm105">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u200-ifu-7-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm106">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u200-ifu-8-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm107">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u200-ifu-9-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm108">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u200-ifu-10-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm109">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u200-ifu-11-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm110">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u200-ifu-12-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm111">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u200-ifu-13-v3.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm112">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u200-ifu-14-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm113">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-inj-sites-v1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm114">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-5sec-clock.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm115">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u200-ifu-16-v2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm117">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u200-ifu-19-v3.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm118">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u200-ifu-20-v3.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm119">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-u200-ifu-21-v3.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm120">
                     <text>Figure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="humalog-QR.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="265f64b9-63d8-4aae-807e-1f4e783635d9"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>Insulin lispro</title>
               <text>
                  <renderMultiMedia referencedObject="lbl500901375"/>
               </text>
               <effectiveTime value="20250401"/>
               <component>
                  <observationMedia ID="lbl500901375">
                     <text>Label Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="lbl500901375.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="c6087dae-4aed-44bf-b4bf-349e6e5145f2"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>Insulin lispro</title>
               <text>
                  <renderMultiMedia referencedObject="lbl500901663"/>
               </text>
               <effectiveTime value="20250401"/>
               <component>
                  <observationMedia ID="lbl500901663">
                     <text>Label Image</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="lbl500901663.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>